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Seeking the Great White Bird of Absolute Truth 
 
from Alan G. MacDiarmid 
The Nobel Prize in Chemistry 2000 
The dependency of any one person's research on the labors of scores of earlier scientific 
pioneers is illustrated very beautifully by a few sentences of this variation from a book by 
Olive Schreiner, written at the turn of the century, entitled, "The Story of an African 
Farm." I would like to share with you this adapted portion. 
The story concerns a young hunter who, in his youth, heard about the great white bird of 
"absolute truth" which lived at the very top of a high mountain far in the east. He had 
spent all his life seeking it without success - and now he was growing old. 
The old thin hands cut the stone ill and jaggedly, for the fingers were stiff and bent. The 
beauty and strength of the man were gone. 
At last, an old, wizened, shrunken face looked out above the rocks. He saw the eternal 
mountains still rising to the white clouds high above him. 
The old hunter folded his tired hands and lay down by the precipice where he had worked 
away his life. 
"I have sought," he said, "for long years I have labored; but I have not found her. By the 
rough and twisted path hewn by countless others before me, I have slowly and 
laboriously climbed. I have not rested. I have not repined. And I have not seen her; now 
my strength is gone. Where I lie down, worn out, other men will stand, young and fresh. 
By the steps that I, and those before me, have cut, they will climb; by the stairs that we 
have built, they will mount. They will never know those who made them, their names are 
forgotten in the mists of time. At the clumsy work they will laugh; when the stones roll, 
they will curse us; but they will mount, and on our work they will climb, and by our stair! 
They will find her, and through us!" 
The tears rolled from beneath the shriveled eyelids. If truth had appeared above him in 
the clouds now, he could not have seen her, the mist of death was in his eyes. 
... Then slowly from the white sky above, through the still air, came something falling ... 
falling ... falling. Softly it fluttered down and dropped on to the breast of the dying man. 
He felt it with his hands – 





As I complete this dissertation, the great challenge of pursuing my doctoral 
degree, I find myself faced with the truly daunting task of expressing my gratitude to God 
and many people who have helped make a reality this experience. These are the people 
who have offered me their friendship, who have given me words of encouragement and 
strength when I was about to give up, who have shown me a smile at just the right 
moment, who have shared their expertise, their time, and their resources, selflessly, 
whenever and wherever I needed, and who have just simply shared with me in great and 
small ways, the highs and lows of my life, as a graduate student and as a brand-new mom. 
I owe a debt of gratitude to my wonderful Ph.D. mentors Dr. Paul F. Cook and Dr. 
Ann H. West, who have supervised me for the past four years. They are the people who 
gave me wings and made me fly. They have always supported me in all projects that I 
was involved in and have been an invaluable resource. Almost all of my knowledge about 
enzymology is from Dr. Cook, and that of X-ray crystallography is from Dr. West. 
Without their guidance and help, none of the results presented in this dissertation would 
have existed. They are unusual mentors in that they give me extensive independence and 
opportunities, always encourage me to ask, think, and explore. Their enthusiasm and 
diligence lead me on a journey to seek the great white bird of absolute truth. 
I am appreciative of the constructive criticism, continual encouragement, and 
sound advice from my graduate advisory committee members, Dr. George B. Richter-
Addo, Dr. Helen I. Zgurskaya, and Dr. David P. Nagle over the years. 
I am thankful for my past and present colleagues in the Cook and West research 
groups, particularly Dr. Fabiola Janiak-Spens, Dr. Stace Porter, Hui Tan, Dr. William 
Karsten, Dr. Lilian Chooback, Dr. Babak Andi, Dr. Ying Lin, Jinghua Qian, Rong Guan, 
Dr. Daniel Copeland, Dr. Xiaodong Zhao, Dr. Lei Li, Alla Kaserer, Deniz Aktas, Devi 
Ekanayake, Ashwani Vashishtha, and Francesca Speroni. It has been a genuine pleasure 
to work with each of them. I am also thankful for Jean Keil, Arlene C. Crawford, and 
Carol Jones for helping with all of the paperwork. 
 vi 
I appreciate all of the past and current students and faculty of the Biochemistry 
Division who have freely shared their knowledge and friendship with me, especially 
during Biochemistry seminars. I have learned a great deal and enjoyed knowing and 
interacting with each of them over the years. 
I want to dedicate this dissertation to my lovely husband Biao Liu who has 
absolutely convinced me that no star is out of reach. I thank him for all of his love and 
trust, for standing behind me all the time, for lifting me up when I could not reach my 
dream, for making me who I really am. I also want to thank my parents Fu Xu and Qilin 
Wen and my sister Shuyi Xu for their life-love and never-ending support. Last but not 
least, I give special thanks to my baby daughter, Sarah Liu, who brings me so much 
happiness and inspiration, who always amazes me and gives me strength. 
The research described in this dissertation is supported by a grant-in-aid from the 
Office of the Research and Administration at the University of Oklahoma (to P. F. C. and 
A. H. W.), the Grayce B. Kerr Endowment to the University of Oklahoma (to P. F. C.), 
and a grant (GM 071417) from the National Institutes of Health (to P. F. C. and A. H. 
W.). 
 vii 




LIST OF TABLES XI 
LIST OF FIGURES XII 
LIST OF SCHEMES XIV 
LIST OF ABBREVIATIONS XV 
ABSTRACT XVIII 
 
CHAPTER 1 INTRODUCTION 1 
1.1 L-lysine Biosynthesis and Catabolism 1 
1.1.1 Biosynthesis of L-lysine in bacteria and plants 1 
1.1.2 Biosynthesis of L-lysine in fungi 2 
1.1.3 L-Lysine Catabolism 3 
1.2 The α-Aminoadipate Pathway 4 
1.2.1 Significance of the α-Aminoadipate Pathway 8 
1.2.2 Regulation of the α-Aminoadipate Pathway 8 
1.2.2.1 Genetic Regulation 8 
1.2.2.2 Regulation of Enzyme Activity 10 
1.3 Enzymes of the α-Aminoadipate Pathway 12 
1.3.1 Homocitrate Synthase 12 
1.3.2 Homoaconitase 14 
1.3.3 Homoisocitrate Dehydrogenase 14 
1.3.4 α-Aminoadipate Aminotransferase 15 
1.3.5 α-Aminoadipate Reductase 16 
1.3.6 Saccharopine Reductase 18 
1.3.7 Saccharopine Dehydrogenase 19 
1.4 Saccharopine Dehydrogenase 20 
1.4.1 Pyridine Nucleotide-Linked Oxidative Deamination 20 
1.4.2 Expression and Purification of SDH 23 
1.4.3 Kinetic Mechanism of SDH 23 
1.4.4 Chemical Mechanism of SDH 24 
1.4.5 Substrate Specificity of SDH 25 
1.4.6 Structure and Sequence Allignment 26 
1.5 Summary 27 
 
CHAPTER 2 MATERIALS AND METHODS 29 
2.1 Chemicals 29 
2.2 Molecular Cloning, Cell Growth, and Protein Expression 30 
2.3 Enzyme Assays 31 
2.4 Initial Velocity Studies 32 
 viii 
2.4.1 Systematic Analysis 32 
2.4.2 Pairwise Analysis 33 
2.5 Determination of Keq and the Haldane Relationship 34 
2.6 Inhibition Studies 34 
2.6.1 Substrate Inhibition Studies 34 
2.6.2 Product and Dead-End Inhibition Studies 35 
2.6.3 Double Inhibition Studies 35 
2.7 pH profiles and pKi profiles 36 
2.8 Isotope Effect Studies 37 
2.8.1 Synthesis of A-side NADD 37 
2.8.2 Primary Substrate Deuterium Kinetic Isotope Effects 37 
2.8.3 Solvent Deuterium Isotope Effects and Proton Inventory Experiments 38 
2.8.4 Multiple Solvent/Substrate Deuterium Isotope Effects 39 
2.9 
1
H NMR Experiments 39 
2.9.1 Measurement of the Saccharopine Secondary Amine pKa by NMR 39 
2.9.2 Product Identification by NMR 40 
2.10 Data Analysis 41 
 
CHAPTER 3 EXPERIMENTAL RESULTS 45 
3.1 Protein Expression and Purification 45 
3.2 Kinetic Mechanism Determination of SDH 45 
3.2.1 Initial Velocity Studies: Systematic Analysis 45 
3.2.2 Initial Velocity Studies: Pairwise Analysis 48 
3.2.3 Determination of Keq 49 
3.2.4 Inhibition Studies: Substrate Inhibition 50 
3.2.5 Inhibition Studies: Product Inhibition 52 
3.2.6 Inhibition Studies: Dead-End Inhibition 53 
3.3 Chemical Mechanism Determination of SDH 56 
3.3.1 pKa of the Saccharopine Secondary Amine: Determination by NMR 56 
3.3.2 pH Dependence of Kinetic Parameters 57 
3.3.3 pH Dependence of the Ki for Oxalylglycine and Leucine 61 
3.3.4. Isotope Effects 62 
3.3.4.1 Primary Substrate Deuterium Kinetic Isotope Effects 62 
3.3.4.2 Solvent Deuterium Isotope Effects and Proton Inventory Studies 63 
3.3.4.3 Multiple Solvent/Substrate Deuterium Isotope Effects 64 
3.4 Substrate Specificity of SDH 64 
3.4.1 Initial Velocity Studies with NAD/NADH Analogues 64 
3.4.2 Inhibition Studies to Determine the Kinetic Mechanism with NADP 66 
3.4.3 Initial Velocity Studies with Keto Acid Substrate Analogues 66 
3.4.4 Confirmation of Product of Reaction with Alternative α-Keto Acid Substrates 
by 
1
H NMR 67 
3.4.5 Deuterium Kinetic Isotope Effects 68 
3.4.6 Dead-end Inhibition by NAD/NADH Analogues 68 
3.4.7 pH Dependence of the Ki for AMP 68 
3.4.8 Dead-end Inhibition by Keto Acid Analogues 71 
3.4.9 Dead-end Inhibition by Amino Acid Analogues 71 
 ix 
3.4.10 Double Inhibition Studies 74 
 
CHAPTER 4 DISCUSSION 75 
4.1 Kinetic Mechanism Determination of SDH 75 
4.1.1 Initial Velocity Studies 75 
4.1.2 Substrate Inhibition Studies 76 
4.1.3 Product Inhibition Studies 78 
4.1.4 Dead-end Inhibition Studies 80 
4.1.5 Quantitative Analysis of Dead-end Inhibition Data 84 
4.1.6 Previously Published Data 86 
4.2 Chemical Mechanism Determination of SDH 88 
4.2.1 Isotope Effects 88 
4.2.1.1 Primary Substrate Deuterium Kinetic Isotope Effects 88 
4.2.1.1.1 Substrate Dependence of Primary Deuterium Isotope Effects 90 
4.2.1.1.2 pH Dependence of Primary Deuterium Isotope Effects 91 
4.2.1.2 Solvent Deuterium Isotope Effects and Proton Inventory Studies 92 
4.2.1.3. Multiple Solvent/Substrate Deuterium Isotope Effects 93 
4.2.1.4. Proton Inventory Studies 94 
4.2.2 Interpretation of the pH Dependence of Kinetic Parameters 95 
4.2.3 Interpretation of pKi profiles 99 
4.2.4 Proposed Chemical Mechanism 100 
4.3 Substrate Specificity of SDH 103 
4.3.1. NAD/NADH Analogues 104 
4.3.1.1 Kinetic Mechanism with NADP/NADPH 104 
4.3.1.2 Substrate Analogues of NAD 106 
4.3.1.3 Inhibitory Nucleotide Analogues 106 
4.3.1.4 pH Dependence of the Ki for AMP 107 
4.3.2 Keto Acid Analogues 108 
4.3.2.1 Kinetic Mechanism with Pyruvate 108 
4.3.2.2 Substrate Analogues of Keto Acid 109 
4.3.2.3 Inhibitory Keto Acid Analogues 109 
4.3.3 Amino Acid Analogues 113 
4.3.3.1 Inhibitory Amino Acid Analogues 113 
4.3.4 Double Inhibition Studies 114 
4.4 Conclusion 115 
4.4.1 Kinetic Mechanism 115 
4.4.2 Chemical Mechanism 116 
4.4.3 Substrate Specificity and Binding Pockets 117 
 
APPENDIX I MULTIPLE SEQUENCE ALIGNMENTS 120 
 
APPENDIX II PRE-STEADY-STATE KINETIC, PHYSICAL, AND SPECTRAL 
PROPERTIES OF SDH 126 
II.1 INTRODUCTION 126 
II.2 MATERIALS AND METHODS 126 
 x 
II.2.1 Pre-Steady-State Study of SDH by Stopped-Flow Kinetic Experiment 126 
II.2.2 Determination of the Oligomerization State of SDH by HPLC 127 
II.2.3 Substrate Binding Study of SDH by Isothermal Titration Calorimetry 128 
II.2.4 Substrate Binding by Fluorescence Titration 128 
II.2.5 Secondary Structure Determination of SDH by Circular Dichroism 129 
II.3 RESULTS AND DISCUSSIONS 129 
II.3.1 Pre-Steady-State Study of SDH 129 
II.3.2 Size Exclusion Chromatography HPLC 131 
II.3.3 Substrate Binding by Isothermal Titration Calorimetry 132 
II.3.4 Substrate Binding by Fluorescence Titration 134 
II.3.5 Secondary Structure Determination of SDH by Circular Dichroism 135 
 
APPENDIX III CRYSTALLIZATION OF SDH 138 
III.1 INTRODUCTION 138 
III.2 MATERIALS AND METHODS 139 
III.2.1 Protein Sample Preparation 139 
III.2.2 Protein Crystallization 139 
III.2.3 Characterization of Crystals 139 
III.2.4 Ellman (DTNB) Assay 140 
III.3 RESULTS AND DISCUSSION 140 
III.3.1 Ellman (DTNB) Assay 140 
III.3.2 Protein Crystallization 141 
 
APPENDIX IV CLONING AND EXPRESSION OF PIPOX 145 
IV. 1 INTRODUCTION 145 
IV. 2 MATERIALS AND METHODS 146 
IV.2.1 Molecular Cloning of PIPOX 146 
IV.2.2 PIPOX Reaction Monitored by NMR 147 





LIST OF TABLES 
Table 1.1: Genes and Enzymes Involved in the α-Aminoadipate Pathway in S. cerevisiae. 
Table 3.1: Kinetic Parameters of Saccharopine Dehydrogenase at pH 7.0. 
Table 3.2: Inhibition Kinetic Constants for Product Inhibitors of SDH. 
Table 3.3: Inhibition Kinetic Constants for Dead-end Inhibitors of SDH. 
Table 3.4: Results of Saccharopine gCOSY Experiments. 
Table 3.5: pH Dependence of Kinetic Parameters for SDH from S. cerevisiae. 
Table 3.6: pH Dependence of Primary Deuterium Kinetic Isotope Effect for SDH. 
Table 3.7: Kinetic Parameters for Alternative Coenzyme Substrates of SDH. 
Table 3.8: Kinetic Parameters of SDH in the Saccharopine Formation Reaction Direction 
at pH 7.0. 
Table 3.9: Kinetic Parameters of SDH using Keto Acid Substrates at pH 7.0. 
Table 3.10: Isotope Effects for SDH at pH 7.0. 
Table 3.11: Inhibition Constants of NAD analogue inhibitors at pH 6.9. 
Table 3.12: Inhibition Constants of α-Kg Substrate Analogue Inhibitors at pH 7.0. 
Table 3.13: Inhibition Constants of Lysine Substrate Analogue Inhibitors. 
Table II.1: Estimated Physical Properties of SDHs by ProtParam Tool. 
Table III.1: Summary of Crystallization Conditions. 
Table III.2: Data-collection and Processing Statistics for SDH Crystals. 
 xii 
LIST OF FIGURES 
Figure 3.1.1: Systematic initial velocity studies of SDH in the saccharopine formation 
reaction direction at pH 7.0 – primary plots. 
Figure 3.1.2: Systematic initial velocity studies of SDH in the saccharopine formation 
reaction direction at pH 7.0 – secondary replots of double-reciprocal plots vs 
α-Kg concentration. 
Figure 3.1.3: Systematic initial velocity studies of SDH in the saccharopine formation 
reaction direction at pH 7.0 – tertiary replots of double-reciprocal plots vs 
lysine concentration. 
Figure 3.2: Pairwise analysis of the SDH oxidative deamination reaction. 
Figure 3.3: Determination of Keq of SDH reaction at pH 7.0. 
Figure 3.4: Competitive substrate inhibition by lysine against NADH. 
Figure 3.5: Substrate inhibition by α-Kg against NADH. 
Figure 3.6: S-parabolic noncompetitive inhibition by glutarate against NADH. 
Figure 3.7: pH dependence of the 
1
H NMR spectrum of saccharopine. 
Figure 3.8: pH dependence of kinetic parameters for the SDH reaction from S. cerevisiae 
in the direction of saccharopine formation. 
Figure 3.9: pH dependence of kinetic parameters for the SDH reaction from S. cerevisiae 
in the direction of lysine formation. 
Figure 3.10: pH dependence of the reciprocal of the inhibition constant for oxalylglycine 
(A) and leucine (B). 
Figure 3.11: pH dependence of primary substrate deuterium kinetic isotope effects of 
SDH. 
 xiii 
Figure 3.12: pH(D) profile of SDH. 
Figure 3.13: Proton Inventories for SDH. 
Figure 3.14: Structures of coenzyme analogues. 
Figure 3.15: pH dependence of the reciprocal of the inhibition constant for AMP. 
Figure 3.16: Structures of α-Kg and L-lysine analogues. 
Figure 3.17: Double inhibition by oxalylglycine and ornithine. 
Figure 4.1: Binding affinity of keto acid substrates against chain length from C3 and 
including the side chain carboxylate. 
Figure II.1: Spectra from rapid-scanning-stopped-flow kinetic experiments. 
Figure II.2: HPLC elution profile. 
Figure II.3: Titrations of SDH with substrates. 
Figure II.4: Fluorescence emission spectra of SDH. 
Figure II.5: Far-UV circular dichroism spectrum of SDH. 
Figure III.1: Four crystal forms of SDH. 
Figure IV.1: Enzymatic synthesis of saccharopine. 
Figure IV.2: 
1
H NMR spectra of PIPOX reaction. 
 xiv 
LIST OF SCHEMES 
Scheme 1.1: The enzymes of the lysine DAP biosynthetic pathway. 
Scheme 1.2: The enzymes of the lysine AAA biosynthetic pathway. 
Scheme 1.3: Proposed general chemical mechanism for amino acid dehydrogenases. 
Scheme 4.1: Schematic of the saccharopine-binding pocket to illustrate possible 
inhibition binding modes. 
Scheme 4.2: Proposed kinetic mechanism for SDH. 
Scheme 4.3: Proposed chemical mechanism for SDH. 
 xv 
LIST OF ABBREVIATIONS 
AAA                      α-aminoadipate acid 
AAS                       α-aminoadipate semialdehyde 
AcCoA                  acetyl CoA 
Amp                      amplicillin 
AMP                     adenosine 5'-monophosphate 
ADP                      adenosine 5'-diphosphate 
3-APAD                3-acetylpyridine adenine dinucleotide (the + charge is omitted for 
convenience) 
ATP                       adenosine triphosphate 
C                            competitive 
CD                         circular dichroism 
Ches                      2-(N-cyclohexylamino)ethanesulfonic acid 
2’,3’-cyclic NADP β-nicotinamide adenine dinucleotide 2’,3’-cyclic monophosphate (the  
+ charge is omitted for convenience) 
DAP                       diaminopimelate 
DCl                        deuterium chloride 
D2O                       deuterium oxide 
DTNB                    5,5’-dithiobis (2-nitrobenzoate) 
HCS                       homocitrate synthase 
Hepes                    N-(2-hydroxyethyl)piperazine-N’-(2-ethanesulfonic acid) 
IPTG                     isopropyl-β-D-1-thiogalactopyranoside 
ITC                        isothermal titration calorimetry 
 xvi 
kDa                       kilodaltons 
α-Kg                     α-ketoglutarate 
LB                         Luria-Bertani 
Mes                       2-(N-morpholino)ethanesulfonic acid, monohydrate 
NaOD                   sodium deuteroxide 
NAD(P)                 β-nicotinamide adenine dinucleotide (phosphate) (the + charge is  
   omitted for convenience) 
NADD                   reduced nicotinamide adenine dinucleotide with deuterium in the 4-A 
position 
NAD(P)H             reduced β-nicotinamide adenine dinucleotide (phosphate) 
NC                        noncompetitive 
NMN                    nicotinamide mononucleotide 
Ni-NTA                nickel-nitrilotriacetic acid 
NTB                      nitrothiobenzoate 
Mes                       2-(N-morpholino)ethane-sulfonic acid, monohydrate 
OAA                     oxaloacetate 
OG                        oxalylglycine 
3-PAAD               3-pyridinealdehyde adenine dinucleotide (the + charge is omitted for 
convenience) 
PCR                      polymerase chain reaction 
PDB                      protein data bank 
PEG                      polyethylene glycol 
PEGMME            polyethylene glycol monomethyl ether 
 xvii 
Sacc                      saccharopine 
SDH                     saccharopine dehydrogenase (L-Lys forming) 
SDS-PAGE          sodium dodecyl sulfate- polyacrylamide gel electrophoresis 
SOI                       slope of intercept 
SOS                      slope of slope 
SR                        saccharopine reductase 
Taps                     N-[tris(hydroxymethyl)methyl]-3-aminopropanesulfonic acid 
thio-NAD             thio-nicotinamide adenine dinucleotide (the + charge is omitted for 
convenience) 




The uniqueness of the α-aminoadipate (AAA) pathway for lysine biosynthesis in 
fungi makes it a target for the rapid detection and growth control of pathogenic yeasts 
and molds. Selective inhibition of the enzyme(s) of this pathway by (an) appropriate 
substrate analog(s) may control or eradicate the growth of fungal pathogens in vivo. 
Saccharopine dehydrogenase (SDH) catalyzes the reversible pyridine nucleotide-
dependent oxidative deamination of saccharopine to generate α-ketoglutarate (α-Kg) and 
lysine using NAD
+
 as an oxidizing agent, the final step in the AAA pathway. 
Kinetic data have been measured for SDH from Saccharomyces cerevisiae, 
suggesting the ordered addition of NAD
+ 
followed by saccharopine in the physiologic 
reaction direction. In the opposite direction, NADH adds to the enzyme first, followed by 
random addition of α-Kg and lysine. Lysine inhibits the reaction at high concentrations 
by binding to free enzyme. The α-Kg substrate inhibition and double inhibition by NAD
+
 
and α-Kg suggest the existence of an abortive E:NAD
+
:α-Kg complex. Saccharopine 
product inhibition suggests a practical irreversibility of the reaction at pH 7.0, in 
agreement with the overall Keq, and the existences of E:NADH:saccharopine and 
E:NAD
+
:saccharopine complexes. Dead-end inhibition studies are consistent with the 
steady-state random mechanism, and also suggest that the lysine-binding site has a higher 
affinity for keto acid analogues than does the α-Kg site or that dicarboxylic acids have 
more than one binding mode on the enzyme. S-parabolic noncompetitive inhibition of 
glutarate indicates the formation of a E:(glutarate)2 complex as a result of occupying both 
the lysine- and α-Kg-binding sites. The equilibrium constant for the reaction has been 
 xix 
measured at pH 7.0 as 3.9 x 10
-7
 M, in very good agreement with the Haldane 
relationship. 
A proton shuttle chemical mechanism is proposed on the basis of the pH 
dependence of kinetic parameters, dissociation constants for competitive inhibitors, and 
isotope effects. In the direction of lysine formation, once NAD
+
 and saccharopine bind, a 
group with a pKa of 6.2 accepts a proton from the secondary amine of saccharopine as it 
is oxidized, and then does not get involved until lysine is formed at end of the reaction. A 
general base with a pKa of 7.2 accepts a proton from H2O as it attacks the Schiff base 
carbon of saccharopine to form the carbinolamine intermediate. The same residue then 
serves as a general acid and donates a proton to the carbinolamine nitrogen. Collapse of 
protonated carbinolamine is then facilitated by the same group accepting a proton from 
the carbinolamine hydroxyl to generate α-Kg and lysine. The amine nitrogen is then 
protonated by the group that originally accepted a proton from the secondary amine of 
saccharopine, and products are released. In the saccharopine formation direction, finite 
primary deuterium isotope effects were observed for all parameters with the exception of 
V2/KNADH, consistent with a steady-state random mechanism and indicative of a 
contribution from hydride transfer to rate limitation. The observed solvent isotope effect 
indicates that proton transfer also contributes to rate limitation. A concerted proton and 
hydride transfer is suggested by multiple isotope effect, as well as a proton transfer in 
another step, likely hydrolysis of the carbinolamine. In agreement, dome-shaped proton 
inventories suggest that proton transfer exists in at least two sequential transition states. 
A number of NAD
+
 analogues, including NADP
+
, 3-acetylpyridine adenine 
dinucleotide (3-APAD
+




nicotinamide adenine dinucleotide (thio-NAD
+
), can serve as a substrate in the oxidative 
deamination reaction, as can a number of α-keto analogues, glyoxylate, pyruvate, α-
ketobutyrate, α-ketovalerate, α-ketomalonate, and α-ketoadipate in the opposite direction. 
Inhibition studies using nucleotide analogues suggest that the majority of the binding 
energy of the dinucleotides comes from the AMP portion, and that distinctly different 
conformations are generated upon binding of the oxidized and reduced dinucleotides. 
Addition of the 2’-phosphate as in NADPH causes poor binding of subsequent substrates, 
but has little effect on coenzyme binding and catalysis. In addition, the 10-fold decrease 
in affinity of 3-APAD in comparison to NAD
+
 suggests that the nicotinamide ring 
binding pocket is hydrophilic. Extensive inhibition studies using aliphatic and aromatic 
keto acid analogues have been carried out to gain insight into the keto acid binding 
pocket. Data suggest that a side chain with 3 carbons (from the α-keto group up to and 
including the side chain carboxylate) is optimal. In addition, the distance between the C1-
C2 unit and the C5 carboxylate of the α-keto acid is also important for binding; the α-oxo 
group contributes a factor of 10 in affinity. The keto acid binding pocket is relatively 
large and flexible, can accommodate the bulky aromatic ring of a pyridine dicarboxylic 
acid, and a negative charge at the C3 but not the C4 position. However, the amino acid 
binding site is hydrophobic and the optimal length of the hydrophobic portion of amino 
acid carbon side chain is 3 or 4 carbons. In addition, the amino acid binding pocket can 




1.1 L-lysine Biosynthesis and Catabolism 
L-lysine is an essential amino acid for humans and animals and can only be 
obtained from protein in the diet. It can be synthesized de novo in bacteria, lower 
eukaryotes, and some plants. Among the 20 common proteinogenic amino acids, L-lysine 
is the only one known to have two distinct biosynthetic pathways: the diaminopimelate 
(DAP) pathway in plants, bacteria and lower fungi, and the α-aminoadipate (AAA) 
pathway in euglenoids and higher fungi (1). Unlike the pathways for lysine synthesis, 
pathways for other amino acid synthesis are similar in bacteria and fungi (2, 3). 
1.1.1 Biosynthesis of L-lysine in bacteria and plants 
The DAP pathway is found in most plants, bacteria, and lower fungi, and consists 
of seven enzyme-catalyzed reactions (Scheme 1.1) (2, 4). It belongs to the aspartate 
family of amino acid biosynthesis with aspartate as the common precursor. This pathway 
is the source of the DAP and lysine that are incorporated into bacterial cell wall 
peptidoglycan and transpeptidative cross-linking. Enzymes in the DAP pathway are 
therefore targets for developing new antibacterial agents (5). 
The pathway begins with the phosphorylation of aspartate by aspartokinase to 
give aspartyl--phosphate followed by an NADPH-dependent reduction to give aspartate 
-semialdehyde. Aldol condensation of aspartate semialdehyde with pyruvate yields, 
upon rearrangement, 2,3-dihydrodipicolinate, which is then reduced by NADPH to 
2 
∆’piperideine-2,6-dicarboxylate. Succinylation (or acetylation) opens the ring to give N-
succinyl (or acetyl) α-amino-є-ketopimelate. After transamination, the acyl group is 
removed to yield L,L-DAP, which can be incorporated directly into the peptidoglycan, or 
racemized to the meso compound before incorporation. Racemization to the meso form is 

























































Scheme 1.1: The enzymes of the lysine DAP biosynthetic pathway are as follows: (1) 
Aspartate kinase (Ask, E.C.2.7.2.4), (2) Aspartate semialdehyde dehydrogenase (Asd, 
E.C.1.2.1.11), (3) Dihydrodipicolinate synthase (DapA, E.C.4.2.1.52), (4) 
Dihydrodipicolinate reductase (DapB, E.C.1.3.1.26), (5) Tetrahydrodipicolinate 
acyltransferase (DapD, E.C.2.3.1.117), (6) N-succinyl-α-amino-ε-ketopimelate-glutamate 
aminotransaminase (DapC, E.C.2.6.1.17), (7) N-acyldiaminopimelate deacylase (DapE, 
E.C.3.5.1.18, E. C. 3.5.1.47), (8) DAP epimerase (DapF, E.C. 5.1.1.7), (9) DAP 
decarboxylase (LysA, E. C. 4.1.1.20). 
 
1.1.2 Biosynthesis of L-lysine in fungi 
The presence of the α-aminoadipate (AAA) pathway for lysine biosynthesis has 
been demonstrated in several yeasts and molds, including Saccharomyces cerevisiae (6, 
7), Yarrowia lipolytica (8), Schizosaccharomyces pombe (9), Rhodotorula glutinis (10), 
Candida maltosa (11), Neurospora crassa (12) and Penicillium chrysogenum (13); 
human pathogenic fungi, such as Candida albicans (14), Cryptococcus neoformans (15), 
and Aspergillus fumigatus (15); and plant pathogens, including Magnaporthe grisea (2, 
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15). The enzymes from S. cerevisiae are highly similar to their closest homologs from C. 
albicans and A. fumigatus. Multiple sequence alignment shows greater than 60% identity 
for all but one (aminotransferase) of the enzymes in the pathway from those organisms. 
The AAA pathway is present only in euglenoids and higher fungi (3, 6, 16, 17), 
with α-ketoglutarate (α-Kg) serving as the precursor for L-lysine. The pathway is shown 
in Scheme 1.2. It is a member of the glutamate family of amino acid biosynthesis and 
resembles the pathway from glutamate to ornithine in bacterial arginine biosynthesis (18, 


































































Scheme 1.2: The enzymes of the lysine AAA biosynthetic pathway are as follows: (1) 
Homocitrate synthase (HCS, E.C. 4.1.3.21), (2) Homoaconitase (HAc, E.C. 4.2.1.36), (3) 
Homoisocitrate dehydrogenase (HIDH, E.C. 1.1.1.87), (4) -aminoadipate 
aminotransferase (AAT, E.C. 2.6.1.39), (5) -aminoadipate reductase (AAR, E.C. 
1.2.1.31), (6) Saccharopine reductase (SR, E.C. 1.5.1.10), (7) Saccharopine 
dehydrogenase (SDH, E.C. 1.2.1.31). 
 
1.1.3 L-Lysine Catabolism 
Lysine degradation is extremely varied in nature. In animals including humans, 
reversal of the yeast AAA pathway [lysine → saccharopine → α-aminoadipate-δ-
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semialdehyde (AAS) → AAA → α-ketoadipate → glutarate] is used for the catabolism of 
lysine (1, 3). Interestingly, animals and plants have a single saccharopine dehydrogenase, 
a bi-functional enzyme, which catalyzes both the saccharopine dehydrogenase (SDH) and 
saccharopine reductase (SR) reactions with NADP as the cofactor (20). The enzyme may 
result from gene duplication and fusion of the two fungal genes. Considering that animals 
and plants do not synthesize lysine but can degrade it, it is possible that the bifunctional 
enzyme has been adapted to the degradation of lysine, whereas separation of the SR and 
the SDH in fungi may make them better suited for lysine synthesis, perhaps allowing 
differential regulation. Both yeast and mammalian SDHs exhibit strict substrate 
specificity and inhibition by ornithine and leucine; however, they differ in their 
coenzyme specificity and molecular weight (3, 20). The evolutionary origin of the lysine 
biosynthetic pathway in yeast and the catabolic pathway in animals still remains a subject 
of great interest. 
The greatest diversity in the degradation of lysine is found in bacteria, yeasts, and 
molds (3). As an example, a survey of 28 yeast strains from several genera and species 
identified two lysine degradative pathways and resulted in separation of the organisms 
into three groups (21). The first of the pathways begins with formation of AAS by the 
action of either lysine 6-dehydrogenase or lysine 6-aminotransferase, whereas the second 
degradative pathway proceeds through a series of acetylated intermediates. 
1.2 The α-Aminoadipate Pathway 
The S. cerevisiae genome has been completely sequenced (22-24). Extensive 
genetic, enzymatic, and regulatory studies of the lysine biosynthetic pathway are being 
carried out in S. cerevisiae (14). Seven enzymes, eight steps and more than 12 nonlinked 
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genes are responsible for the biosynthesis of lysine in S. cerevisiae (5, 25, 26). Genes and 
their encoded enzymes involved in the AAA pathway are listed in Table 1.1, and the 
enzymatic steps are briefly described below. 
 





Homoaconitase LYS4 (LYS7) 
Homoisocitrate dehydrogenase LYS12 





Saccharopine reductase LYS9 (regulated by LYS14) 
Saccahropine dehydrogenase LYS1 
 
 
The first half of the pathway, formation of AAA from acetyl CoA (AcCoA) and 
α-Kg, takes place in the mitochondrion (27). The pathway is initiated by the homocitrate 
synthase (HCS)-catalyzed condensation of AcCoA and α-Kg to give the enzyme-bound 
intermediate homocitryl CoA, which is hydrolyzed by the same enzyme to give 
homocitrate. HCS catalyzes the first and committed step in the pathway, is highly 
regulated to economize the use of resources, and its reaction is thought to be the rate-
limiting step in the pathway. 
Homoaconitase (HAc), likely an enzyme containing an FeS cluster, catalyzes the 
interconversion of homocitrate and homoisocitrate via the intermediate homoaconitate. 
The enzyme is a member of the aconitase superfamily, which includes isopropylmalate 
isomerase (a member of the leucine biosynthetic pathway in bacteria and fungi) and 
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aconitases. This is the first documented evolutionary link between the AAA pathway in 
fungi and nonfungal organisms (28). 
The resulting homoisocitrate is then oxidatively decarboxylated by the pyridine 
nucleotide-linked homoisocitrate dehydrogenase (HIDH) to give α-ketoadipate. This 
enzyme belongs to the pyridine nucleotide-linked β-hydroxyacid oxidative decarboxylase 
family, which is a well-studied class of enzymes (29). 
α-Aminoadipate is then formed via a pyridoxal 5’-phosphate (PLP)-dependent 
aminotransferase (AAT) by using L-glutamate as the amino donor. Although the first half 
of the pathway takes place in the mitochondrion, the aminotransferase is thought to be 
present in both mitochondrion and cytoplasm. The aminotransferase reaction is also a 
branch point to secondary metabolism, including the de novo synthesis of β-lactam 
antibiotics. In addition, the product AAA can serve as the sole nitrogen source for 
Filobasidiella neoformans, S. pombe, C. albicans, and A. fumigatus (30). 
In the cytoplasm, the AAA reductase (AAR) then reduces AAA to AAS via an 
adenosylated derivative, a unique process involving both adenylation and reduction that 
is found only in fungi. However, this enzyme has to be activated by a 
phosphopantetheinyl transferase (PPT). This unique two component system represents a 
novel reaction in fungal amino acid metabolism. In addition, phylogenetic studies and 
BLAST results show that the AAR in fungal lysine synthesis is evolutionarily related to 
some bacterial antibiotic peptide synthetases (20). The reductase-catalyzed reaction is 
believed to be the key to evolution of fungal lysine synthesis (20). 
Once the semialdehyde is formed, it is condensed with glutamate, and the imine is 
reduced by NADPH to L-saccharopine (Sacc) catalyzed by SR. Finally, SDH catalyzes 
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the oxidative deamination of saccharopine to give L-lysine. It is of interest that 
saccharopine is a stable intermediate and pyridine nucleotides, rather than a vitamin B6-
dependent transamination of the semialdehyde is used by fungi. The last two enzymes 
have very little sequence homology at the amino acid level, but both enzymes are fungi 
specific and catalyze very similar reactions. Since NADPH and NADH are used as 
coenzymes by these two enzymes, respectively, a high NADPH-to-NADH ratio may 
favor the synthesis of lysine from AAS, whereas a low ratio would discourage such 
synthesis and favor the reverse reactions. 
The pathway occurs in two compartments. One of the reasons may be because of 
the availability of NAD(P)H and adenosine triphosphate (ATP), of allosteric regulators, 
or the proper environment to give the active site residues of the enzymes an optimum 
protonation state to catalyze the reactions involved along the pathway. The split between 
two compartments also may contribute to a better overall regulation of the whole 
pathway, or a secondary metabolic pathway. 
An AAA-like pathway is also found in Thermus thermophilus and Pyrococcus 
horikoshii (31, 32). However, this pathway is not the same as that found in fungi. The 
first half of the pathway is similar to that found in fungi, but AAA is first converted to N-
acetyl-α-aminoadipate, which is phosphorylated at the ε-carboxylate, and then 
reductively dephosphorylated to the ε-aldehyde. The aldehyde is then transaminated to N-
acetyl-L-lysine, which is deacetylated to give L-lysine (18, 20). In T. thermophilus, it has 
been recently reported that HAc catalyzes the reversible hydration of cis-homoaconitate 
to (2R, 3S)-homoisocitrate (135). However, no apparent “homocitrate dehydratase” 
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activity was observed for HAc, and the identity of the catalyst for this reaction is 
unknown. 
1.2.1 Significance of the α-Aminoadipate Pathway 
Several fungal alkaloids or peptides have lysine as a structural element or 
biosynthetic precursor. In addition, several AAA pathway intermediates are incorporated 
into secondary metabolites. The best example is AAA as an essential precursor for 
penicillins in the synthesis of ACV (L-δ-(α-aminoadipoyl)-L-cysteinyl-D-valine) 
tripeptide (1, 33). 
The uniqueness of the AAA pathway makes it a target for the rapid detection and 
control of pathogenic yeasts and molds. Selective inhibition of the enzyme(s) of this 
pathway by (an) appropriate substrate analog(s) may control or eradicate the growth of 
fungal pathogens in vivo (9, 14). To date, however, there are only a few novel compounds 
designed to target early steps in the pathway, specifically those steps involving the 
synthesis of (R)-homocitrate and (2R, 3S)-homoisocitrate (34). 
1.2.2 Regulation of the α-Aminoadipate Pathway 
The AAA pathway for the biosynthesis of lysine is highly regulated at the level of 
both enzyme synthesis and activity (6). 
1.2.2.1 Genetic Regulation 
The pathway is regulated by the general mechanism for the control of amino acid 
biosynthesis as well as a pathway-specific co-inducer-dependent transcriptional 
activation (27, 35-37). The co-inducer is AAS, which is an intermediate of the pathway 
(35). In S. cerevisiae, expression of the lysine genes can be stimulated by Lys14p in the 
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presence of its co-inducer AAS (35). Production of the co-inducer is also under the 
control of the metabolic flux mediated by feedback inhibition by lysine of the first 
enzyme in the pathway, HCS (38, 39). Thus, lysine can repress the expression of its 
biosynthetic genes. Excess lysine also acts as a repressor of six of the enzymes of the 
pathway (27, 40). Feller et al. (41) have proposed a mechanism to correlate these two 
types of regulation. Lysine inhibits its own biosynthesis by feedback inhibition of HCS, 
which decreases the concentration of AAS, and eliminates induction by Lys14p. 
Two unlinked genes, LYS9 (saccharopine reductase) and LYS14 (transcriptional 
activator), are required for the production of saccharopine in S. cerevisiae (25). Strains 
mutated in these genes accumulate AAS and show a significant reduction in SR activity. 
Mutation of LYS9 results in lysine auxotrophy and no reductase activity. Mutation of 
LYS14 causes yeast to grow slowly in the absence of lysine with a low level of reductase 
activity. Lys14p is required for the expression of the LYS9 gene, and it has a regulatory 
role with AAS as the co-inducer of transcriptional activation. Therefore, a low level of 
reductase activity in the LYS14 mutants is because of the weak expression of the LYS9 
gene in the absence of the semialdehyde coinduction (1, 35). 
Lys14p is a 90-kDa (790-amino acid) protein that participates in a complicated 
network of protein-protein interactions with 65 other proteins (Biomolecular Interaction 
Network Database; www.bind.ca). Lys14p contains a DNA binding domain similar to the 
Zn2Cys6 binuclear cluster of other fungal transcriptional activators such as Gal4p and 
Ppr1p (42, 43). Promoters of genes responding to this type of transcriptional activator 
usually contain an upstream activating sequence (UAS) that, in most instances, consists 
of two CGG triplets that are separated by a specific number of bases dependent on the 
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specific activator. In Gal4p and Ppr1p, the intervening sequence consists of 11 and 6 bp, 
respectively. These proteins bind as a dimer to the target sequence (UAS) with each of 
the zinc clusters binding to a CGG triplet (44-46). 
Using a deletion and insertion approach, a UAS responsible for binding Lys14p 
has been identified in the promoter regions of the LYS1 (SDH) and LYS9 (SR) genes from 
S. cerevisiae that differs slightly from the aforementioned consensus sequence (37). The 
UAS for the transcriptional activation of the LYS1 and LYS9 genes consists of a TCC and 
GGA triplet separated by 3 bp. One or several copies of this 9-bp sequence has been 
found in the promoter of at least four other LYS genes, including LYS20 (cytosolic HCS), 
LYS21 (mitochondrial HCS), LYS2 (AAR), and LYS4 (HAc). LYS5 (PPT), which does not 
respond to the Lys14p transcriptional activation, does not contain the UAS element (37). 
In S. cerevisiae, one cannot exclude the possibility that some other enzyme-
catalyzed step(s) may be rate-limiting step(s) and act in a manner similar to HCS in the 
regulation of lysine synthesis. For example, in P. chrysogenum, overexpression of HCS 
does not lead to an increase in AAA even in a strain in which the LYS2 gene, which 
encodes AAR, is disrupted. These results suggest the presence of at least one additional 
rate-limiting step between the HCS and the AAR catalyzed reactions (47). 
1.2.2.2 Regulation of Enzyme Activity 
The activity of HCS is highly regulated. It can be feedback inhibited by lysine, the 
end product of the pathway. The Ki for lysine inhibition of HCS in T. thermophilus and P. 
chrysogenum is only approx 9 μM (13), whereas in S. cerevisiae it is approx 40 μM (49). 
A Ki for lysine inhibition in S. cerevisiae from steady-state kinetic studies is 500 μM, 
which differs from its Kd value of 40 μM determined from fluorescence titration (49). 
11 
There are two conformers of HCS, one active, and the other less active, with lysine 
binding to the less-active conformer of the free enzyme. Although lysine behaves as a 
competitive inhibitor, it binds to an allosteric site as indicated by HCS mutants that are 
still very active, even though they have lost sensitivity to lysine inhibition. 
The concentration of Na
+
 also influences the activity of HCS, by binding to free 
enzyme (49). When the concentration of AcCoA is high and α-Kg is low, Na
+
 gives a 4-
fold activation of HCS. However, when the concentrations of AcCoA and α-Kg are low, 
Na
+
 is an activator at a low concentration, but an inhibitor at high concentration. This 
phenomenon is also observed with other metal ions. The inhibition is due to Na
+
 binding 
to the AcCoA site, whereas activation is because of Na
+
 likely binding to an allosteric site 
on free enzyme (not the lysine site). On the basis of the effects of lysine and Na
+
 and 
given their physiological concentrations, the authors proposed that the concentration of α-
Kg would determine the flux through the lysine biosynthetic pathway. 
In P. chrysogenum, the synthesis of penicillin is regulated by lysine through the 
inhibition of HCS (50, 51), which results in a decrease in the concentration of α-
aminoadipic acid, the branch point for the biosynthesis of penicillin and lysine. The effect 
of lysine can be reversed by addition of aminoadipic acid and other intermediates of the 
pathway such as α-ketoadipate and homocitrate. The inhibition by lysine in S. cerevisiae 
is linear (49), whereas it is partial in P. chrysogenum (13). It’s been suggested that the 
partial inhibition is essential for maintaining a steady-state level of AAA for penicillin 
production (52). 
The inhibition of HCS by lysine is pH dependent in P. chrysogenum (13). 
Inhibition could not be detected at pH 6.6 to 7.0, but at pH 8.0. In P. chrysogenum, the 
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cytosolic pH is controlled by a proton gradient, generated by a cytoplasmic membrane 
ATPase. A decrease in the ATP concentration will result in a decreased cytosolic pH and 
an increase in HCS activity, allowing the fungus to use intermediates from the lysine 
biosynthetic pathway to produce secondary metabolites. 
It’s also been reported that CoA, the product of the HCS reaction, can inactivate 
the enzyme from S. cerevisiae and this could be prevented by lysine and α-Kg (53-56). 
The inactive enzyme could not be reactivated by addition of AcCoA. 
 
1.3 Enzymes of the α-Aminoadipate Pathway 
1.3.1 Homocitrate Synthase 
HCS [3-hydroxy-3-carboxyadipate-2-oxoglutarate-lyase (CoA-acetylating); EC 



















Recent studies of the HCS from S. cerevisiae indicate it self-associates, and its 
native molecular weight has not yet been determined, although the majority of the 
activity is associated with lower molecular weight forms (15). Two isoenzymes of HCS 
were identified in S. cerevisiae, both of which could be inhibited by lysine (39). HCS is a 
Zn
2+
-metalloenzyme (57) and not stable as isolated. A solution containing 100 mM 
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guanidine hydrochloride, 100 mM α-cyclodextrin, and 600 mM ammonium sulfate has 
been used to stabilize the HCS from S. cerevisiae (15). 
An ordered Bi-Bi kinetic mechanism has been proposed for HSC with α-Kg 
binding to the enzyme first, followed by acetyl-CoA, and CoA released before 
homocitrate (58). A chemical mechanism of HCS has been proposed (57). α-Kg binds 
with its α-carboxylate and α-oxo groups coordinated to an active site Zn. AcCoA is then 
bound with its thioester oxygen hydrogen-bonded to an enzyme side chain and its methyl 
group in the vicinity of an enzyme residue that will function as a general base. The 
general base abstracts a proton from the methyl group of AcCoA, to generate the enol (or 
enolate). The C2 carbon will then carry out a nucleophilic attack on the carbonyl of α-Kg 
to give homocitryl-CoA likely facilitated by an enzyme general acid. It will attack the re-
face, and the resulting homocitryl-CoA is then hydrolyzed.  
Structure is currently not available for a HCS. However, HCS shares two 
conserved regions, signature patterns, with α-IPMS (59) for which a three-dimensional 
(3D) structure has been determined. The first of the conserved regions is 
(TXLRDGXQX10K) (where X is any amino acid), located near the N-terminus, and the 
second is [L/I/V/M/E]X2HXH[D/N]DXGX[G/A/S]X[G/A/S], located in the center of the 
HCS sequence. The two conserved histidines shown in bold are proposed to be involved 
in catalysis, and Copley et al. (60) propose that the HXH motif is involved in metal ion 
binding. Using the domain prediction program 3D-PSSM, circular dichroism spectra, and 
multiple sequence alignment, it is suggested that HCS has a (βα)8 TIM barrel domain at 
the N-terminal and a regulatory domain at its C-terminal (15, 60). 
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1.3.2 Homoaconitase 
Homoaconitase (EC 4.2.1.36) also known as homoaconitate hydratase, encoded 
by the LYS4 gene in S. cerevisiae, catalyzes the interconversion of homocitrate and 





















The enzyme is a member of the aconitase superfamily. It is a mitochondrial 
enzyme that is repressed by both lysine and glucose. The enzyme from Aspergillus 
nidulans is 55% sequence identical to that from S. cerevisiae, with the greatest similarity 
in the region attributed to binding of an FeS cluster (1). However, little is known of the 
mechanism of the enzyme, but its mechanism may be similar to that of aconitase (61). 
1.3.3 Homoisocitrate Dehydrogenase 
Homoisocitrate dehydrogenase (3-carboxy-2-hydroxyadipate dehydrogenase; EC 























Other than its sequence, almost nothing is known about the mechanism of this 
enzyme. Based on the general mechanism of the pyridine nucleotide-linked β-
hydroxyacid oxidative decarboxylases (29), the mechanism may be similar to that of 
isocitrate dehydrogenase (IDH) (62). Whether the enzyme requires a divalent metal ion to 
catalyze its reaction as does IDH will have to be determined. 
1.3.4 α-Aminoadipate Aminotransferase 
α-Aminoadipate aminotransferase (EC 2.6.1.39) is a PLP-dependent enzyme 
responsible for the conversion of α-ketoadipate to AAA by using L-glutamate as the 
amino donor and generating α-Kg as the second product (eq 1.4). The aminotransferase 
reaction is also a branch point to secondary metabolism, including the de novo synthesis 























In S. cerevisiae, two isozymes of the aminotransferase have been isolated (1, 63, 
64). Isozyme I is localized in the mitochondrion, is inhibited by α-Kg, and will utilize 
either L-glutamate or L-aspartate as the amino donor, but it exhibits only weak activity 
with AAA as the amino donor. Isozyme II is localized in the cytosol, has a strict 
requirement for L-glutamate as the amino donor, and is not inhibited by α-Kg. Neither 
isoform is inhibited by lysine, but the activity of isozyme II is repressed by AAA and 
slightly repressed by glucose. Only the cytosolic isoform seems to be specific for AAA 
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pathway. Its mechanism is expected to be ping pong on the basis of ample precedence 
from other aminotransferases, but its specific mechanism will have to await future studies. 
1.3.5 α-Aminoadipate Reductase 
α-Aminoadipate reductase (EC 1.2.1.31), also known as AAS dehydrogenase, 
catalyzes the reduction of  AAA to AAS in the cytoplasm, a unique reaction involving 

















On the basis of early investigations (65, 66), the AAR-catalyzed reaction is 
thought to be a three-step process, with the amino acid first reacting with ATP to form an 
adenylyl derivative, followed by the reduction of the adenylyl derivative of AAA by 
NADPH, followed by cleavage of the reduced adenylyl derivative of the amino acid to 
form AAS. The first and second steps require MgATP and NADPH, respectively, 
whereas the third step requires no co-factors. The product of the first step was 
successfully isolated and identified as a δ-5’-adenylyl-L-α-aminoadipate by 
Bhattacharjee’s group, whereas the product of the second step was too unstable to be 
identified (67). Formation of the δ-5’-adenylyl-L-α-aminoadipate, rather than 
phosphorylation of the substrate by ATP, makes this reaction a unique process. 
The enzymatic conversion of AAA to AAS requires expression of two genes in S. 
cerevisiae, LYS2 and LYS5. The reductase, encoded by LYS2, contains domains for ATP 
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hydrolysis, thioester formation with a 4-phosphopantetheine-binding consensus sequence, 
and an active site serine residue. The reductase is feedback inhibited by lysine and 
thialysine (1, 68). The active form of the reductase requires an additional activity 
catalyzed by Lys5p, a member of the PPT family (69). It has recently been shown that 
Lys5p is a posttranslational modification catalyst, which uses coenzyme A (CoASH) as a 
cosubstrate to phosphopantetheinylate Ser880 of AAR, activating it for catalysis (70). 
Thus, the PPT and AAR (Lys2p/Lys5p heterodimer) represent a two-component system 
with the transferase covalently priming the reductase, a novel mechanism for fungal 
amino acid-metabolizing enzymes. A human homolog of the AAR-PPT gene has been 
identified (71). The posttranslational activation of the LYS2 encoded AAR from C. 
albicans has also been investigated (72). 
A mechanism for the reductase from S. cerevisiae has been proposed by Walsh’s 
group (70). The reductase is first activated by phosphopantetheinylation using the 
transferase. The activated reductase then catalyzes the adenylation of the δ-carboxylate of 
AAA via the adenylation (A) domain, followed by acyl transfer of the aminoadipoyl 
moiety to the thiol of the phosphopantetheine to generate the thioester of the 
phosphopantetheinyl cleavage protein domain. Hydrolysis of the MgPPi product of the 
adenylation reaction is used to drive the reaction toward the adenylated intermediate. The 
covalent thioester intermediate is reduced by NADPH to regenerate reduced 
phosphopantetheine and the final semialdehyde product. The latter reaction is similar to 
the reverse of the glyceraldehyde 3-phosphate dehydrogenase reaction. Each of the partial 
reactions of the overall reaction can be studied independently, but mechanistic details 
will have to await future studies. 
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The S. cerevisiae AAR is evolutionarily related to some of the bacterial antibiotic 
peptide synthetases (20). Multienzyme complexes also exist for adenylation and partner-
protein-specific posttranslational activation of nonribosomal peptide synthetases (NRPS) 
in the synthesis of antibiotics, e.g. bacitracin, cyclosporine, penicillin, and vancomycin 
(69). However, the yeast AAR has two unusual features as a nonribosomal peptide 
synthetase type catalyst, an unusual organization with a reductase domain fused down-
stream of the prototypic adenylation/peptidyl carrier protein domains, and an unusual 
regiospecific activation of its amino acid substrate (70). Nonetheless, the homology of 
adenylation and posttranslational modification of AAR to those of NRPS suggests the 
reductase-catalyzed reaction is the key to the evolution of fungal lysine synthesis. The 
link between AAR and NRPS may be useful for the design of antifungal agents because 
Lys2p and Lys5p are essential for fungal growth. 
1.3.6 Saccharopine Reductase 
Saccharopine reductase (EC 1.5.1.10), also known as aminoadipate semialdehyde-
glutamate reductase or saccharopine dehydrogenase [N
6
-(L-1,3-dicarboxypropyl)-L-
lysine:NADP oxidoreductase (L-glutamate-forming)], is the penultimate enzyme of the 
AAA pathway for lysine biosynthesis (3, 12, 73). The enzyme catalyzes the synthesis of 
saccharopine via the reversible condensation of AAS with L-glutamate by using NADPH 
as the reducing agent (eq 1.6). 
The structure of SR in the apo form from S. cerevisiae has been solved (74). The 
polypeptide chain of the SR folds into three domains. The first domain is a variant of the 
dinucleotide-binding Rossmann fold (75) that binds to NADP or NADPH. The second 
domain is an α/β fold known as the SR fold. This domain consists of a central seven-
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stranded mixed β-sheet. The third domain is an all-helical domain that moves upon 





























A chemical mechanism can be written using the general mechanism for amino 
acid dehydrogenases. An imine is formed by attack of the α-amine of glutamate on the δ-
aldehyde of AAS, likely facilitated by a general acid-base catalyst. Reduction of the 
imine then gives the product saccharopine. A second possibility involves the cyclic imine 
formed by attack of the α-amine of AAS on its δ-aldehyde. In this case, the α-amine of 
glutamate attacks the imine carbon in a transimination reaction, generating the same 
imine intermediate. Similar acid-base chemistry is used, but the physical rearrangement 
to generate the common imine may not be accommodated in the SR active site. The 
conformation of saccharopine as bound in the E:NADPH:saccharopine structure from M. 
grisea favors the first possibility (76). In addition, the principle of microscopic 
reversibility requires the imine be formed as the product in the reverse reaction, which is 
unlikely. Nevertheless, this mechanism cannot be ruled out at present. 




lysine forming); (EC 1.5.1.7)] is the last enzyme in the AAA pathway for lysine 
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biosynthesis. It catalyzes the reversible pyridine nucleotide-dependent oxidative 
deamination of saccharopine to generate α-Kg and lysine using NAD as an oxidant, as 
























1.4 Saccharopine Dehydrogenase 
1.4.1 Pyridine Nucleotide-Linked Oxidative Deamination 
The overall reaction catalyzed by SDH place it in the class of pyridine nucleotide-
linked amino acid oxidoreductases. Enzymes in this class include amino acid 
dehydrogenases such as L-glutamate (GluDH), L-leucine (LeuDH), L-alanine (AlaDH), 
and L-phenylalanine (PheDH) dehydrogenases. They catalyze the reversible oxidative 
deamination of an amino acid to its keto acid and ammonia with the concomitant 





NAD(P) NH4 HH2O C
O
R COO
++ + + + NAD(P)H (1.8)
 
 
The kinetic mechanism reported for most amino acid dehydrogenases is ordered 
with coenzyme bound first and released last. Among amino acid dehydrogenases, AlaDH 
and GluDH are the two most extensively studied enzymes. A chemical mechanism 
consistent with data obtained for these two enzymes is shown in Scheme 1.3. The bound 
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amino acid is first oxidized by NAD(P) to an imine. A general base, usually an imidazole 
side chain, activates water to attack the imine to form a carbinolamine intermediate. The 
hydroxyl of the carbinolamine is deprotonated, resulting in the expulsion of ammonia, 





























Scheme 1.3: Proposed general chemical mechanism for amino acid dehydrogenases. 
 
For the AlaDH reaction, a combination of 
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N, solvent deuterium, and primary 
deuterium isotope effects suggested rate limitation at limiting substrate concentration is 
shared by all of the chemical-steps, oxidization of amino acid to imine, imine formation, 
and carbinolamine formation (78). The overall AlaDH reaction, i.e. at saturating reactant 
concentrations, is limited by the release of reduced nucleotide. In agreement with this 
suggestion, AlaDH and GluDH both exhibit substrate inhibition, resulting from formation 
of a dead-end ternary E:NAD(P)H:amino acid complex (79, 80). Only when alternative 
dinucleotides or substrates were used for AlaDH or GluDH did hydride transfer 
contribute to limitation under V conditions. The pro-S (B side) stereospecificity of 
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hydride transfer is highly conserved among amino acid dehydrogenases, with notable 
exceptions being L-alanine dehydrogenase (81, 82), L-lysine ε-dehydrogenase (83), and 
meso-DAP dehydrogenase (84), which are  pro-R (A side) specific. In addition, SDH is 
pro-R specific (85, 86). 
3-D structures are available for Glu (87), Leu (88), Ala (89), Phe (90), and meso-
DAP dehydrogenases (84). Among them, meso-DAP dehydrogenase is unique in that it 
catalyzes the oxidative deamination of a D-amino acid. All structures share very high 
similarity in that they have the same quaternary structure, similar active sites, and 
identical residues involved in catalysis with one exception, i.e. AlaDH. A subunit is 
composed of large N- and C-terminal domains that are separated by a deep cleft 
containing the active site (84, 87, 88). One of the domains (usually C-terminal) contains 
the “Rossmann fold”, providing binding interactions for the pyridine nucleotide, whereas 
the other domain binds the amino acid. In addition, a conformational transition exists 
from an “open” to a “closed” form upon binding of substrates or inhibitors in the amino 
acid binding site (84, 87). However, a combination of amino acid substitutions and subtle 
main chain movement in the substrate side-chain binding sites linked to the quaternary 
structure account for differences in substrate specificity seen within this family of 
enzymes (91). These changes are also expected in the SR and SDH structures. 
In contrast, the structure of AlaDH, obtained from the Phormidium lapideum and 
Bacillus stearothermophilus (89) is structurally different, with a subunit structure, 
identity of residues in the dinucleotide binding fold, and active site location similar to the 
D-2-hydroxyacid dehydrogenases and component dI of transhydrogenase (89). In all of 
these enzymes, a histidine residue acts as the acid-base catalyst activated by an adjacent 
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glutamate or aspartate carboxyl group, whereas the substrate carbonyl group is polarized 
by hydrogen bonding to the guanidinium group of an arginine or the amino group of a 
lysine residue. The substrate carboxyl group is anchored by interactions with either the 
guanidinium group of a second arginine or with two main chain NH groups (89). 
1.4.2 Expression and Purification of SDH 
A monomeric subunit structure was reported for the enzyme from S. cerevisiae 
with a molecular weight of 39,000 Da (92). It is a basic protein with a pI of 10.1, and is 
stable for months at -20 °C at concentrations greater than or equal to 0.1 mg/ml and a pH 
of 5.0-8.0 (92). It contains four cysteine residues but no disulfide bonds, and one binding 
site for reactants per molecule of enzyme (93). The LYS1 gene has been cloned from C. 
albicans (14) and S. pombe (94). 
1.4.3 Kinetic Mechanism of SDH 
The overall reaction catalyzed by SDH is reversible. The S. cerevisiae enzyme has 
pH optimum of 10.0 in the direction of lysine formation and 7.0 in the direction of 
saccharopine formation (1, 95). The Km values for NAD, saccharopine, lysine, α-Kg, and 
NADH were estimated as 0.1, 1.7, 2, 0.55, and 0.089 mM, respectively (1). An ordered 
Bi-Ter kinetic mechanism was proposed for the SDH with NAD binding first, followed 
by saccharopine, and products released in the order of lysine, α-Kg, and NADH (1, 96, 
97). Because all substrates must add to the enzyme before any product is released, the 
enzyme may be considered to have separate binding sites for the coenzyme, keto and 
amino substrates. With pyruvate as a substrate, data also suggest an ordered Ter-reactant 
mechanism in the direction of ε-N-(L-propionyl-2)-L-lysine formation, but with the order 
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NAD, ε-N-(L-propionyl-2)-L-lysine, pyruvate, lysine, and NADH (98). The reversal in 
the release of lysine and the keto acid suggests that there may be a randomness in 
substrate binding. 
1.4.4 Chemical Mechanism of SDH 
SDH is a pro-R specific for hydride transfer from C-2 of the saccharopine glutaryl 
moiety to the nicotinamide ring of NAD (85, 86). A series of chemical modification 
experiments suggested the presence of essential cysteine (93), histidine (99), lysine (100), 
and arginine residues (101) that may be involved in substrate binding and/or catalysis. 
A chemical mechanism of the SDH has been proposed on the basis of pH-rate 
profiles and product and dead-end inhibition studies (86). Saccharopine is first oxidized 
to ε-glutariminyl-L-lysine. A general base then activates water for attack to form a 
carbinolamine intermediate, which collapses to give the products, L-lysine and α-Kg by 
using general acid, general base chemistry. 
In the direction of saccharopine formation, the pH dependence of V/KLys exhibits a 
pK of 6.3 for a group that must be unprotonated, and a pK of 8.0 for a group that must be 
protonated for activity (86). Temperature and solvent perturbation studies are consistent 
with these groups being histidines. The V/Kα-Kg pH profile exhibits a single pK of 8.4 for a 
group that must be protonated for α-Kg binding (86). In the direction of saccharopine 
cleavage, the V/KSacc pH profile shows two pK values of 6.0 and 7.1 that must both be 
unprotonated for catalysis and/or binding of saccharopine (86). Although the mechanism 
proposed is certainly consistent with the data, studies are incomplete and the identity of 
the groups involved is based on the observed pK values, their temperature dependence, 
and chemical modification studies; all are notoriously inaccurate. 
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1.4.5 Substrate Specificity of SDH 
SDH from S. cerevisiae shows very strict substrate specificity with respect to its 
amino acid and keto acid substrates (102). Only pyruvate has been observed as an 
alternative substrate in the direction of ε-N-(L-propionyl-2)-L-lysine formation (103). In 
addition, the enzyme exhibits a high degree of coenzyme specificity (102, 104). It does 
use NADPH as a poor substrate, but with a much lower affinity compared to NADH (95). 
Furthermore, binding of NADPH causes an increase in the Km values for α-Kg and lysine 
(95). Coenzyme fragments, such as AMP, ADP, ADP-Ribose, and ATP, inhibit the 
enzyme activity, but no inhibition is observed by adenine, 3’-AMP, 2’-deoxy-5’-AMP, 
IMP, GMP, pyrimidine nucleotides, NMN
+
, and NMNH (95). Data suggest that the AMP 
moiety of NAD is responsible for the majority of the binding energy. The lack of 
inhibitory effect of 2’-deoxy-5’-AMP and low affinities of NADPH suggest that the 
interaction of the oxygen at the 2’ position of the adenosine moiety with the enzyme is 
important in binding (95). No binding of lysine or α-Kg to free enzyme was detected. 
Several pyridine nucleotide dehydrogenases that have an ordered kinetic 
mechanism exhibit substrate inhibition. SDH was reported to exhibit inhibition by high 
concentrations of α-Kg and lysine in the direction of saccharopine formation, but not by 
saccharopine in the oxidative direction (105). 
Hydrophobic amino acids with five and six carbon atoms, leucine, norleucine, and 
norvaline, were potent inhibitors, whereas branched chain isomers, valine, isoleucine, and 
α-aminobutyrate inhibited weakly, and no inhibition was observed by aspartate, 
glutamate, or AAA (96). It appears that a hydrophobic interaction between the side chain 
of an amino acid and the enzyme is important in binding the amino acid reactant. 
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Inhibition observed with keto acid analogues was more complicated. Noncompetitive 
inhibition was observed with OAA, pyruvate, α-ketobutyrate, α-ketovalerate, and α-
ketocaproate, whether NADH, α-Kg, or lysine was the varied substrate, inconsistent with 
the proposed kinetic mechanism. Data suggested combination of the dead-end inhibitors 
with more than one enzyme form, but this aspect will have to await future studies. 
1.4.6 Structure and Sequence Allignment 
In S. cerevisiae, Y. lipolytica, and C. albicans, an 11-amino acid active site 
peptide, GRCGSGALIDL, has been identified that is thought to originate from the 
Rossmann fold responsible for the binding of the adenosine moiety of NADH (106). In 
the Rossmann fold, the Gly is strictly conserved to eliminate steric hindrance in binding 
the ribose ring, and the terminal Glu (Asp) is conserved because of its function in 
hydrogen bonding the 2’-OH of the adenosine ribose. 
Multiple sequence alignment indicates SDH has a similar sequence in three fungi 
(C. albicans, Y. lipolytica, and S. pombe), four animals (Caenorhabditis elegans, Mus 
musculus, Homo sapiens, and Bos Taurus), one plant (Zea mays), and nine prokaryotes 
(20). Construction of a phylogenetic tree indicates SDH and prokaryotic L-AlaDH have a 
common ancestor (20). L-AlaDH, catalyzes the NADH-dependent reversible reductive 
amination of pyruvate to L-alanine and is the key factor in the assimilation of L-alanine 
as an energy source via the tricarboxylic acid cycle during sporulation in Bacillus spp. 
The structure of L-AlaDH has been solved (89), and sequence alignment of it and SDH 
shows that the residues involved in the active site of AlaDH, Arg15, His95, and Lys74, 
are highly conserved in SDH. 
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1.5 Summary 
Although mechanistic precedence for each of the enzyme-catalyzed reactions 
discussed above in the AAA pathway is available, none of the mechanisms of the 
enzymes in the first half of the pathway is known with any certainty. However, some 
information is available for enzymes in the second half of the pathway. A general 
mechanism has been proposed for the AAR (69), but all mechanistic detail is lacking. For 
the SR, only structural information is available, with virtually nothing known of its 
mechanism. Significant, but incomplete, mechanistic data have been collected for the 
SDH, but no structural information is available. Regulation of the pathway at the enzyme 
level is not completely clear and little is known about the mechanism of regulation. 
Our understanding of the AAA pathway for lysine synthesis at the molecular level 
has been increasing dramatically, together with a growth in genomic information. 
However, a complete understanding of the gene-enzyme relationship, mechanisms of the 
enzymes, regulation of the AAA pathway, and a comparative study of the cloned genes 
would help to gain an understanding of the functions of the biosynthetic and catabolic 
genes and enzymes. Knowledge gained using biochemical and molecular techniques with 
S. cerevisiae can be applied to pathogenic fungi to gain a basic understanding of the 
metabolism of fungal pathogens. Systemic fungal infections are among the most difficult 
infectious diseases to treat and are life-threatening for individuals who are immune-
suppressed, including those with AIDS and other autoimmune diseases, those undergoing 
chemotherapy, and those who have undergone a transplant. All of the presently available 
antifungal drugs have side effects, including nausea, vomiting, and diarrhea; toxicities, 
including hepatotoxicity and renal insufficiency; and drug interactions. It is thus 
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important to develop new antifungal drugs that are more effective and less toxic. The 
metabolic pathway for the biosynthesis of lysine in fungi is for the most part unique to 
these organisms, which has prompted speculation that the enzymes involved in the 
pathway may be viable targets for selective antifungal agents. Selective inhibition of the 
enzyme(s) by an appropriate substrate analog(s) may control the growth of fungal 
pathogens in vivo. Similarly, the novelty of several genes in the pathway may permit 
them to serve as a molecular marker to facilitate rapid identification of fungal pathogens. 
 
Preliminary mechanistic data have been collected for the SDH. However, the 
proposed kinetic mechanism was considered suspect because of the inconsistency of data, 
and chemical mechanism studies are incomplete. The identity of the groups involved in 
the reaction is based on the observed pKa values, their temperature dependence, and 
chemical modification studies, which are less than diagnostic. The specificity 
determinants for binding saccharopine are not clear, nor are those for substrate specificity 
in either the oxidative deamination or reductive amination reaction directions. In this 
dissertation, the kinetic and chemical mechanisms of SDH from S. cerevisiae have been 
fully determined, as well as the topography of the active site. Data are also discussed in 
terms of potential rate limiting steps along the reaction pathway. 
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CHAPTER 2 
MATERIALS AND METHODS 
2.1 Chemicals 
All chemicals were of the highest grade commercially available and were used 
without further purification. L-Saccharopine, L-lysine, D-lysine, L-ornithine, L-valine, L-
norvaline, L-methionine, L-leucine, L-isoleucine, L-asparagine, L-glutamine, L-arginine, 
adenosine, AMP, ADP, ADP-ribose, NMN, 3-APAD, 3-PAAD, thio-NAD, 2’,3’-cyclic 
NADP, α-Kg, pyruvate, glyoxylate, α-ketobutyrate (α-Kb), α-ketovalerate (α-Kv), α-
ketomalonate (α-Km), α-ketoadipate (α-Ka), malonate, oxaloacetate (OAA), adipate, 
glutarate, α-ketoisovalerate (α-Kiv), α-ketopimalate (α-Kp), pyridine 2,4-dicarboxylate, 
pyridine 2,3-dicarboxylate, pyridine 2,5-dicarboxylate, L-pipecolic acid, imidazole, 
chloramphenicol, yeast lactate, alcohol, and aldehyde dehydrogenases were obtained 
from Sigma. β-NAD(P)H, β-NAD(P), Luria-Bertani (LB) broth, and LB agar were 
purchased from USB. The Ni-NTA agarose resin was from Qiagen. Isopropyl-β-D-1-
thiogalactopyranoside (IPTG), SmaI, NdeI, BamHI, Platinum Pfx polymerase, and T4 
DNA ligase were from Invitrogen. Ampicillin (Amp) was from Fisher Biotechnologies. 
Oxalylglycine (OG) was from Frontier Scientific. Succinate and oxalate were from Fisher 
Scientific. Mes, Hepes, Ches, and Taps were from Research Organics, Inc. Deuterium 
oxide (D2O) (99 atom % D) and ethanol-d6 (99 atom % D) were purchased from 
Cambridge Isotope Laboratories, Inc. AG MP-1 and Bio-Gel P-2 resins were from Bio-
Rad. All other chemicals and reagents were obtained from commercial sources, were 
reagent grade, and were used without further purification. 
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2.2 Molecular Cloning, Cell Growth, and Protein Expression 
A 1154 bp DNA fragment encoding SDH was amplified by polymerase chain 
reaction (PCR) with 200 ng of yeast genomic DNA as the template using the following 
protocol: one cycle of initial denaturation at 94 °C for 2 min, followed by 35 cycles of 
denaturation at 94 °C for 45 s, annealing at 50 °C for 45 s, and extension at 72 °C for 3 
min. The enzyme used was Platinum Pfx polymerase, which produces blunt end PCR 
products. The pUC12 cloning vector was digested with SmaI to create a blunt-end linear 
vector that was gel purified. The purified Lys1 DNA was ligated into linearized pUC12 
vector. Escherichia coli DH5α cells were transformed with the plasmid, and single 
colonies were grown on LB/Amp medium. Plasmids from each clone were isolated, and 
restriction endonuclease mapping was carried out on the plasmids to confirm the presence 
of the insert. 
For subcloning into the expression vector, the Lys1 insert was excised from the 
pUC12-Lys1 plasmid with NdeI/BamHI restriction endonucleases and the digested 
plasmid was electrophoresed on a 1% agarose gel. The fragment containing the Lys1 gene 
was gel-purified and subcloned using T4 ligase into the pET16b expression vector, which 
was previously digested with NdeI/BamHI. E. coli BL21 (DE3) RIL cells were then 
transformed, and the new plasmid was designated sdhHX1. The entire gene was then 
sequenced at the Laboratory for Genomics and Bioinformatics of the University of 
Oklahoma Health Science Center in Oklahoma City, OK. 
The sdhHX1 plasmid-containing strain was grown at 37 °C in LB supplemented 
with 100 μg/mL amplicillin and 25 μg/mL chloramphenicol. Induction by 1 mM IPTG 
(final concentration) was accomplished once the OD600 reached 0.7-0.9. Cell growth was 
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then continued at 32 ºC overnight. After centrifugation, the harvested cells were 
suspended in 100 mM Hepes at pH 7.0 and sonicated on ice for 1.5 minutes, with a 15 s 
pulse followed by a 30 s rest, using a MISONIX Sonicator XL. After the cell debris was 
removed by centrifugation at 12000g for 15 min, the collected supernatant was mixed 
with the Ni-NTA resin at 4 ºC, washed with 20 mM imidazole at pH 7.0, and then eluted 
with buffer containing 300 mM imidazole at pH 7.0. The SDH-containing sample, 
identified by SDS-PAGE, was concentrated using an Amicon ultrafiltration device with a 
YM 10 membrane. Protein concentration was determined either by the Bradford method 
using bovine serum albumin as a standard or by the intrinsic enzyme absorbance at 280 




. The protein concentrations determined by the two 
methods were identical within error. 
2.3 Enzyme Assays 
The SDH-catalyzed oxidative deamination reaction was followed by monitoring 
the increase (or decrease) in absorbance at 340 nm as NAD(P) is reduced or NAD(P)H is 
oxidized, and by monitoring the increase in absorbance at 363, 358, and 395 nm as 3-
APAD, 3-PAAD, and thio-NAD are reduced, respectively, using a Beckman DU640 
UV/vis spectrophotometer. The following extinction coefficients were used for NAD(P)H, 


















All kinetic assays were carried out at 25 °C, and the temperature was maintained 
by a Neslab RTE-111 circulating water bath. A unit of enzyme activity is defined as the 
amount of enzyme catalyzing the production or utilization of 1 μmole of dinucleotide 
substrate analogs per min at 25 °C. Reactions were carried out in semi-micro quartz 
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cuvettes with a path length of 1 cm in a final volume of 1 or 0.5 ml containing 100 mM 
buffer (Mes, pH 5.5-6.8; Hepes, pH 6.8-8.2; Ches, pH 8.2-10.0) and variable 
concentrations of substrates as indicated below. Reactions were initiated by the addition 
of small amount (10 or 20 μL) of an appropriately diluted enzyme solution to a mixture 
that contained all other reaction components, and the initial linear portion of the time 
course was used to calculate the initial velocity. Because the diluted enzyme solution 
(protein concentrations less than 100 μg/mL) is not stable, 50% glycerol was added to the 
enzyme solution to minimize any activity loss, and the diluted enzyme solution was 
prepared fresh daily. 
2.4 Initial Velocity Studies 
2.4.1 Systematic Analysis 
The initial rate in the direction of saccharopine formation was measured as a 
function of NADH concentration (0.015-0.2 mM), different fixed concentrations of α-Kg 
(0.1-1 mM), and a fixed concentration of L-lysine (0.5 mM). The experiment was then 
repeated at several additional L-lysine concentrations (0.71-5 mM). Initial velocity 
studies were also carried out in the direction of saccharopine oxidation at pH 7.0. In this 
case, the initial rate was measured as a function of NAD
 
(0.2-2 mM) at different fixed 
levels of saccharopine (5-50 mM). The amount of enzyme used for each reaction in the 
direction of saccharopine oxidation was twice that used in the reverse reaction (final 
concentration 0.014 μM). 
When NADPH was used as the coenzyme in the direction of saccharopine 
formation, a systematic initial velocity study was performed at pH 7.0 in a similar manner 
as mentioned above. Briefly, the initial rate was measured as a function of the NADPH 
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concentration and at different fixed levels of α-Kg and a fixed concentration of lysine. 
The experiment was then repeated at different lysine concentrations. The concentration 
ranges for NADPH, α-Kg, and lysine are 0.05-0.3, 1-10, and 2-20 mM, respectively. 
Systematic initial velocity studies were also carried out when pyruvate served as the keto 
acid substrate. In this case, initial rates were measured as a function of the pyruvate 
concentration (5-50 mM) at different fixed levels of lysine (30-300 mM), with NADH 
fixed at 0.2 mM at pH 7.0. The amount of enzyme used for each reaction was 6.5 times 
that used in SDH reactions with the natural substrates. 
In the direction of saccharopine oxidation, initial rates were also measured as a 
function of the concentration of the coenzyme analogues, NADP, 3-APAD, 3-PAAD, and 
thio-NAD, respectively, with saccharopine fixed at 6 mM; the pH was maintained at 7.55 
or 9.2. Since the concentration of saccharopine used was relatively low (Km), the Kia of 
oxidized dinucleotides were obtained. In order to estimate the apparent Km values of the 
keto acid substrates, glyoxylate, α-Kb, α-Kv, α-Km, and α-Ka, initial rates were 
measured as a function of the concentration of keto acid substrates, with NADH fixed at 
0.2 mM, and lysine at 20 or 40 mM, at pH 7.0. 
2.4.2 Pairwise Analysis 
Initial rates were measured varying one substrate at different fixed concentrations 
of a second and with the third substrate saturating. For example, the initial rate was 
measured as a function of NADH at several fixed levels of α-Kg and with lysine fixed at 
10Km. The fixed saturating concentrations of NADH, α-Kg, and L-lysine were 0.2 mM 
(5Km), 5 mM (20Km), and 12.5 mM (10Km), respectively. 
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2.5 Determination of Keq and the Haldane Relationship 
In a 1 mL reaction mixture, the concentrations of NADH, α-Kg, L-lysine, and 
saccharopine were fixed at 0.05, 0.1, 0.1, and 2.5 mM, respectively, and the concentration 
of NAD was varied over the range of 0.1-5 mM in separate reactions. The reaction was 
initiated by the addition of enzyme. The difference in A340 representing the displacement 
from equilibrium was plotted against the NAD concentration. The Keq is obtained using 
the concentrations given above and the concentration of NAD that gave a ∆A340 of 0 
according to eq 2.1. 
 
   
  nesaccharopiNAD
lysineKgαNADH L 
eqK                                                                                 (2.1) 
 
The Keq was also estimated from the Haldane relationship for a Bi-Ter kinetic 

















                                                                                               (2.2) 
2.6 Inhibition Studies 
2.6.1 Substrate Inhibition Studies 
Lysine substrate inhibition studies were carried out by measuring the initial rates 
as a function of the lysine concentration (5-200 mM), with the concentration of the other 
two substrates both fixed at their respective Km values. In the case of α-Kg substrate 
inhibition, the initial rates were measured as a function of the NADH concentration and 
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different fixed α-Kg concentrations (0.1-50 mM) and with the lysine concentration fixed 
at 6 times its Km value. 
2.6.2 Product and Dead-End Inhibition Studies 
Inhibition patterns were obtained by measuring the initial rate at different 
concentrations of one reactant, with the concentration of the other reactants fixed at 
different levels (see Tables and Figure Legends), and at different fixed concentrations of 
the inhibitor including zero. In all cases, an initial estimate of the Ki for the inhibitor was 
obtained by fixing the varied substrate at its Km value and varying the inhibitor 
concentration. The appKi is estimated by Dixon analysis, a plot of 1/v vs I, extrapolating 
to 1/v equal to 0, and dividing by 2. 
2.6.3 Double Inhibition Studies 
A double-inhibition study was performed to investigate the existence of the 
E:NAD:α-Kg dead-end complex. The initial rates were measured as a function of NAD 
(0-8 mM) at different fixed levels of α-Kg (20-50 mM), with the concentration of the 
other substrates, NADH and lysine, both fixed at their respective Km values. 
Double-inhibition studies were also performed to determine whether synergism of 
binding occurs between analogues of α-Kg and lysine. In the direction of saccharopine 
formation, initial rates were measured as a function of OG (0-0.2 mM) or pyridine 2,4-
dicarboxylic acid (0-4 mM), respectively, at different fixed levels of ornithine (0-15 mM), 
with the concentration of NADH maintained saturating (10Km), while α-Kg and lysine 
were maintained at their respective Km values. 
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2.7 pH profiles and pKi profiles 
In order to determine whether the kinetic mechanism changes with pH and to 
obtain estimates of the Km values of all of the substrates as a function of pH, initial 
velocity patterns were obtained at pH 5.5, 7.0, 8.0, 8.5, 9.5, in a same manner as 
described in Materials and Methods 2.4.1. Initial velocity studies were also carried out 
in the direction of saccharopine oxidation at the pH extremes (6.0 and 9.6). The pH 
dependence of V and V/K for all substrates was then obtained under conditions in which 
one substrate concentration was varied with the others maintained at saturation (≥ 10Km). 
At different pH, inhibition constants were obtained for inhibitors competitive with 
NADH, α-Kg, and lysine, respectively, at a fixed concentration of the other two 
substrates (Km) and different fixed levels of inhibitor including zero. 
The pH was maintained using the following buffers at ≥ 100 mM concentration: 
Mes 5.5-6.8; Hepes, 6.8-8.2; Ches; 8.2-10.0. Sufficient overlap was obtained upon 
changing buffers to determine whether the buffer effects the reaction (no effects were 
detected). The pH was recorded before and after initial velocity data were measured with 
changes limited to ≤ 0.1 pH unit. The enzyme is stable when incubated for 20 min over 
the pH range 5.5-9.8. pH profiles were then evaluated graphically for quality of data by 
plotting logV or log(V/K) against pH, while the inhibition profiles for AMP, OG, and 
leucine were evaluated by plotting log(1/Ki) against pH. 
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2.8 Isotope Effect Studies 
2.8.1 Synthesis of 4R-NADD (A-side) 
The 4R-NADD was prepared according to (107, 108). The reaction mixture 
contained 2.8 mM ethanol-d6, 5.6 mM NAD, 50 units of yeast alcohol dehydrogenase, 
and 100 units of yeast aldehyde dehydrogenase in 10 ml of 6 mM Taps, at pH 9.0 and 25 
C. The pH was adjusted to 9.0 with KOH throughout the reaction since protons are 
being produced and the reaction mixture is lightly buffered. The reaction was allowed to 
proceed overnight, several drops of CHCl3 were added to the mixture to quench the 
reaction, and the aqueous layer was adjusted to pH 10.0 with KOH and removed for ion-
exchange chromatography. The NADD eluted in a large single peak with baseline 
separation from NAD when eluted isocratically from an 4 x 25-cm AG MP-1 column 
with 1 M LiCl, pH 10.0. The reported ratio of absorbance at 260 and 340 nm for A-side 
NADD was 2.15 ± 0.05 (107). The ratio obtained for the sample prepared above is 2.2 ± 
0.05. The purified A-side NADD was concentrated by rotary evaporation at 25 C to 
about 5 mL. The concentrated solution was then desalted via a 1.6 x 60-cm Bio-Gel P-2 
column. The concentrations of NADH(D) stock solutions were adjusted 





2.8.2 Primary Substrate Deuterium Kinetic Isotope Effects 
Isotope effects were measured by direct comparison of initial velocities, with 




(V2/KLys) were obtained in triplicate by 
measuring the initial rate as a function of lysine concentration at saturating levels of 




(V2/Kα-Kg) were obtained in the 
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(V2/KLys) were also measured as a function of pH. 
Primary deuterium kinetic isotope effects were also measured for the reaction in 
which pyruvate replaced α-Kg by direct comparison of initial rates with NADH and 
NADD. The fixed concentrations used for NADH(D), pyruvate, and lysine are 0.2 mM 
(~3Km), 50 mM (~12.5Km), and 300 mM (~5Km), respectively. 
2.8.3 Solvent Deuterium Isotope Effects and Proton Inventory Experiments 
Initial velocities were measured in H2O and D2O. For rates measured in D2O, 
substrates (NADH, α-Kg and lysine) and buffers were first dissolved in a small amount of 
D2O and lyophilized overnight to remove exchangeable protons. The lyophilized powders 
were then dissolved in D2O to give the desired concentrations and the pD was adjusted 
using either DCl or NaOD. A value of 0.4 was added to pH meter readings to calculate 
pD (109). Data were obtained with lysine as the variable substrate at fixed concentrations 
(10Km) of NADH and α-Kg. The isotope effects were obtained by direct comparison of 
initial rates in H2O and D2O over the pH(D) range 6.6-8.3, around the pH-independent 
region of the V and V/K pH-rate profile. Reactions were initiated by adding 10 μL of 
enzyme solution in H2O, such that the final percentage of D2O is ca. 99%. 
In the direction of saccharopine formation, finite isotope effects were observed, 
and proton inventory experiments were carried out to measure the solvent deuterium 
kinetic isotope effects more accurately and estimate the number of proton(s) in flight in 
the rate-determining transition state(s) (110). V2 and V2/KLys were measured at pH(D) 7.1 
in 100% H2O, 25% D2O, 50% D2O, 75% D2O, and ~100% D2O with lysine as the 
variable substrate at a fixed concentration of NADH and α-Kg (10Km). 
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2.8.4 Multiple Solvent/Substrate Deuterium Isotope Effects 
The multiple isotope effect was obtained by direct comparison of initial rates in 
H2O and D2O with lysine varied and NADD and α-Kg fixed at 10Km. It was also 
measured by comparison of initial rates using NADH and NADD in D2O with lysine as 
the varied substrate. Rates were measured at pH(D) 7.1, the pH-independent region of the 
V and V/K pH-rate profile. 
Nomenclature. Isotope effects are expressed using the nomenclature developed 
by Northrop (111) and Cook and Cleland (112). Primary and solvent deuterium kinetic 
isotope effects are written with a leading superscript D and D2O; e.g., a primary 
deuterium isotope effect on V/K is written 
D
(V/K). Multiple isotope effects are written 
with a leading superscript to depict the isotope varied and a following subscript to depict 
the fixed isotope; e.g., a solvent deuterium isotope effect measured with A-side NADD 
would be written 
D2O
(V/K)D. A “sticky” substrate is one that reacts to give product as fast 
as or faster than it dissociates from the enzyme complex. 
2.9 
1
H NMR Experiments 
2.9.1 Measurement of the Saccharopine Secondary Amine pKa by NMR 
The pKa value of saccharopine was determined by measuring the 
1
H NMR 
chemical shifts of protons β to the secondary amine nitrogen of saccharopine as a 
function of pH at 21 C. Solutions in D2O of 20 mM saccharopine and 20 mM K2HPO4 
buffer were prepared. The solution was adjusted to different pD values (5.0-11.9) using 
either DCl or NaOD. All 1D and 2D NMR experiments were performed on a Varian 
Mercury VX-300 MHz spectrometer with a Varian 4-nuclei auto-switchable PFG probe. 
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1
H NMR spectra were collected using the PRESAT pulse sequence supplied by Varian, 
Inc. The spectra were collected with a sweep width of 1510.1 Hz, eight transients, and an 
acquisition time of 5.490 s and processed with 32K points resulting in a 0.09 Hz digital 
resolution. Assignment of chemical shifts was aided by gCOSY experiments. The 
gCOSY pulse sequence supplied by Varian, Inc., was used, and data were collected with 
1 transient and 128 increments. 
2.9.2 Product Identification by NMR 
When keto acid analogues were used as slow substrates, products were identified 
by measuring the 
1
H NMR chemical shifts of protons β to the secondary amine nitrogen 
of the new products at 21 C. Reaction mixtures containing 2 mM NADH, 20 mM keto 
acid analogues, and 2 mM lysine were prepared in 20 mM K2HPO4 buffer, and were 
adjusted to a pD value of 7.4 using either DCl or NaOD before SDH was added. The 
purified SDH was dialyzed against 20 mM K2HPO4 at pD 7.4. Once the enzyme was 
added, the reaction mixtures were kept at 4 ºC overnight, allowing sufficient time for the 
reaction to reach completion (monitored spectrophotometrically). Once the reactions 
were complete, several drops of CHCl3 were added to the mixtures to precipitate the 
enzyme, and sufficient heat acid-activated charcoal was then added to remove the 
dinucleotides. The remaining reaction mixtures were then analyzed by 
1
H NMR. All 
NMR experiments were performed on the same instrument mentioned above, and the 
spectra were collected with a sweep width of 4803.1 Hz, 8 transients, and an acquisition 
time of 1.998 seconds. 
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2.10 Data Analysis 
Initial velocity data were first analyzed graphically using double-reciprocal plots 
of initial velocities vs substrate concentrations and suitable secondary and tertiary plots. 
Data were then fitted using the appropriate equation as discussed below, using the 
Marquardt-Levenberg algorithm (113), supplied with the EnzFitter program from 
BIOSOFT, Cambridge, U.K. and the Fortran programs of Cleland (114). Kinetic 
parameters and their corresponding standard errors were estimated using a simple 
weighting method. 
Data obtained from the systematic initial velocity studies of SDH using natural 
substrates at different pH in the direction of saccharopine formation were fitted using eqs 
2.3 and 2.4 for a terreactant kinetic mechanism (115), while in the direction of 
saccharopine oxidation at different pH, data were fitted using eq 2.5. The three data sets 
obtained from the pairwise analysis in the direction of saccharopine formation were fitted 
using either eq 2.5 for a sequential mechanism or eq 2.6 with the constant term absent. 
Data conforming to competitive (C), noncompetitive (NC), or uncompetitive (UC) 
inhibition were fitted using eqs 2.7-2.9. Data for double inhibition by NAD/α-Kg were 
fitted using eq 2.10. Data for glutarate inhibition against NADH were fitted using eq 2.11. 
Data for V and V/K deuterium isotope effects were fitted using eq 2.12. Data obtained 
from systematic initial velocity studies using α-Kg substrate analogues in the direction of 
saccharopine formation, or using NADPH as the coenzyme substrate were fitted using eq 
2.13 for a terreactant kinetic mechanism. When NADP, 3-APAD, 3-PAAD, and thio-
NAD were used as coenzyme, respectively, in the direction of saccharopine oxidation, 
data were fitted using eq 2.14. When concentrations of pyruvate and lysine were varied at 
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a fixed NADH concentration, data obtained were fitted using eq 2.5 for a bireactant 
mechanism. Data for double inhibition studies by OG/ornithine and pyridine 2,4-
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In eqs 2.3-2.14, v and V are initial and maximum velocities, A, B, and C are 
substrate concentrations, I and J are inhibitor concentrations, and Ka, Kb, and Kc are 
Michaelis constants for substrates A, B, and C, respectively. In eqs 2.3 and 2.4, the 
constant and coef terms are products of kinetic constants that dependent on the kinetic 
mechanism and will be defined in the Discussion 4.1.1. In eq 2.5, Kia is the dissociation 
constant of A from the EA complex, while in eq 2.13, Kia, Kib, and Kic.are inhibition 
constants for A from EA, B from EAB, and C from EAC, respectively. In eqs 2.7-2.9, Kis 
and Kii represent inhibition constants for the slope and intercept, respectively. In eq 2.10, 
Ki and Kj are dissociation constants for EI and EJ complexes, respectively, and v0 is the 
rate in the absence of inhibitors and α is the interaction constant that estimates the 
influence of one inhibitor upon binding of the other. In eq 2.11, Kis is the average 
dissociation constant for glutarate from the E:glutarate and E:(glutarate)2 complexes, and 
all other terms are the same as defined above. In eq 2.12, Fi is the fraction of D2O in the 
solvent or deuterium label in the substrate, and EV/K and EV are the isotope effects minus 
1 on V/K and V, respectively. 
Data for pH-rate profiles that decreased with a slope of 1 at low pH and a slope of 
-1 at high pH were fitted using eq 2.15. Data for pH-rate profiles with a slope of 1 at low 
pH were fitted using eq 2.16, while data for pH-rate profiles with a slope of -1 at high pH 
were fitted using eq 2.17. Data for pH-rate profile that decreased with a slope of 2 at low 
pH were fitted using eq 2.18. In the direction of saccharopine formation, data for the logV 
pH-rate profile over the pH range 5.0-7.0 were fitted using eq 2.16, data for V for the pH 
44 
range 6.5-10.0 and data for the leucine pKi profile were fitted using eq 2.19, while data 
















































































































































































                                                                             (2.20) 
 
In eqs 2.15-2.20, y is the observed value of the parameter as a function of pH (V, V/K, or 
1/Ki), C is the pH-independent value of y, H is the hydrogen ion concentration, K1 and K2 
represent acid dissociation constants for enzyme or substrate functional groups important 
in a given protonation state for optimal binding and/or catalysis, and YL and YH are 




3.1 Protein Expression and Purification 
The expression of SDH is very high under conditions used to induce expression. 
After the enzyme is washed with 20 mM imidazole, it is eluted from the Ni-NTA column 
most efficiently by 300 mM imidazole, and the purity of the eluted SDH is about 98% by 
densitometric scanning (data not shown). The amount of purified enzyme obtained is 35-
40 mg from 200 mL cell culture (500 mg wet cell pellet). His-Tagged SDH is active and 
stable for months when kept at 4°C at concentrations ≥ 0.1 mg/mL and pH 7.0. 
3.2 Kinetic Mechanism Determination of SDH 
3.2.1 Initial Velocity Studies: Systematic Analysis 
Double-reciprocal initial velocity patterns in the direction of saccharopine 
formation were obtained by varying the concentration of NADH and α-Kg at different 
fixed concentrations of lysine. The crossover points for all double-reciprocal plots are to 
the left of the ordinate, Fig. 3.1.1. All of the initial velocity data were fitted to the 
equation for a fully random terreactant mechanism (eq 2.3) to determine which terms, if 
any, in the denominator of the rate equation were absent. Data were then fitted to eq 2.4, 
which describes a kinetic mechanism with ordered addition of A followed by random 
addition of B and C. Values of the kinetic parameters determined were identical to those 


























Figure 3.1.1: Systematic initial velocity studies of SDH in the saccharopine formation 
reaction direction at pH 7.0 -- primary plots. Double-reciprocal plots obtained upon 
varying the concentrations of NADH at different fixed levels of α-Kg (0.1 mM ■, 0.14 
mM ♦, 0.25 mM ▲, and 1 mM ●) and a fixed concentration of lysine (0.71mM (a), 1.25 
mM (b), and 5 mM (c)) were measured in 100 mM Hepes at pH 7.0 and 25°C. The points 





Figure 3.1.2: Systematic initial velocity studies of SDH in the saccharopine formation 
reaction direction at pH 7.0 -- secondary replots of double-reciprocal plots vs α-Kg 
concentration. (a) is the secondary slope replot, while (b) is the secondary intercept replot. 






































































Figure 3.1.3: Systematic initial velocity studies of SDH in the saccharopine formation 
reaction direction at pH 7.0 -- tertiary replots of double-reciprocal plots vs lysine 
concentration. (a) is slope of slope replot; (b) is intercept of slope replot; (c) is slope of 
intercept replot; and (d) is intercept of intercept replot. 
 
 
Initial rates were also obtained in the direction of saccharopine oxidation at pH 
7.0, as a function of the NAD concentration and different fixed levels of saccharopine. 
The pattern intersects to the left of the ordinate (data not shown). Estimates of all of the 
kinetic parameters in this reaction direction were obtained by fitting the data to eq 2.5 for 
a sequential mechanism. All kinetic parameters for both reaction directions are 
summarized in Table 3.1. Values of KNADH, KLys, and Kα-Kg are identical, within error, to 
























































































Table 3.1: Kinetic Parameters of Saccharopine Dehydrogenase at pH 7.0. 
 
Forward Reaction 
KNAD (mM) 0.9 ± 0.1 
KSacc  (mM) 6.7 ± 1.4 
KiNAD (mM) 1.1 ± 0.3 
V1/Et (s
-1



















KNADH (mM) 0.019 ± 0.002 
KLys (mM) 1.1 ± 0.2 
Kα-Kg (mM) 0.11 ± 0.03 
constant (mM)
3
 0.013 ± 0.002 
coef A (mM)
2
 0.71 ± 0.08 
V2/Et (s
-1
























varied substrate substrate inhibitor Ki (mM) inhibition pattern 
NADH L-lysine 27.8 ± 0.3 C 
NADH α-Kg 28 ± 7 UC 
 
3.2.2 Initial Velocity Studies: Pairwise Analysis 
To further define the kinetic mechanism, initial velocity patterns obtained by 
varying one substrate at different fixed concentrations of a second and with the third 
substrate saturating were obtained and are shown in Fig. 3.2A-C. An intersecting initial 
velocity pattern was observed for the α-Kg/lysine pair (Fig. 3.2A), while the NADH/α-
Kg and NADH/lysine pairs gave parallel patterns (Fig. 3.2B, C). Patterns are consistent 
with the ordered addition of NADH followed by the random addition of α-Kg and lysine. 
Kinetic parameters were obtained by fitting the data to eqs 2.5 and 2.6. Values of kinetic 








Figure 3.2: Pairwise analysis of the SDH oxidative deamination reaction. Double-
reciprocal plots obtained upon varying one substrate at different fixed concentrations of a 
second and with the third substrate saturating. Rates were measured in 100 mM Hepes at 
pH 7.0 and 25°C. (A) Initial velocity pattern obtained with the α-Kg/lysine pair with 
NADH at 0.2 mM (5KNADH). (B) Initial velocity pattern obtained for the NADH/α-Kg pair 
with lysine at 12.5 mM (10KLys). (C) Initial velocity pattern obtained for the 
NADH/lysine pair with α-Kg at 5 mM (20Kα-Kg). The points are experimental, while the 
solid lines are theoretical based on a fit to eq 2.5 in A and to eq 2.6 in B and C. 
 
3.2.3 Determination of Keq 
With all reactants, with the exception of NAD, fixed as discussed in Materials 
and Methods 2.5, the change in A340 (once the system has attained equilibrium after 
enzyme was added to the reaction mixture) was plotted against the NAD concentration. 
The ∆A340 is an indicator of displacement from equilibrium position (Fig. 3.3). The 
concentration of NAD
 
that gave a ∆A340 of 0 is about 0.5 mM. The Keq calculated using 
fixed concentrations of the other reactants and 0.5 mM NAD (eq 2.1) is 3.9 x 10
-7
 M, 
while the Keq calculated from the Haldane relationship is about 2.9 x 10
-7
























































Figure 3.3: Determination of Keq of SDH reaction at pH 7.0. The difference in A340 vs the 
NAD concentration (0.1-1.2 mM). The points are experimental, while the solid line is 
theoretical based on a fit to the equation for a straight line. 
 
3.2.4 Inhibition Studies: Substrate Inhibition 
When the initial rate was measured over a wide range of lysine concentrations (5-
200 mM), with the concentrations of the other two substrates fixed at their respective Km, 
the double-reciprocal plot exhibits substrate inhibition as the lysine concentration 
increases above 60 mM (Fig.3.4A). Inhibition by lysine vs NADH is competitive (Fig. 
3.4B). Substrate inhibition parameters are summarized in Table 3.1. 
The initial velocity pattern obtained with lysine at 6 times its Km and NADH 
varied at different fixed concentration of α-Kg exhibits substrate inhibition that is 
uncompetitive vs NADH (Fig. 3.5A). Data suggest the binding of α-Kg to the E:NAD 
complex. A double-inhibition experiment obtained with NADH and lysine fixed at their 
Km values and NAD and α-Kg varied is consistent with the formation of an E:NAD:α-Kg 
complex (Fig. 3.5B). The rate in the absence of inhibitors, v0, was 6.7 ± 0.2 μM/min. The 
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respectively. The interaction constant α was 0.12 ± 0.09, indicating synergism of binding 





Figure 3.4: Competitive substrate inhibition by lysine against NADH. (A) Plot of the 
reciprocal initial rate vs the lysine concentration, with the other substrates fixed at their 
respective Km. (B) Double-reciprocal plot exhibiting competitive substrate inhibition by 
lysine [100 mM (■), 200mM (♦), and 400 mM (▲)] vs NADH, with α-Kg fixed at its Km. 
Rates were measured in 100 mM Hepes at pH 7.0 and 25°C. The points are experimental, 





Figure 3.5: Substrate inhibition by α-Kg against NADH. (A) Uncompetitive inhibition by 
α-Kg vs NADH. The concentrations of α-Kg were 0.1 mM (■), 0.143 mM (♦), 0.25 mM 
(▲), 1 mM (●), 20 mM (□), and 50 mM (◊). The concentration of lysine is fixed at 5 mM. 
(B) Double inhibition by NAD and α-Kg. Plot of the reciprocal initial rate vs NAD 
concentration (0-8 mM) at different levels of α-Kg [20 mM (■), 30 mM (♦), 50 mM 
(▲)].The points are experimental, while the solid lines are theoretical based on a fit to eq 





































































































NAD 28 ± 8 107 ± 96 NC 
NAD Sacc (1.5Km) NADH 0.0032 ± 0.0004 -- C 
Sacc NAD
 
(Km) NADH 0.033 ± 0.003 0.0105 ± 0.0003 NC 
NAD Sacc (1.5Km) lysine 19 ± 3 33 ± 4 NC 
Sacc NAD
 
(Km) lysine 2.84 ± 0.06 -- C 
Sacc NAD
 
(20Km) α-Kg 6.0 ± 0.7 64 ± 6 NC 
 
 
3.2.5 Inhibition Studies: Product Inhibition 
Product inhibition data in both reaction directions are summarized in Table 3.2. In 
the direction of saccharopine formation, saccharopine is uncompetitive vs NADH and 
noncompetitive vs lysine and α-Kg, while NAD is competitive vs NADH and 
noncompetitive vs lysine and α-Kg. In the opposite direction, NADH is competitive vs 
NAD and noncompetitive vs saccharopine, while lysine is noncompetitive vs NAD and 
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competitive vs saccharopine. Product inhibition by α-Kg is only observed at high NAD 
concentrations (≥20Km), and it is noncompetitive vs saccharopine. 
3.2.6 Inhibition Studies: Dead-End Inhibition 
Inhibition by leucine, chosen as a dead-end analogue of lysine, was competitive 
vs lysine, uncompetitive vs NADH, and noncompetitive vs α-Kg. OG was chosen as a 
dead-end analogue of α-Kg, and it exhibited a competitive inhibition vs α-Kg, 
uncompetitive inhibition vs NADH, and noncompetitive vs lysine. OAA was also chosen 
as a dead-end analogue of α-Kg, but it is competitive vs lysine, and noncompetitive vs 
NADH and α-Kg. 
When glutarate is used as a dead-end inhibitor, it is competitive vs lysine and 
noncompetitive vs NADH and α-Kg. The secondary slope replot for glutarate inhibition 
vs NADH, however, is parabolic, while the intercept replot is linear, indicating S-
parabolic noncompetitive inhibition (Fig. 3.6A-C). 
Pyruvate is an alternative keto acid substrate but only when both lysine and 
pyruvate concentrations are very high. Under conditions where inhibition studies are 
carried out, pyruvate is treated as a dead-end α-Kg substrate analogue. Surprisingly, it 
shows competitive inhibition vs both lysine and α-Kg and uncompetitive inhibition vs 
















Figure 3.6: S-parabolic noncompetitive inhibition by glutarate against NADH. (A) 
Primary plot exhibiting the S-parabolic noncompetitive inhibition by glutarate [0 mM (■), 
0.5 mM (♦), 1 mM (▲), 1.5 mM (●), 2 mM (□), 3.5 mM (◊), and 5mM (∆)] vs NADH, 
with lysine and α-Kg fixed at their respective Km. (B) Secondary plot of the slope vs the 
glutarate concentration. (C) Secondary plot of the intercept vs the glutarate concentration. 
Rates were measured in 100 mM Hepes at pH 7.0 and 25°C. The points are experimental 
or from a graphical analysis, whereas the solid lines are theoretical based on the kinetic 








































































0.44 ± 0.03 






1.12 ± 0.26 
(0.64 ± 0.15) 
0.23 ± 0.02 







0.06 ± 0.02 






0.154 ± 0.004 
(0.070 ± 0.002) 
0.36 ± 0.01 






0.100 ± 0.002 
































glutarate 1.1 ± 0.2
b










glutarate 1.0 ± 0.1 2.3 ± 0.5 NC 
a
 The values in parentheses are the corrected values for the fixed substrates where 
applicable. 
b
 Average Ki for binding two molecules of glutarate to E. 
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3.3 Chemical Mechanism Determination of SDH 
3.3.1 pKa of the Saccharopine Secondary Amine: Determination by NMR 
1
H NMR spectra of saccharopine were obtained at pH 6.86 and referenced to 
HDO (4.68 ppm). Chemical shifts are as follows:  3.6 [t, 1H, J = 6.7 Hz, C(2)-H],  
[t, 1H, J = 5.8 Hz, C(8)-H],  2.9 [t, 2H, J = 7.9 Hz, C(6)-H2],  2.3 [t, 2H, J = 7.2 Hz, 
C(10)-H2],  1.95 [dd, 2H, J = 7.2, 5.8 Hz, C(9)-H2],  1.78 [m, 2H, C(3)-H2],  1.64 [p, 
2H, J = 7.9 Hz, C(5)-H2],  1.38 [m, 2H, C(4)-H2]. The 
1
H NMR chemical shifts of 
saccharopine were assigned by gCOSY at pH 6.86 and 11.9. The correlations at pH 6.86 
and 11.9 were identical. The correlations at pH 6.86 are listed in Table 3.4. 
 
Table 3.4: Results of Saccharopine gCOSY Experiments. 
 
Chemical Shift Correlation 
3.62  C(2)-H 1.78  C(3)-H2 
3.48  C(8)-H 1.95  C(9)-H2 
2.93  C(6)-H2 1.64  C(5)-H2 
2.26  C(10)-H2 1.95  C(9)-H2 
1.95  C(9)-H2 3.48  C(8)-H, 2.26  C(10)-H2 
1.78  C(3)-H2 3.62  C(2)-H, 1.38  C(4)-H2, 
1.64  C(5)-H2 2.93  C(6)-H2, 1.38  C(4)-H2 
1.38  C(4)-H2 1.78  C(3)-H2, 1.64  C(5)-H2 
 
The chemical shifts of peaks corresponding to C(2)-H, C(8)-H, and C(6)-H2 
changed significantly as the pD was increased (Fig. 3.7A). The largest changes were seen 
in C(8)-H and C(6)-H2 (reflecting the protons β to the secondary amine) which moved 
0.59 and 0.58 ppm, respectively, upfield as the pH was increased from 6.86 to 11.90. A 
plot of the chemical shift vs pH was used to estimate the pKa value of the secondary 
amine of saccharopine (Fig. 3.7B). Data were fitted by eq 2.19, which gave an estimated 
pKa of 10.5 ± 0.2. The pKa in H2O is 10.1 ± 0.2 [obtained by subtracting 0.4 (109)] in the 





Figure 3.7: pH dependence of the 
1
H NMR spectrum of saccharopine. (A) 
1
H NMR 
spectra of saccharopine measured at the indicated pH values. Chemical shifts are 
referrenced to the carbons of saccharopine. (B) pH dependence of the chemical shift of 
protons β to the secondary amine of saccharopine. Data are presented for the C(8)-H (■) 
and C(6)-H2 (▲) positions. (C) Structure of saccharopine with main chain atoms labeled. 
 
3.3.2 pH Dependence of Kinetic Parameters 
The pH dependence of kinetic parameters potentially provides information on the 
optimum protonation state of enzyme and/or reactant functional groups required for 
enzyme conformation, binding, and catalysis. To be certain the kinetic mechanism of the 
enzyme does not change with pH and to obtain estimates of the Km values of all of the 
substrates as a function of pH, initial velocity patterns and diagnostic dead-end inhibition 
patterns were obtained at pH 5.0, 7.0, 8.0, 8.5, and 9.5. In the direction of saccharopine 
formation, initial velocity patterns and leucine dead-end inhibition patterns are consistent 





















random addition of α-Kg and lysine at pH 7.0, and the mechanism also applies at pH 8.0. 
However, the mechanism changes at the pH extremes (5.0, 8.5, and 9.5) to an ordered 
one with NADH binding first, followed by rapid equilibrium addition of α-Kg before 
lysine. In the direction of lysine formation, initial velocity and dead-end inhibition 
patterns obtained at the pH extremes (6.0 and 9.6) are consistent with a sequential 
ordered mechanism in which NAD is the first substrate bound and saccharopine binds 
second (data not shown). 
The pH dependence of the kinetic parameters for SDH was determined, and the 
results are shown in Figs 3.8 and 3.9. In the direction of lysine formation, V1/Et and 
V1/KNADEt decrease at low pH with a limiting slope of +1, giving a pKa value of about 7.3 
- 7.4 (Fig. 3.8A, B), while V1/KSaccEt decreases at low pH with a limiting slope of +2, 
giving pKa values of 6.2 and 7.2 (Fig. 3.8C). The pKa of the saccharopine secondary 
amine is 10.1, outside the pH range used for the V1/KSaccEt pH-rate profile. NAD is the 
first reactant bound, and the pH dependence of V1/KNADEt (the on-rate constant for 
binding NAD) reflects a group important for binding NAD. Since NAD and saccharopine 
have no pKa values over the pH range that was studied, the pKa of 7.2-7.4 exhibited in 
V1/Et, V1/KNADEt, and V1/KSaccEt may reflect the same enzyme side chain important in 
catalysis and binding (see Discussion 4.2.2). The group on enzyme with the pKa of 6.2 in 
the V1/KSaccEt pH-rate profile likely contributes to the binding of saccharopine, since it is 
not observed in the V1/Et pH-rate profile. pKa values are summarized in Table 3.5. 
Estimates of the pH-independent values of the kinetic parameters are as follows: V1/Et, 
(9.5 ± 0.9) s
-1

















Figure 3.8: pH dependence of kinetic parameters for the SDH reaction from S. cerevisiae 
in the direction of saccharopine formation. Data were obtained at 25 °C for V1/Et (A), 
V1/KNADEt (B), and V1/KSaccEt (C). The points shown are the experimentally determined 
values, while the curves are theoretical based on fits of the data using eq 2.14 for V1/Et 
and V1/KNADEt, and eq 2.18 for V1/KSaccEt. 
 
Table 3.5: pH Dependence of Kinetic Parameters for SDH from S. cerevisiae. 
 
Parameter 
pKa ± SE 
Acid side Basic side 
V1 7.3 ± 0.2 -- 
V1/KNAD 7.4 ± 0.2 -- 
V1/KSacc 6.2 ± 0.3 
7.2 ± 0.2 
-- 
V2 5.8 ± 0.2 8.4 ± 0.5 
V2/KNADH -- 9.6 ± 0.2 
V2/Kα-Kg -- 8.9 ± 0.1 
V2/KLys 7.2 ± 0.5
a
 -- 











pKa for the EH complex. 
c 
pKa for the EH:leucine complex. 
 
In the reverse reaction direction, V2/Et decreases at low pH with a limiting slope 
of +1 giving a pKa value of about 5.8 and decreases at high pH to a new constant value 
exhibiting a pKa of about 8.4 (Fig.3.9A). The pKa of 5.8 suggests an enzyme group 
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important for catalysis, while the group with a pKa of about 8.4 suggests an enzyme 
group important, but not essential, for catalysis. The V2/KEt values for NADH and α-Kg 
both decrease at high pH with a slope of -1 giving pKa values of 9.6 and 8.9, respectively 
(Fig. 3.9B, C). V2/KNADH is the on-rate constant for NADH, and the pKa of about 9.6 
reflects a group on enzyme important for binding the reduced cofactor. (Note that the 
group with a pKa of 7.2 important for NAD binding is not observed in the V2/KNADHEt 
profile.) The V2/KEt for lysine exhibits a bell-shaped pH-rate profile, which decreases at 
low pH with a slope of +1 and at high pH with a slope of -1 (Fig. 3.9D). Because the 
difference in these two pKa values is less than 0.6, they were considered identical, and an 
average pKa of about 7.2 was estimated. pKa values are summarized in Table 3.5. The 
pH-independent values of kinetic parameters are as follows: V2/Et, (58 ± 3) s
-1
, 












, and V2/KLysEt, 









Figure 3.9: pH dependence of kinetic parameters for the SDH reaction from S. cerevisiae 
in the direction of lysine formation. Data were obtained at 25 °C for V2/Et (A), V2/KNADHEt 
(B), V2/Kα-KgEt (C), and V2/KLysEt (D). The points shown are the experimentally 
determined values, while the curves are theoretical based on fits of the data using eq 2.17 
for V2/KNADHEt and V2/Kα-KgEt and eq 2.15 for V2/KLysEt, while the V2/Et profile was fitted 
as described in Materials and Methods 2.10. 
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3.3.3 pH Dependence of the Ki for Oxalylglycine and Leucine 
The pH dependence of the dissociation constant for competitive inhibitors vs α-
Kg and lysine was determined in order to obtain an estimate of intrinsic pK value(s) of 
group(s) required for optimum binding of reactants. OG was utilized as a dead-end 
analogue of α-Kg to measure its pKi profile. At pH 5.45 and 9.58, it is competitive vs α-
Kg, and its pKi profile is shown in Fig. 3.10A. It shows an increase in its Ki as the pH is 
decreased below 6, and increased above 8. Over the pH range studied, leucine is a 
competitive inhibitor against lysine. Its pKi decreases from a constant value below pH 6 
to another constant value above pH 9.0 (Fig. 3.10B). A pKa of about 6.2 is estimated for 
the enzyme complex EH:NADH:α-Kg, and this pKa is perturbed to about 9.2 in the 
EH:NADH:α-Kg:leucine complex (Table 3.5). The pH-independent dissociation constant 
for leucine is 0.09 ± 0.01 mM for EH:NADH:α-Kg:leucine, and increases to 30 ± 6 mM 




Figure 3.10: pH dependence of the reciprocal of the inhibition constant for oxalylglycine 
(A) and leucine (B). The points shown are the experimentally determined values, while 
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3.3.4. Isotope Effects 
3.3.4.1 Primary Substrate Deuterium Kinetic Isotope Effects 
Primary deuterium kinetic isotope effects were measured by direct comparison of 
initial rates at pH 7.1 with A-side NADH(D) used as the labeled substrate. Finite effects 
were observed in all parameters, with the exception of V2/KNADH. 
D
V2 = 1.45 ± 0.07, 
D
(V2/KNADH) = 0.92 ± 0.08, 
D
(V2/Kα-Kg) = 1.9 ± 0.1, and  
D
(V2/KLys) = 1.56 ± 0.05. Isotope 
effects on V2 and V2/KLys were also obtained as a function of pH and are shown in Table 
3.6. Since the isotope effects tend to unity as the pH is increased, data are also plotted as 
the log(IE minus 1) (Fig. 3.11) to better estimate the pKa for the process. 
 







pH 5.6 1.20 ± 0.07 1.66 ± 0.12 
pH 6.1 1.44 ± 0.13 1.76 ± 0.10 
pH 7.1 1.45 ± 0.07 1.56 ± 0.05 
pH 7.9 1.3 ± 0.05 1.20 ± 0.08 





Figure 3.11: pH dependence of primary substrate deuterium kinetic isotope effects of 
SDH. Data were plotted as the logarithm of the isotope effect minus 1. (A) V2/KLys. (B) V2. 
The points shown are the experimentally determined values, while the curves are 







































3.3.4.2 Solvent Deuterium Isotope Effects and Proton Inventory Studies 
The pH(D) dependence of kinetic parameters was measured over the pH(D) range 
6.5-8.5 to determine whether a solvent deuterium kinetic isotope effect is observed on V2 




V2/KLys of 2.2 ± 0.1 and 1.9 ± 0.1, respectively. The pH(D) profile is shown in Fig. 
3.12. Proton inventories (110) measured at pH(D) 7.1 is shown in Fig. 3.13. The proton 
inventories can be described as dome-shaped or bulging upward for V2 and V2/KLys. The 
concavity is pronounced in the case of V2, and shallow in the case of V2/KLys. 
 
Figure 3.12: pH(D) profile of SDH. (A) log(V2/KLys) (B) log(V2). Kinetic parameters were 
obtained in H2O (■) and in D2O (▲). The points shown are the experimentally 
determined values, while the curves are drawn by eye. 
 
 
Figure 3.13: Proton Inventories for SDH. Solvent deuterium dependence of 
n
(V2) (A) and 
n
(V2/KLys) (B) (ratio of V2 and V2/KLys at n fraction of D2O to that at 99.9% D2O) on the 
fraction of deuterium (n) in solvent. Velocities were measured at pH(D)-independent 
value of 7.1 in 100% H2O, 25% D2O, 50% D2O, 75% D2O, and ~100% D2O. Points are 
experimental values, and curves are drawn by eye. The dotted line in B is theoretical for a 

























































3.3.4.3 Multiple Solvent/Substrate Deuterium Isotope Effects 
Multiple isotope effects allow one to determine whether two isotope effects 
reflect the same or different steps. A multiple kinetic deuterium isotope effect is obtained 
when A-side NADD is used in both H2O and D2O (80%) with 
D2O
(V2)D = 1.76 ± 0.08 and 
D2O
(V2/KLys)D = 1.86 ± 0.08. The multiple kinetic deuterium isotope effect obtained by 
using NADH(D) in D2O (90%) gives 
D
(V2)D2O = 1.50 ± 0.15 and 
D
(V2/KLys)D2O = 1.55 ± 
0.14. 
3.4 Substrate Specificity of SDH 
3.4.1 Initial Velocity Studies with NAD/NADH Analogues 
In the physiological reaction direction, NADP, 3-APAD, 3-PAAD, and thio-NAD 
all can serve as the oxidant in the oxidative deamination reaction, while in the reverse 
reaction direction, NADPH can substitute for NADH. In the direction of saccharopine 
oxidation, initial rates were obtained as a function of the concentrations of NAD 
analogues and fixed concentration of saccharopine (6 mM) at pH 7.55 and 9.2. Estimates 
of the kinetic parameters are provided in Table 3.7. 
Double-reciprocal initial velocity patterns in the direction of reductive amination 
using NADPH as the reductant were obtained by varying the concentrations of NADPH 
and α-Kg at different fixed concentrations of lysine at pH 7.0 and 25 ˚C. The crossover 
points for all double-reciprocal plots are to the left of the ordinate (data not shown). All 
of the initial velocity data were fitted to eq 2.13 for a terreactant mechanism. Substrate 
inhibition by α-Kg and lysine was observed as α-Kg and lysine concentration increased 
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above 50 mM and 100 mM, respectively (data not shown). Kinetic parameters are 
summarized in Table 3.8 and compared to data obtained previously with NADH (124). 
 
 
Table 3.7: Kinetic Parameters for Alternative Coenzyme Substrates of SDH. 
 
 Ki (mM) Vapp (μM/min) 
NAD 
1.1 ± 0.3 (Ki) 
a
 





2.3 ± 0.4 
b
 
5.7 ± 0.9 
c
 




8.9 ± 1.7 
b
 
8 ± 1 
c
 




0.88 ± 0.06 
b
 
2.1 ± 0.4 
c
 




0.48 ± 0.05 
b
 
0.6 ± 0.1 
c
 




value from reference at pH 7.0 (124). 
b 
data obtained at pH 7.55 and 
c 
data obtained at pH 9.2. 
 
 





Kcoenzyme (mM) 0.019 ± 0.002 0.48 ± 0.17 
Kα-Kg (mM) 0.11 ± 0.03 12 ± 4 
KLys (mM) 1.1 ± 0.2 22 ± 9 
Kicoenzyme (mM) 0.018 ± 0.004 0.04 ± 0.01 
Kiα-Kg (mM) 0.6 ± 0.1 6.0 ± 1.4 
KiLys (mM) -- 9.4 ± 2.0 
V/Et (s
-1





) (1.6 ± 0.2) x 10
6







) (2.8 ± 0.7) x 10
5







) (2.5 ± 0.4) x 10
4











NAD NADH 1.56 ± 0.03
 a
 C 
NADP NADPH 3.5 ± 0.6 C 
L-leucine NADPH 5.6 ± 0.3 UC 
L-leucine NADH
 b
 69 ± 2 UC 
a 
value from reference at pH 7.0 (124); 
b 




3.4.2 Inhibition Studies to Determine the Kinetic Mechanism with NADP 
In the direction of saccharopine formation, product inhibition by NAD is 
competitive vs NADH. Similarly, product inhibition by NADP is competitive vs NADPH 
when NADPH serves as the coenzyme, while dead-end inhibition by leucine (lysine 
analogue) is uncompetitive vs NADPH. 
3.4.3 Initial Velocity Studies with Keto Acid Substrate Analogues 
In addition to pyruvate, five keto acids have been identified as alternative 
substrates for the SDH-catalyzed reaction in the direction of saccharopine formation. 
These include glyoxylate, α-Kb, α-Kv, α-Km, and α-Ka. Kinetic parameters obtained by 
measuring the initial rate at fixed NADH and lysine are summarized in Table 3. 
Initial velocity patterns obtained with pyruvate as the substrate, and varying the 
concentrations of pyruvate and lysine with NADH fixed at 0.2 mM (~3Km) intersects to 
the left of the ordinate (data not shown), consistent with the proposed sequential kinetic 
mechanism (124). All kinetic parameters are listed in Table 3.9. 
Table 3.9: Kinetic Parameters of SDH using Keto Acid Substrates at pH 7.0. 














 4.1 ± 0.2 2.55 ± 0.02 381 ± 3 
Glyoxylate
 c
 6.4 ± 0.6 1.85 ± 0.09 289 ± 31 
α-Ketobutyrate
 c
 153 ± 34 27.4 ± 4.8 179 ± 31 
α-Ketovalerate
 c
 94 ± 13 9.5 ± 0.9 101 ± 10 
α-Ketomalonate
 c
 24 ± 1 12.5 ± 0.5 521 ± 21 
α-Ketoadipate
  c
 5.3 ± 0.2 4.43 ± 0.05 836 ± 9 
a 
value from reference (124); 
b 
Km value of lysine for pyruvate reaction is 62 ± 1 mM; 
c 
The lysine concentrations used are 225 mM and 40 mM for glyoxylate and α-Kv reactions, 
respectively, and 20 mM for α-Kb, α-Km, and α-Ka reactions. 
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With glyoxylate as the substrate, a background rate was observed when the 
absorbance at 340 nm was monitored in the absence of enzyme. The stock glyoxylate 
solution (500 mM) has a slight yellow color, and this was thought to account for the 
absorbance at 340 nm. The increased presence of D2O decreased the background rate, 
suggesting it is related to the dehydration of glyoxylate. A solvent deuterium isotope 
effect has been observed for dehydration of glyoxylate (137). Thus, the SDH reaction in 
the presence of glyoxylate was corrected for the background rate. Kinetic parameters are 
shown in Table 3.9. 
Although there appeared to be an OAA-dependent decrease in A340 in the 
presence of NADH, lysine, and SDH, the rate was due to pyruvate contaminating the 
OAA solution, a result of nonenzymatic decarboxylation, as shown using lactate 
dehydrogenase. 




When keto acid analogues were used as alternative substrates, products were 
identified by measuring the 
1
H NMR chemical shifts of protons β to the secondary amine 
nitrogen in the products. A control spectrum with lysine exhibits chemical shifts at 3.7 
and 3.0 ppm, close to product peaks at 3.5 and 2.9 ppm, corresponding to C(8)-H and 
C(6)-H2 of saccharopine, respectively (138). However, there is no overlap of the 
chemical shifts of the keto acid analogues and products. Therefore, experiments were 
carried out with the keto acid analogue in excess and with lysine limiting. Completeness 
of the reaction was monitored using the absorbance at 340 nm in a separate reaction using 
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similar conditions. In all cases the chemical shifts corresponding to the product C(8)-H 
and C(6)-H2 resonances were observed, confirming product formation. 
3.4.5 Deuterium Kinetic Isotope Effects 
Primary deuterium kinetic isotope effects with pyruvate in place of α-Kg were 
measured by direct comparison of initial rates at pH 7.0 with A-side NADH(D). Finite 
effects were observed on all kinetic parameters, and are listed in Table 3.10. 
 
Table 3.10: Isotope Effects for SDH at pH 7.0. 
 




V 1.45 ± 0.07 1.29 ± 0.09 
D
(V/KNADH) 0.92 ± 0.08 2.2 ± 0.1 
D
(V/Kketo acid ) 1.9 ± 0.1 1.9 ± 0.1 
D
(V/KLys) 1.56 ± 0.05 2.3 ± 0.2 
a 
value from reference (124).
 
 
3.4.6 Dead-end Inhibition by NAD/NADH Analogues 
Inhibition by dinucleotide analogues AMP, ADP, ADP-ribose, NMN, 2’,3’-cyclic 
NADP, and NADP, was competitive vs NADH at pH 7.0. All inhibition constants are 
summarized in Table 3.11, and structures of all dinucleotide analogues are shown in Fig. 
3.14. 
3.4.7 pH Dependence of the Ki for AMP 
The pH dependence of the dissociation constant of AMP was determined in order 
to obtain an estimate of intrinsic pK value(s) of group(s) required for optimum binding of 
NADH. Over the pH range studied, AMP is a competitive inhibitor against NADH, and 
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the pKiAMP profile is shown in Fig. 3.15. The pKi decreases from a constant value at pH 
7.0 to another constant value below a pH of 6.0, and decreases as pH increases above 7.5. 
The decrease at low pH exhibits a slope of 2 indicating two groups must be unprotonated 
for optimum binding of AMP, while the decrease at high pH is with a slope of -1 
indicating a group must be protonated for optimum binding of AMP. An average pKa 
value of about 7.1 is estimated for all three of the groups. 
 
Table 3.11: Inhibition Constants of NAD analogue inhibitors at pH 6.9. 
Substrate/Inhibitor Ki (mM) 
NADH 0.018 ± 0.004
 a
 
Adenosine 0.42 ± 0.04 
AMP 0.055 ± 0.006 
ADP 0.093 ± 0.006 
ADP-ribose 0.29 ± 0.01 
NMN 7.2 
NADP 1.2 ± 0.4 
2’,3’-cyclic NADP 1.5 ± 0.1 
NADP
 b
 3.5 ± 0.6 




value from reference (124); 
Varied substrate is NADH with the exception of 
b



















































































































































































Figure 3.15: pH dependence of the reciprocal of the inhibition constant for AMP. The 
points shown are the experimental determined values, while the curve is theoretical based 
on the fit of the data using eq 2.20. 
 
3.4.8 Dead-end Inhibition by Keto Acid Analogues 
A number of α-Kg analogues exhibit competitive inhibition patterns against α-Kg 
at pH 7.0 in the direction of saccharopine formation, Table 3.12. In addition, pyridine 
2,5-dicarboxylate and L-pipecolic acid gave no observed inhibition at a concentration of 
50 mM. Structures of the α-Kg analogues are shown in Fig. 3.16B-C. 
3.4.9 Dead-end Inhibition by Amino Acid Analogues 
SDH shows a very strict substrate specificity towards its amino acid substrate, L-
lysine. A number of lysine analogues show competitive inhibition vs L-lysine, including 
L-ornithine and D-lysine. L-Asparagine gave no inhibition at a concentration of 50 mM. 
Since L-leucine, a competitive inhibitor of L-lysine, binds better at pH values below 6, 
the Ki for amino acid analogues with aliphatic side chains such as L-valine and L-
isoleucine were measured at pH 6.0 and 7.0. All Ki values are summarized in Table 3.13, 













































L-Lysine 1.7 ± 0.2 (Km) 
a
 1.1 ± 0.2 (Km) 
a
 
D-Lysine -- 5.5 ± 0.4 
L-Ornithine 3.6 ± 0.1 (pH 7.6) 5.0 ± 0.1 
L-Valine 62 ± 5 140 
L-Norvaline 0.71 ± 0.04 1.13 ± 0.05 
L-Methionine 0.96 ± 0.03 3.12 ± 0.08 
L-Leucine 0.125 ± 0.002
 a
 0.44 ± 0.03
 a
 
L-Isoleucine 10.7 ± 0.4 22 ± 2.0 
L-Arginine -- 16.4 ± 0.4 
L-Glutamine -- 16.0 ± 0.8 
L-Asparagine -- No inhibition 
a 
value from reference (124).
 
α-Kg analogue inhibitors Ki (mM) 
Oxalate 36 ± 4 
α-Keto Dicarboxylic Acids 
α-Ketomalonate 24 ± 1 (Km) 





 0.6 ± 0.1 (Kib)
 a
 
Oxalylglycine 0.100 ± 0.002
 a
 
α-Ketoadipate 5.3 ± 0.2 (Km) 
α-Ketopimelate 18 ± 2 
Dicarboxylic Acids 
Malonate 24 ± 2 
Succinate 21 ± 1 
Glutarate 1.0 ± 0.1
 a
 (NC) 
Adipate 50 ± 2 
Other 
α-Ketoisovalerate 36 ± 1 
Pyridine 2,4-dicarboxylate 1.10 ± 0.01 
Pyridine 2,3-dicarboxylate 18.3 ± 0.4 
a 
value from reference (124); 
b 





Figure 3.16: Structures of α-Kg and L-lysine analogues. (A) lysine analogue inhibitors (B) 


















































































































































































































3.4.10 Double Inhibition Studies 
In order to determine whether the binding of lysine and α-Kg affect one another, 
double-inhibition experiments with competitive inhibitors of the two substrates were 
carried out. The initial rate was measured at saturating NADH, with α-Kg and lysine 
fixed at their respective Km values, and varying the concentrations of OG and ornithine, 
Fig. 3.17. The rate in the absence of inhibitors, v0, was 11.8 ± 0.2 μM/min, while the 
appKi values for E:NADH:OG and E:NADH:ornithine complexes are 0.050 ± 0.002 and 
4.6 ± 0.2 mM, respectively. The interaction constant, α, was 0.7 ± 0.1, indicating slight 
synergism of binding between OG and ornithine. A double-inhibition pattern obtained 
with ornithine and the bulky pyridine 2,4-dicarboxylic acid gave quite different results, 
with Ki values for E:NADH:pyridine 2,4-dicarboxylic acid and E:NADH:ornithine 
complexes of 1.99 ± 0.06 and 5.0 ± 0.1 mM, respectively.  A value of 2.4 ± 0.4 for α was 












Figure 3.17: Double inhibition by oxalylglycine and ornithine. Plot of the reciprocal 
initial rate versus the ornithine concentration (0-15 mM) at different levels of 
oxalylglycine [0 mM (■), 0.05 mM (♦), and 0.1 mM (▲)]. The points are experimental, 




4.1 Kinetic Mechanism Determination of SDH 
4.1.1 Initial Velocity Studies 
In general, for a sequential terreactant mechanism, the initial velocity patterns 
obtained by varying concentrations of any two substrates with the third fixed at a 
nonsaturating concentration are all intersecting. If the second substrate to add in an 
ordered mechanism is fixed at a saturating concentration, the initial velocity pattern 
obtained by varying the first substrate at different fixed levels of the last becomes parallel 
(117); while three intersecting patterns would be consistent with a fully random 
mechanism whatever the concentration of the fixed reactant. Random binding of A and B 
to E followed by binding of C to EAB also gives intersecting patterns when any of the 
substrates is saturating and the other two are varied. However, ordered binding of A 
followed by random addition of B and C will give two parallel patterns when A and C or 
A and B are varied at saturating levels of B and C, respectively (117). 
In the direction of reductive amination of α-Kg catalyzed by SDH, saturation with 
NADH and varying α-Kg/lysine gave an intersecting pattern, while two parallel patterns 
were observed for the NADH/α-Kg and NADH/lysine pairs at saturating concentrations 
of lysine and α-Kg, respectively (Fig. 3.2A-C). These initial velocity patterns suggest the 
ordered addition of NADH, followed by the random addition of lysine and α-Kg. The 
binding of NADH to free enzyme has also been demonstrated by isothermal titration 
calorimetry (ITC) (see Appendix II). No direct binding between lysine or α-Kg to the 
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free enzyme was detected by ITC, which would result from a high Kd or the lack of a 
defined binding site in the absence of NADH. 
When data from a systematic analysis of initial velocities varying all reactant 
concentrations were fitted to eq 2.3 for a fully random terreactant mechanism, the B and 
C terms in the denominator of the rate equation were not defined, which suggests that the 
EB (E:α-Kg) and EC (E:lysine) binary complexes are not present. Data are consistent 
with the above mechanism that suggests that lysine and α-Kg cannot add until NADH 
does. 
The intersecting initial velocity pattern obtained in the direction of saccharopine 
oxidation indicates a sequential mechanism for the addition of NAD and saccharopine, 
consistent with data obtained in the opposite direction. The initial velocity data in the 
absence of added inhibitors do not define the order of addition. Data obtained from initial 
velocity studies in the direction of saccharopine formation alone do not discriminate 
between the ordered and random addition of reactants, and thus, the kinetic mechanism 
was further defined via product and dead-end inhibition studies. 
4.1.2 Substrate Inhibition Studies 
A number of pyridine nucleotide-linked dehydrogenases are inhibited by high 
concentrations of the substrates. Generally, the substrate inhibition is considered to be 
caused by forming a dead-end enzyme:oxidized coenzyme:oxidized substrate complex or 
a dead-end enzyme:reduced coenzyme:reduced substrate complex. Substrate inhibition 
resulting from the combination of a substrate with central complexes has also been 
reported (118). 
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It has been reported that in the reductive amination reaction direction, SDH is 
inhibited by high concentrations of lysine and α-Kg (both show uncompetitive inhibition 
against NADH) but not by NADH, while NAD and saccharopine show no substrate 
inhibition in the physiologic reaction direction (105). If the lysine substrate inhibition 
arises from the formation of a dead-end E:NAD:substrate complex, one would expect 
uncompetitive inhibition by lysine vs NADH. The observed competitive inhibition by 
lysine vs NADH indicates that lysine binds to free enzyme at high concentrations, 
forming a dead-end E:lysine complex. 
The substrate inhibition by α-Kg is uncompetitive with respect to NADH at 
saturating lysine, suggesting a combination to the E:NAD product complex. For α-Kg to 
cause any substrate inhibition, the E:NAD complex must exist in the steady state, which 
suggests that the release of NAD from E:NAD contributes to the overall rate limitation at 
saturating substrate concentrations (V/Et). Uncompetitive substrate inhibition is common 
in the nonphysiological direction of a steady-state ordered mechanism (119). Whether the 
inhibition by α-Kg results from the formation of a E:NAD:α-Kg dead-end complex was 
further tested via a double-inhibition experiment measuring the initial rate at fixed low 
NADH and lysine and varying the NAD concentration at different inhibitory levels of α-
Kg (Fig. 3.5B). The inhibition by NAD alone in Fig. 3.5B is observed as the line with ■ 
reflecting the E:NAD complex, while the inhibition by α-Kg alone (ordinate) reflects the 
binding of α-Kg to the E:NAD that exists in the steady state in the absence of added NAD. 
The slope effect indicates an enhancement of inhibition as a result of synergism of 
binding between NAD and α-Kg. A value of 0.12 is obtained for α, suggesting an 8-fold 
increase in the affinity of α-Kg in the presence of NAD, compared to its absence. Under 
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the conditions examined, saccharopine substrate inhibition was not observed over a 
concentration range of 5-50 mM, in 100 mM Hepes and pH 7.0. 
4.1.3 Product Inhibition Studies 
The order of product release in the direction of saccharopine formation was 
examined using product inhibition by NAD and saccharopine. If the overall reaction is 
reversible and NAD is the last product to leave, the inhibition by NAD
 
would be 
competitive with respect to NADH and noncompetitive vs the other two substrates. 
Indeed, inhibition patterns predicted by these assumptions were obtained (Table 3.2). The 
competitive inhibition by NAD vs NADH at low lysine and α-Kg indicates that NAD is 
the last product to leave in the direction of reduction amination. The noncompetitive 
inhibition by NAD vs the other two reactants is consistent with NAD binding to free 
enzyme. Thus, the order of product release would be saccharopine followed by NAD. 
The high Kii value obtained for the noncompetitive inhibition by NAD against α-Kg is 
likely due to the low concentration of free enzyme (12%), as a result of the high NADH 
(3Km) and lysine (2.5Km) concentrations used. Correction for the enzyme concentration 
gives a value of 13 mM, in reasonable agreement with the Kis value of 28 mM (Table 3.2). 
According to the proposed mechanism, if saccharopine is the first product to 
dissociate, one would predict noncompetitive inhibition by saccharopine against all three 
substrates. However, uncompetitive inhibition by saccharopine vs NADH was observed. 
The lack of a slope effect can be explained by the combination of saccharopine with 
E:NADH in dead-end fashion, or with E:NAD with no reversal of the reaction, or both. 
The noncompetitive patterns observed for saccharopine vs lysine or α-Kg can be 
explained on the basis of the combination with E:NAD and E:NADH. The inability of 
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saccharopine to reverse the reaction is fully consistent with the Keq of 2.9 x 10
-7
 M 
measured for the reaction at pH 7.0. The uncompetitive substrate inhibition by α-Kg and 
double inhibition by NAD/α-Kg suggest the presence of E:NAD in the steady state, and 
this is the normal complex with which saccharopine combines as a reactant. It is not 
unreasonable that saccharopine would bind to the E: NAD and E: NADH complexes 
because of the structural similarity of the dinucleotide substrates. Both combinations of 
saccharopine would give an uncompetitive pattern vs NADH and noncompetitive patterns 
vs lysine and α-Kg. In addition, the high Kii value obtained for the noncompetitive 
inhibition by saccharopine against α-Kg is likely due to the low concentration of the 
E:NAD complex to which saccharopine binds, as a result of the low NADH (KNADH) and 
lysine (KLys) concentrations used. 
In the direction of saccharopine oxidation, all products were used as product 
inhibitors. The inhibition by α-Kg was only observed when NAD is saturating (20Km) 
and resulted largely from the formation of the abortive E:NAD:α-Kg complex (see 
discussion of double-inhibition experiments above). The combination of α-Kg with 
E:NAD would be expected to give competitive inhibition vs saccharopine, and the 
combinations of α-Kg with E:NADH and E:NADH:lysine enzyme forms would give 
noncompetitive inhibition. The observed noncompetitive inhibition pattern is thus 
consistent with the proposed mechanism. The high Kii value results from the low 
concentrations of E:NADH and E:NADH:lysine complexes present in the steady state 
(saccharopine fixed at 1.5KSacc). 
The product NADH exhibits competitive inhibition against NAD, suggesting that 
NADH and NAD
 
bind to free enzyme. NADH exhibits noncompetitive inhibition vs 
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saccharopine, consistent with NADH binding before saccharopine along the reaction 
pathway, in accordance with the proposed mechanism, that is, the addition of NAD 
before saccharopine. 
Lysine is competitive vs saccharopine under conditions where NAD is fixed at its 
Km. It thus appears that no significant E:NADH or E:NADH:α-Kg is present in the steady 
state under these conditions. This is consistent with the lack of substrate inhibition by 
saccharopine. The noncompetitive inhibition vs NAD then results from the combination 
of lysine with E (see lysine substrate inhibition above) and E:NAD when higher lysine 
concentrations are used. 
4.1.4 Dead-end Inhibition Studies 
Dead-end inhibitors structurally resembles the substrate and compete with the 
substrate for a binding site on the enzyme; however, they do not undergo chemical 
transformation like the substrate. As a result, it is often more straightforward to interpret 
data from dead-end inhibition, and these experiments are invaluable in establishing the 
order of substrate binding (120). 
Leucine was chosen as a dead-end analogue of lysine and was competitive vs 
lysine, indicating that it competes with lysine for its binding site on the enzyme. The 
uncompetitive inhibition observed vs NADH is consistent with leucine binding to a form 
of enzyme that exists when NADH is saturating. The noncompetitive inhibition against α-
Kg results from the combination with an enzyme form that α-Kg binds and one that is 
present at saturating α-Kg, viz., the E:NADH and E:NADH:α-Kg enzyme forms. All of 
the leucine dead-end patterns are consistent with the random addition of lysine and α-Kg 
once NADH is bound. 
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OG was chosen as a dead-end analogue of α-Kg. It was competitive vs α-Kg, 
indicating that it competes with α-Kg for its binding site on the enzyme. The 
uncompetitive inhibition observed vs NADH is consistent with OG binding to a form of 
the enzyme that exists when NADH is saturating. The noncompetitive inhibition against 
lysine results from the combination of E:NADH and E:NADH:lysine enzyme forms. All 
of the OG dead-end patterns are consistent with the random addition of lysine and α-Kg 
once NADH is bound. 
OAA was also chosen as a dead-end analog of α-Kg. However, OAA exhibited 
behavior similar to that of leucine. It was competitive vs lysine, suggesting that it binds to 
the same enzyme form(s) as does lysine. However, it was noncompetitive vs both α-Kg 
and NADH, suggesting that it binds to E as well as the E:NADH and E:NADH:α-Kg 
enzyme forms. 
Glutarate as a dead-end inhibitor is competitive vs lysine and noncompetitive vs 
α-Kg, as are leucine and OAA. However, it exhibits S-parabolic noncompetitive 
inhibition vs NADH. Thus, in addition to binding to E:NADH and E:NADH:α-Kg, 
glutarate binds to E, as does OAA. The parabolic slope effect indicates the formation of a 
E:(glutarate)2 complex, likely as a result of occupying both the lysine- and α-Kg-binding 
sites. This is a reasonable result because glutarate can be seen as a mimic of both halves 
of saccharopine. Attempts to fit the data using eq 4.1 were unsuccessful, giving a Ki1 
higher than the concentration range used for glutarate and a Ki2 lower than the 

















                                                                      (4.1) 
82 
In eq 4.1, Ki1 and Ki2 are dissociation constants for glutarate from the E:glutarate and 
E:(glutarate)2 complexes, respectively. A fit to eq 2.11, a modified version of eq 4.1, with 
the I/Ki1 term missing, gives good estimates and indicates that the first molecule of 
glutarate bound has a very low affinity, while the second glutarate molecule bound 
increases the affinity of the first dramatically, trapping it on the enzyme. As a result, an 
average Kis is obtained for dissociation of both molecules from the E:(glutarate)2 complex. 
Pyruvate was reported as a slow alternative keto acid substrate (98, 103). Enzyme 
activity with pyruvate was observed in these studies only when the lysine concentration 
was fixed at 40 times the value of KLys obtained for the normal reaction using α-Kg, and a 
pyruvate concentration is 200 times higher than α-Kg needed for the normal reaction. As 
a result, pyruvate is treated as a dead-end analogue of α-Kg. Surprisingly, it shows 
competitive inhibition vs both lysine and α-Kg and uncompetitive inhibition vs NADH, 
indicating that it binds to both E:NADH:α-Kg and E:NADH:lysine enzyme forms, so that 
it, like glutarate, binds to both subsites occupied by saccharopine. 
The binding mode of the two glutarate molecules in the E:(glutarate)2 complex 
and the competitive inhibition patterns observed for pyruvate vs both lysine and α-Kg are 
reasonable considering that their structure mimics both reactants, in part, i.e., α-keto acid 
and dicarboxylic acid. A schematic representation of the saccharopine-binding pocket is 
shown in Scheme 4.1. There are likely three subsites (I, II, and III) for the interaction of 
the three carboxylates of saccharopine (Scheme 4.1A). Production of lysine and α-Kg 
would then give their binding modes as in Scheme 4.1B. Binding of glutarate may then 
be accommodated at both sites as shown in Scheme 4.1C. It is also possible that binding 






Scheme 4.1: Schematic of the saccharopine-binding pocket to illustrate possible 
inhibition binding modes. A and B show a possible binding pocket for saccharopine, 
lysine, and α-Kg. C shows possible binding modes for glutarate. 
 
 
On the basis of the initial velocity studies in the absence and presence of product 
and dead-end inhibitors, SDH has a relatively flexible and large substrate-binding pocket 
for saccharopine and its products, lysine and α-Kg. The binding of NADH causes a 
conformational change, increasing the affinity of the enzyme for lysine and α-Kg as 
indicated by the difference in the substrate inhibition constant and the Km (steady-state 
dissociation constant) for lysine. An overall kinetic mechanism can thus be proposed and 
is shown in Scheme 4.2. For the fully defined kinetic mechanism, the rate equation in the 
direction of saccharopine formation (eq 2.4) can be defined in terms of kinetic constants 








v                                 (4.2) 
 
In eq 4.2, Kia and Kib are dissociation constants of A from EA and B from EAB 
complexes, respectively, and all other terms are the same as defined above. A refit of all 
initial velocity data in the direction of saccharopine formation using eq 4.2 gives Kia a 
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value of 0.018 ± 0.004 mM and Kib a value of 0.6 ± 0.1 mM. All other constants are given 










Scheme 4.2: Proposed kinetic mechanism for SDH. E represents SDH. Kinetic data 
suggest that the reaction is irreversible in agreement with the Keq of the reaction. 
 
4.1.5 Quantitative Analysis of Dead-end Inhibition Data 
For dead-end inhibitors, the correction of the observed Ki values for the fixed 
substrate concentrations should give the same Ki value whatever substrate is varied. Thus, 
for inhibition by OG and leucine, the observed Kis and Kii values must be corrected for 
the concentration of the fixed substrates. We give an example of how this is done below. 
Given eq 4.2, each of the terms in the denominator represents an enzyme form. The EA 
and EAC forms of the enzyme bound OG, represented by KibKcA and KbAC, respectively, 
and these terms would be multiplied by (1 + I/Ki1) and (1 + I/Ki2), respectively, where I is 
OG and Ki1 and  Ki2 are dissociation constants for E:NADH:OG, and E:NADH:Lys:OG, 
respectively. However, because Ki1 = Ki2 in this case (see below), eq 4.3 is correct. The 
presence of the inhibitor adds a (1 + I/Ki) term to each of the denominator terms 
representing EA and EAC enzyme forms to which B binds, KibKcA and KbAC, to give eq 
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slope                                      (4.5) 
 
































CACI app                                                   (4.6) 
 
where the appKis values are those given in Table 3.3. 
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intercept                                 (4.8) 
 


































app                                                      (4.9) 
 
With C varied, the expression for Kis and Kii can be derived in a similar manner and the 
true Ki can be calculated. Values of Ki1 and Ki2 are obtained by correcting the slope (Kis) 
and intercept (Kis) values measured for the noncompetitive inhibition vs lysine (Table 
3.3). Note that these values, 0.07 mM and 0.06 mM are identical within error, justifying 
the use of eq 4.3 above. The corrected values of Ki are given in parentheses in Table 3.3, 
and all are in very good agreement with one another. 
Similar corrections have been done for leucine inhibition patterns and could be 
carried out for all other dead-end inhibition patterns, but this serves to illustrate the 
process. Data are then consistent with the proposed kinetic mechanism. 
4.1.6 Previously Published Data 
Previously, an ordered kinetic mechanism was proposed for SDH (96, 97). Data 
suggested that when α-Kg was used as the keto acid substrate, the mechanism was 
defined as ordered with NAD bound first, followed by saccharopine, and products were 
released in the order lysine, α-Kg, and NADH. However, when α-Kg was substituted by 
the alternative slow keto acid substrate pyruvate, the mechanism was still ordered but 
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with the order of product release pyruvate, lysine, and NADH (98). In addition, one of 
the pairwise initial velocity patterns obtained by the authors, NADH/lysine at saturating 
levels of α-Kg, was not consistent with the proposed ordered mechanism (95). 
Noncompetitive inhibition patterns observed with OAA, pyruvate, α-ketobutyrate, α-
ketovalerate, and α-ketocaproate were observed previously (96), whether NADH, α-Kg, 
or lysine was the varied substrate, and these patterns are also inconsistent with a 
sequential ordered kinetic mechanism. The ordered mechanism proposed previously 
differs from that proposed on the basis of studies presented here. Previous results fit well 
into the mechanism that we propose. The keto acid substrates bind to E:NADH and 
E:NADH:lysine complexes, consistent with the random addition of the keto acid 
substrate and lysine. In addition, however, a number of dead-end complexes exist that 
were not observed previously, and some mono- and dicarboxylic acid inhibitors can 
apparently bind to both subsites of the saccharopine-binding site (Scheme 4.1). 
Differences between the previous studies and those in this dissertation may be 
caused by a number of reasons. The specific activity of the His-tagged SDH in this study 
is 243.9 units/mg, more than twice the value of 130 units/mg reported in previous studies 
(95). Hepes buffer was used in all of the studies presented, rather than the phosphate 
buffer used previously, to eliminate possible inhibition by phosphate. A systematic 
analysis of initial velocities that covers limiting and saturating concentrations of all three 
reactants at once was performed in this study in addition to the pairwise analysis. Finally, 
the kinetic mechanism was probed in both reaction directions as opposed to the reductive 
amination direction alone. 
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Interestingly, inhibition patterns obtained differ between the two studies, and this 
appears to be largely a result of the conditions utilized. For example, a lack of inhibition 
by glutarate as a dead-end analogue was reported previously (96), and this is almost 
certainly due to the limited glutarate concentration range examined and the unique type 
of inhibition in which two molecules of glutarate are apparently needed for significant 
affinity. All of the inhibition patterns obtained in these studies can be reconciled on the 
basis of the promiscuity of the saccharopine-binding site. Overall, the present studies 
present a complete description of the kinetic mechanism of SDH at pH 7.0. 
 
4.2 Chemical Mechanism Determination of SDH 
4.2.1 Isotope Effects 
The study of deuterium isotope effects has enabled investigators to obtain 
information about the nature of the transition state in reactions catalyzed by specific 
dehydrogenases, e.g., formate dehydrogenase (121) and alanine dehydrogenase (78). In 
many cases, it has given an indication of the relative rates of the catalytic steps in the 
mechanism compared to the overall rate of the reaction. 
4.2.1.1 Primary Substrate Deuterium Kinetic Isotope Effects 
The kinetic mechanism of SDH in the direction of saccharopine formation at 





















where A, B, C, P, and Q represent NADH, α-Kg, lysine, saccharopine, and NAD, 
respectively. The rate constants k1 and k2 are for binding and dissociation of A; k3, k4, k7, 
and k8 are for binding and dissociation of α-Kg, and k5, k6, k9, and k10 are for binding and 
dissociation of lysine; k11 and k12 are the forward and reverse net rate constants for the 
catalytic pathway; while k13 and k15 are for release of saccharopine and NAD, 
respectively. 
The substrate deuterium sensitive step, hydride transfer, contained in k11, the net 
rate constant for catalysis, may exhibit an isotope effect upon deuteration of NADH at the 
C-4 pro-R hydrogen of the dihydronicotinamide ring if it contributes to rate limitation. 
Conditions for measurement of V/K for a given reactant require all other reactants to be 
present at saturation. Thus, the expressions for V, V/Kb, and V/Kc are given by eqs 4.11-
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4.2.1.1.1 Substrate Dependence of Primary Deuterium Isotope Effects 
In an ordered kinetic mechanism, V/Ka, is the on-rate constant for binding of the 
first substrate and is not sensitive to substitution of deuterium for protium, and thus the 





information on the preference of the two pathways in eq 4.10. The larger the value of 
D
(V/K), the lower the value of the commitment factors, cf and cr. The lower commitment 









(V/Kc), there are two possibilities. First, neither substrate B nor 
substrate C is sticky, suggesting that the kinetic mechanism is rapid equilibrium random. 
Second, both substrate B and substrate C are equally sticky, indicating a steady-state 
random addition of B and C, with k6 = k7 (123). 
For the SDH reaction, 
D
(V2/KNADH) is 0.92 ± 0.08 at pH 7.1 and 25 °C, within 
error, identical to 1, consistent with the proposed ordered addition of NADH before -Kg 




(V2/KLys) are both finite, their order of addition 
must be random, consistent with the proposed mechanism, and since 
D
(V2/Kα-Kg) is greater 
than 
D
(V2/KLys), the preferred pathway is E:NADH to E:NADH:Lys to E:NADH:Lys:-
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(V2/KLys), the off-rate for lysine from E:NADH:Lys:-Kg is 
likely about the same as that of NAD from E:NAD. That E:NAD exists in the steady state 
is known as a result of uncompetitive substrate inhibition by -Kg (124). The off-rate for 
-Kg from E:NADH:Lys:-Kg is greater than that of lysine from the same complex. 
4.2.1.1.2 pH Dependence of Primary Deuterium Isotope Effects 
Kinetic parameters depend on pH as a result of titration of groups responsible for 
reactant binding, catalysis, or maintaining the correct conformation of the enzyme. 
Information on the kinetic and chemical mechanism can be obtained if the isotope effects 
are measured at the optimum pH and a pH where the kinetic parameter is decreasing by a 
factor of 10 per pH unit (123). In the case where the isotope-sensitive step is not solely 
rate-determining and substrate is sticky, the observed isotope effect can be enhanced by 
changing the pH and eliminating substrate stickiness by making the catalytic pathway 
slow. For the SDH reaction, the maximum isotope effect is observed at low pH (1.7-1.8), 
and the effect decreases as the pH is increased above the pKa observed in the V2/KLys pH-
rate profile. 
At low pH, the isotope effect on V2/KLys increases compared to that measured at 
neutral pH and becomes equal to 
D
(V2/Kα-Kg). It thus appears that lysine is sticky, while -





, can be estimated using the value of 1.8 for the 






















max                                                                                            (4.14) 
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(V/K)max, a cf of about 0.4 is calculated, 
suggesting that at neutral pH, once lysine is bound, it dissociates from the enzyme 2.5 
times faster than the rate of the catalytic pathway. The maximum value of 1.8 is not the 
intrinsic isotope effect, since the hydride transfer step is not completely limiting for the 
overall reaction (see below). 
The value of 
D
(V2/KLys) decreases to about unity as the pH increases over the pH 
range where V2/KLys is decreasing by a factor of 10 per pH unit. V2 does not vary 
significantly as the pH is decreased to 6.1, nor does 
D
V2. However, the isotope effect does 
decrease toward unity as the pH is increased, as does 
D
(V2/KLys), even though V2 
decreases only slightly as the pH increases. In addition, 
D
V2 decreases as the pH is 
decreased below 6.0. Data suggest that the pH- and isotope-dependent steps are not the 
same in the direction of saccharopine formation (125) and that an isotope independent 
step contribute to V2 at low pH. Data will be discussed in the context of the mechanism 
below. 
4.2.1.2 Solvent Deuterium Isotope Effects and Proton Inventory Studies 
The pH(D) dependence of kinetic parameters was measured for lysine with 
NADH and α-Kg maintained at saturation, over the pH(D) range 6.5-8.5 to determine 
whether a solvent deuterium kinetic isotope effect was observed. As predicted, the profile 
in D2O is shifted to higher pD as a result of the equilibrium solvent deuterium isotope 
effect on the pKa values (109) (Fig. 3.12). The solvent kinetic deuterium isotope effects, 
obtained as the ratio of the pH(D)-independent values of the kinetic parameters, are 




V2/KLys values of 2.2 ± 0.1 and 1.9 ± 0.1, 
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respectively, suggesting a significant contribution from proton transfer step(s) to rate 
limitation of the overall reaction. 
4.2.1.3. Multiple Solvent/Substrate Deuterium Isotope Effects 
Multiple isotope effects potentially allow one to define the interrelationship 
between two isotope-sensitive steps (126). Isotope effects that reflect the same transition 
state are independent of one another, since they reflect the same step. If the step is 
completely rate-limiting, the isotope effect will not change in the presence of the second 
isotope, while if it is not completely rate-limiting, the isotope effect will increase. If 
substrate and solvent deuterium isotope effects do not reflect the same step, deuteration 
of the substrate decreases the observed solvent isotope effect by making the deuterium-
sensitive step more rate-limiting. Two kinds of multiple isotope effects are used in these 
studies, a solvent deuterium isotope effect measured with NADD and a primary substrate 
deuterium isotope effect measured in D2O. There is no significant decrease in the solvent 
deuterium isotope effect on V2 and V2/KLys when obtained using NADD compared to that 





(V2/KLys) in 90% D2O compared to that in H2O. These data suggest a concerted 
proton and hydride transfer that is completely rate-limiting for the overall reaction. 
However, the isotope effect on V2/Kα-Kg is greater than that observed for V2/KLys at pH 7.1, 
D
(V2/KLys) increases as the pH is decreased, and 
D2O
(V2)D is decreased compared to 
D2O
(V2)H. Thus, hydride transfer cannot be the sole rate-limiting step. The data can be 
reconciled by suggesting proton transfer in the hydride transfer step and in some other 
step. The one in the hydride transfer step results in an increase in the primary deuterium 
isotope effect, while the one in another step causes it to decrease, giving no net change in 
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the isotope effect. In addition, the lack of change in the solvent deuterium isotope effect 
indicates that the effect is likely reflected differently by the two solvent-sensitive steps 
with NADH and NADD, but the weighted average is the same in both cases. The origin 
of the proton transferred in the hydride transfer step is likely a proton transferred from the 
protonated secondary amine of saccharopine to an enzyme base as the hydride is 
transferred. There are several possibilities for the (an)other proton transfer step(s), 
including hydrolysis of the imine that results from the oxidation of saccharopine. 
4.2.1.4. Proton Inventory Studies 
An estimate of the number of protons important to the overall reaction and the 
number of proton transfer steps that contribute to rate limitation can be obtained from the 
proton inventory method (110). If a single proton is transferred in the rate-limiting 
transition state, a plot of the rate constant vs atom fraction of deuterium (n) will be linear. 
If more than one proton is transferred in a single transition state, the plot will be bowl-
shaped (concave upward), while if protons are transferred in multiple transition states, the 
plot will be a dome-shaped plot (concave downward). Dome-shaped proton inventories 
require offsetting normal and inverse contributions to the solvent isotope effect and can 
have several mechanistic origins (110). The replot of V2 vs the percent D2O at pH 7.1 
gives a bulging dome-shaped plot (Fig. 3.13A), suggestive of contribution from proton 
transfer with a significant inverse contribution effect likely from a medium effect. 
However, the slight curvature observed in the case of V/K is more consistent with isotope 
effects in two or more sequential transition states, but with the absence of significant 
medium effect (Fig. 3.13B). Data are thus consistent with the multiple isotope effects and 
suggest that rate-limiting proton transfer exists in at least two sequential transition states, 
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for example, substrate (de)protonation, hydride transfer, water elimination, or an enzyme 
conformational change. Of these, hydride transfer and formation of the imine from the 
carbinolamine are most likely. The medium effect seen in V2, but not V2/KLys, suggests 
that it is caused by a step(s) not included in V2/KLys under conditions of saturating 
substrate concentration, i.e., either product release or a conformational change once 
substrates are bound, e.g., isomerization of E:NAD, E:NADH, or E:NADH:α-Kg. This 
will be further discussed below. 
4.2.2 Interpretation of the pH Dependence of Kinetic Parameters 
The pH dependence of log(V/K) vs pH is obtained at a limiting concentration of 
one of the reactants and saturating levels of all others, with free substrate and the enzyme 
form to which it binds predominant in the steady state. The logV vs pH profile is obtained 
at saturating concentrations of all substrates with the enzyme form(s) that build(s) up in 
the steady state predominant. The V profile will thus reflect groups on the enzyme 
required for catalysis, while the V/K profile will reflect the protonation state of group(s) 
on the enzyme and/or reactant responsible in a given protonation state for binding and/or 
catalysis (120). In the case of an ordered mechanism, the V/K for the first substrate is the 
rate constant for binding reactant to enzyme and will thus reflect groups important for 
binding, which may also contribute to catalysis, for example, if a catalytic group 
hydrogen bonds to or is in the vicinity of the substrate. 
The determination of a steady-state partial random mechanism at pH 7.0-8.0 and a 
rapid equilibrium ordered mechanism at low and high pH for SDH allow the pH profiles 
to be interpreted in terms of enzyme forms or species that predominate under any given 
conditions. In the direction of lysine formation, free enzyme and NAD predominate for 
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the V1/KNAD profile, while the E:NAD enzyme form and saccharopine predominate for the 
V1/KSacc profile. Finite primary deuterium and solvent deuterium kinetic isotope effects 
and proton inventory studies suggest that central complexes (primarily E:NAD:Sacc and 
E:NADH:imine, where imine is the oxidized form of saccharopine) predominate for the 
V1 profile. In the reverse reaction direction, the free enzyme and NADH predominate for 
the V2/KNADH profile; while E:NADH:lysine and -Kg predominate for the V2/K-Kg 
profile at 5.0 < pH < 8.5, and at pH values lower and higher, E:NADH and -Kg 
predominate. In the case of the V2/KLys profile, E:NADH:-Kg and lysine predominate, 
while central complexes and E:NAD, or E:NADH, or E:NADH:-Kg predominate for 
the V2 pH profile (see discussion of isotope effects above). 
The V1/KNAD is equal to the on-rate constant for NAD binding, and the pKa of 7.4 
reflects a group that must be deprotonated for optimum binding of NAD. The V1/KSacc 
pH-rate profile exhibits pKa values of 6.2 and 7.2, while the V1 pH-rate profile shows a 
pKa of 7.2. The pKa of 7.2 likely reflects the same enzyme group in E:NAD and central 
complexes, which likely serves as a general base in the overall reaction needed to activate 
water in the hydrolysis of the imine formed upon oxidation of saccharopine. The second 
group in V1/KSacc pH-rate profile with a pKa of 6.2 which needs to be deprotonated likely 
contributes to the binding of saccharopine only, since it is not observed in the V1 pH-rate 
profile. Since neither NAD nor saccharopine have pKa values in the pH range studied, the 
pKa must represent ionization of a group on the enzyme. Therefore, there are two groups 
on the enzyme with pKa values of 6.2 and 7.2 that must be deprotonated for binding of 
saccharopine and catalysis, respectively. A group on the enzyme with a pKa of about 7.2-
7.4 is likely the same one that affects V1, V1/KNAD, and V1/KSacc, a catalytic group that also 
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affects the binding of NAD. The protonation state of this group does not affect binding of 
NADH, and it is thus likely to be a cationic acid located in the vicinity of the positively 
charged nicotinamide ring of NAD. 
In the direction of saccharopine formation, the SDH has a random kinetic 
mechanism with NADH bound to free enzyme first, followed by random addition of α-
Kg and lysine at neutral pH. The V2/KNADH Et decreases at high pH with a slope of -1 
giving pKa value of 9.6 ± 0.2. Since NADH is the first substrate bound, and considering 
that the pKa of the pyrophosphate moiety of NADH is about 1-2, it is suggested that the 
group on the enzyme with a pKa of 9.6 likely contributes to the binding of NADH and 
must be protonated for optimal binding, likely interacting with the negatively charged 
phosphoryl oxygens of NADH via an ionic interaction. This group was not seen in the 
V1/KNAD pH-rate profile in the forward direction reaction, because the parameter was not 
measured above pH 9.0 in that reaction direction; the Km for saccharopine has become 
about 10 mM at pH values above 9. 
The V2/Kα-Kg profile shows a single group with a pKa of 8.9 that must be 
protonated for optimum binding. In addition, V2 decreases to a new constant value at high 
pH exhibiting a pKa of about 8.4. These pKa values are identical, within error. The kinetic 
mechanism of SDH changes from random to rapid equilibrium ordered when the pH is 
above 8.0 or below 5.5. The V2/Kα-Kg pH-rate profile is independent of pH from 5.5 to 
about 8.0, but the rate constant decreases when the pH is increased above 8.0, at the point 
where the mechanism changes. Between pH 5.5 and 8.0, the predominant enzyme form is 
E:NADH:Lys, while above 8, the E:NAD form predominates. The decrease in V2/Kα-Kg 
likely reflects a kinetic pKa resulting from the change in kinetic mechanism due to a 
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slower pathway with α-Kg binding before lysine. In agreement with the V2/Kα-Kg, V2 also 
decreases at high pH, giving a partial change in activity, likely reflecting the same kinetic 
mechanism change. The group with a pKa of 7.2 in the V2/KLys profile is not observed in 
the V2/Kα-Kg pH-rate profile. Under these conditions lysine is bound, and the group with a 
pKa of 7.2 is likely locked in its correct protonation state. Since the group seen on the 
acid side functions to deprotonate the lysine є-amine, it is reasonable the group would not 
be observed with lysine bound. Overall, data are consistent with the steady-state random 
nature of the mechanism with the E:NADH to E:NADH:Lys pathway preferred and faster 
than that with E:NADH:-Kg. 
The bell-shaped pH profile for V2/KLys observed in the reverse reaction direction 
shows that a group with a pKa of about 7.2 must be unprotonated and a group with a pKa 
of about 7.2 must be protonated for binding lysine to the E:NADH:-Kg complex and 
catalysis. Since lysine has no ionizing groups corresponding to 7.2, they must reflect the 
ionization of groups on the enzyme. A group on the enzyme with a pKa of 7.2 exhibited 
in V1, V1/KNAD, and V1/KSacc profiles must be deprotonated for catalysis in the direction of 
lysine formation. On the basis of the acid-base chemistry required in the oxidative 
deamination reaction, the group with a pKa of 7.2 is believed to represent a general base 
required to abstract a proton from H2O as it attacks the carbon of the imine formed upon 
oxidation of saccharopine. In the opposite direction reaction, the same group, seen in the 
V2/KLys pH-rate profile, must be protonated to donate a proton to the hydroxyl of the 
carbinolamine intermediate to facilitate H2O elimination. The second group observed on 
the acid side of the V2/KLys profile with a pKa of 7.2 is responsible for deprotonating the є-
amine of lysine, so that it can act as a nucleophile to form an imine with the α-oxo group 
99 
of α-Kg. In the slow reaction direction (formation of lysine), the observed pKa in the 
V1/KSacc pH-rate profile is 6.2. This pKa is likely the intrinsic pKa for the binding group, 
while it is perturbed to higher pH in the opposite direction (V2/KLys pH-rate profile), 
suggesting lysine is sticky (see pKiLeu). 
V2 also decreases at low pH with a limiting slope of +1 giving a pKa value of 5.8, 
indicating that another group on the enzyme must be deprotonated for optimum activity. 
It is possible that this pKa reflects a pH-dependent conformational change in the enzyme 
once all substrates are bound; perhaps the same conformational change seen as a medium 
effect in the proton inventory of V2. In agreement with this suggestion, the primary 
deuterium isotope effect decreases from 1.6 at pH 6.1 to 1.2 at pH 5.6, suggestive of a 
step other the hydride transfer becoming rate-limiting at low pH. 
4.2.3 Interpretation of pKi profiles 
The pKi profile for leucine, a competitive inhibitor of lysine, indicates a group 
with a pKa of 6.2 must be protonated for optimal binding of leucine. This is the same pKa 
observed in the V1/KSacc pH-rate profile that must be unprotonated to bind saccharopine. 
The group must also be unprotonated to accept a proton from the є-amine of lysine. The 
difference between lysine and leucine is that one has a positive charge and the other is 
hydrophobic. Since the group must be protonated to allow binding of the hydrophobic 
side chain of leucine, it is likely that it is a neutral acid (Asp or Glu). The perturbation of 
the pKa observed in the V2/KLys pH-rate profile is in agreement with the stickiness of 
lysine, as discussed above under the pH dependence of primary deuterium isotope effect. 
Given the large standard error on the pKa values, the isotope effects provide a better 
quantitative estimate of stickiness. In addition, the pKa perturbation likely reflects an 
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environmental change as lysine binds to the enzyme. Consistent with this suggestion, 
when leucine is bound, the pKa of the binding group increases to about 9.2, consistent 
with a neutral acid in a more hydrophobic environment. 
The pKiOG profile within the pH range 6.0-8.0 where the overall kinetic 
mechanism is random and OG binds to E:NADH:Lys is largely pH-independent with an 
average Ki value of 100 μM. As the pH is increased above 8 and below 6 where the 
kinetic mechanism changes to equilibrium ordered, the pKi also becomes pH-independent 
with an average Ki value of about 500 μM. The approximately 5-fold change in the Ki 
value (see the boxes in Fig. 3.10A) over these two pH ranges likely reflects the change in 
mechanism itself and the difference in affinity of OG for E:NADH:Lys and E:NADH. 
There is a transition between the two pH-independent regions, but the scatter in the data 
makes it difficult to see where the transition occurs. The boxes drawn in Fig. 3.10A are 
simply to highlight the two pH-independent regions. 
4.2.4 Proposed Chemical Mechanism 
The pH-rate profiles and isotope effect experiments discussed above are 
consistent with a proton shuttle chemical mechanism as shown in Scheme 4.3. Two 
groups serve as acid-base catalysts in the reaction, but one of them catalyzes most of the 
steps. In the direction of lysine formation, once NAD and saccharopine bind (I, in 
Scheme 4.3), the group with a pKa of 6.2, likely Asp or Glu as suggested on the basis of 
the difference in V2/KLys and pKiLeu pH-rate profiles, accepts a proton from the secondary 
amine of saccharopine as it is oxidized. This protonated general base then does not 
function until lysine is formed at the completion of the reaction. The concerted proton 
and hydride transfer is corroborated by the D/D2O multiple isotope effect. The general 
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base with a pKa of 7.2, likely a cationic acid such as Lys or His (on the basis of the 
differences in V1/KNAD and V2/KNADH pH-rate profile), accepts a proton from H2O as it 
attacks the Schiff base carbon (II) to form the carbinolamine intermediate (III). It is 
likely this step that reflects the solvent isotope effect on the step outside hydride transfer. 
The same residue then serves as a general acid and donates a proton to the carbinolamine 
nitrogen to give the protonated carbinolamine (IV). The carbinolamine collapses, 
facilitated by the proton shuttle accepting a proton from the carbinolamine hydroxyl to 
generate α-Kg and lysine (V). The amine nitrogen is then protonated by the group that 















































































Scheme 4.3: Proposed chemical mechanism for SDH. I. the formed central complex 
E:NAD:saccharopine once NAD and saccharopine bind. II. Schiff base intermediate. III. 
carbinolamine intermediate. IV. protonated carbinolamine. V. the generated central 
complex E:NADH:α-Kg-Lys. VI. protonated lysine. With the exception of saccharopine, 
no stereochemistry is implied. 
 
Isotope effect data suggest a difference in the pH-dependent and isotope-
dependent step (hydride transfer) at high pH. Data most likely reflect a pathway in which 
the general base with a pKa of 7.2 becomes deprotonated along the reaction pathway, 
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committing reactants to go on to products. A protonated carbinolamine (IV) is formed 
from lysine and α-Kg (V). The base then accepts a proton from the carbinolamine 
nitrogen to generate the neutral carbinolamine (III). Deprotonation of the base at this 
point causes the reaction to be committed to forming saccharopine. This step precedes the 
hydride transfer step and would still require protonation of the leaving hydroxide to 
generate the imine. This proton could be generated by the imine itself in II or from some 
other secondary proton donor. These details await additional experiments to sort out. 
As we were completing the chemical mechanism study, the structure of apo-SDH 
was solved (Albert M. Berghuis, McGill University, Canada, personal communication). 
The active site could be located using a binary complex of AlaDH with pyruvate bound; 
AlaDH is the closest homolog of SDH (20). On the basis of a superposition of the binary 
complex structures of AlaDH (E:NAD and E:pyruvate) and the apo-structure of SDH, the 
active site of the two enzymes has significant similarity. There are several Arg residues 
that may be in proper position to ion pair the three carboxylates of saccharopine, in 
agreement with the proposed role of arginine (101). The neutral acid suggested in our 
study that deprotonates saccharopine and lysine may be Asp 281, which located in the 
approximate vicinity predicted for the lysine side chain. In addition, the group with a pKa 
of about 7.2 in the proposed mechanism is likely Lys77, which is close to Lys 13, which 
may function as a Lys-Lys pair to serve as the general acid-base in the reaction. The Lys-
Lys pair would account for the low pKa observed in the pH-rate profiles for V1, V1/KNAD, 
V1KSacc, and V2/KLys. If protonated, the binding of NAD would be hindered as a result of 
the positive charge in the vicinity of the nicotinamide ring. 
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A couple of additional points should be mentioned. The proton to be transferred to 
the group with a pKa of 6.2 requires that there be a better match of the pKa values of the 
base and proton donor. The latter have solution values of 10-10.5 (saccharopine 
secondary amine and lysine є-amine), > 4 pH units higher than the base. As a result, there 
must be a shift in the pKa of the base to a higher value and the proton donor to a lower 
value, likely by about 2 pH units for each. The pKa perturbation likely results from 
neutralization of the charge of the binding groups in the active site (substrate 
carboxylates and Arg), which will make the site more hydrophobic, resulting in an 
increase in the putative enzymic carboxylate pKa and a decrease in the pKa of the proton 
donor (lysine є-amine or saccharopine secondary amine). The pKa of 9.2 observed in the 
pKiLeu profile once leucine is bound is consistent with the pKa perturbation. Another 
important point is that although the group with a pKa of 6.2 is unprotonated at the 
beginning and end of the reaction, the group with a pKa of 7.2 is in opposite protonation 
states at the beginning and end of the reaction and must be deprotonated for a new round 
of catalysis, and the proton is most likely exchanged with bulk solvent after the active site 
is open and products are released. 
 
4.3 Substrate Specificity of SDH 
The substrate specificity exhibited by most enzymes is a hallmark of biological 
systems, which distinguishes them from non-biological catalysts. A survey of substrate 
analogues was undertaken to determine which substrate functional groups are responsible 
for substrate binding, to determine the stereochemistry involved in substrate/inhibitor 
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binding, and to potentially define the geometry of the substrate binding site. These 
aspects are discussed below. 
4.3.1. NAD/NADH Analogues 
4.3.1.1 Kinetic Mechanism with NADP/NADPH 
In contrast to the previously published results (95), NADP does serve as a 
substrate, albeit poorly, in the direction of saccharopine oxidation. Under the conditions 
we examined, 6.5 times more enzyme was needed with NADP compared to assay 
conditions with NAD as the natural substrate at pH 7.55 and 9.2 (124). The Kia value of 
NADP increased about 2-fold, which is the same extent as the increase of Kia of NADPH 
comparing to that of NADH, suggesting that the presence of the phosphate at the C2 of 
the adenosine moiety of the coenzyme decreases its affinity only slightly. 
In the direction of saccharopine formation, substitution of NADPH for NADH 
results in the formation of saccharopine. Systematic initial velocity studies were carried 
out by varying the concentrations of NADPH and α-Kg at different fixed concentrations 
of lysine at pH 7.0 and 25 ˚C. Double-reciprocal patterns all intersects to the left of the 
ordinate, indicating a sequential kinetic mechanism. When data obtained were fitted to eq 
2.13 for a terreactant mechanism defined using NADH as a substrate (124), all terms in 
the denominator of the rate equation were present, and all parameters were well defined, 
consistent with a similar mechanism with NADPH. To test this hypothesis further, 
inhibition studies were carried out and are discussed below. 
As a competitive inhibitor of lysine, leucine competes with lysine for its binding 
site on the enzyme (124). An uncompetitive inhibition pattern is observed vs NADPH, 
indicating that leucine or lysine binds to an enzyme form that exists when NADPH is 
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saturating, suggesting that NADPH is the first substrate bound to the free enzyme in a 
sequential kinetic mechanism. The order of product release in the direction of 
saccharopine formation was examined using product inhibition by NADP. The 
competitive inhibition by NADP vs NADPH at low α-Kg and lysine concentrations 
indicates that NADP binds to the free enzyme, competing with NADPH, suggesting it is 
the last product released in the direction of saccharopine formation. 
The Ki value of NADPH increased about 2-fold compared to that of NADH. 
However, the presence of the 2’-phosphate resulted in about an order of magnitude 
increase in the Michaelis constants for all of the substrates. Km is equal to the product of 
the steady state concentration of substrate and the enzyme forms that are present at near 
zero substrate concentration divided by the concentration of enzyme forms that are 
present at saturating substrate concentration. Thus, the increase in Km likely reflects either 
an increase in the off-rate for NADP, which would increase the concentration of enzyme 
forms at near zero substrate, or a decrease in the affinity of the E:NADPH complex for 
lysine and α-Kg. Given the data in Table 3.8, it is the latter that is affected; note the 10- 
fold increase in Kiα-Kg when NADPH is the substrate compared to that with NADH. Data 
are consistent with a difference in the conformation of the E:NADH and E:NADPH 
complexes. 
When initial rates were measured with NADPH as the coenzyme, the double-
reciprocal plot exhibited substrate inhibition as the concentrations of α-Kg and lysine 
were increased above 50 mM and 100 mM, respectively. The observed substrate 
inhibition by α-Kg suggests the existence of the dead-end E:NADP:α-Kg complex, as is 
true with NADH as the substrate (124). In order to form this complex, the E:NADP form 
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must exist in the steady-state, which suggests that the release of NADP from E:NADP 
contributes to the overall rate limitation. The substrate inhibition by lysine suggests the 
existence of the dead-end E:Lys complex at high lysine concentrations, as is true with 
NADH as the substrate (124). 
4.3.1.2 Substrate Analogues of NAD 
In addition to NADP, the dinucleotide analogues 3-APAD, 3-PAAD, and thio-
NAD that contain modified nicotinamide rings, all support the oxidative deamination 
reaction. Because the concentrations of saccharopine used were roughly estimated to be 
around Km values, Kia values, dissociation constants for each of the dinucleotide 
analogues from the E:dinucleotide complex, and apparent Vmax values were obtained. The 
Kia values obtained at pH 7.55 and 9.2 indicate that there is no pH dependence over this 
range, as is true for NAD. 3-PAAD and thio-NAD bind to free enzyme with about the 
same affinity as NAD, suggesting that the amide NH2 of the nicotinamide ring does not 
contribute much in terms of coenzyme binding. The Kia value of 3-APAD is increased 
10-fold, suggesting that the binding pocket of the nicotinamide ring is relatively 
hydrophilic, and cannot accommodate the hydrophobic methyl group of 3-APAD very 
well. 
4.3.1.3 Inhibitory Nucleotide Analogues 
Ki values for dead-end inhibitors provide information on the importance of 
substrate binding since they occupy the same binding site as the substrate. With 
NAD(P)H as the varied substrate, NAD, NADP and 2’,3’-cyclic NADP all have about the 
same Ki, suggesting little or no effect of the 2’-phosphate on dinucleotide binding. NMN 
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binds poorly to the dinucleotide-binding site, with a 5-fold lower affinity. Some of the 
lower affinity can be explained by the 75-fold tighter binding of NADH than NAD, and 
the tighter binding of NAD at pH values above 7.2 (124). Consistent with this suggestion, 
ADP-ribose binds to free enzyme with a 5-fold increased affinity. This is still about 20-
fold lower than the affinity for NADH, indicative of the preference for the reduced 
nicotinamide ring. Elimination of the nicotinamide portion of the molecule as in ADP 
gives a 3-fold increase in affinity compared to ADP-ribose, but still 5-fold lower than 
NADH; while AMP has only a 3-fold lower affinity compared to NADH. Nonetheless, 
AMP binds 30-fold tighter than NAD. Adenosine binds with an 8-fold lower affinity 
compared to AMP, indicative of the importance of the α-phosphate. 
Data indicate that the majority of the binding energy of NAD comes from the 
AMP portion. In the case of ADP-ribose, the β-phosphate groups account for the lower 
affinity, suggesting that the binding pocket is slightly hydrophobic and/or negatively 
charged. Since NAD binds with an about 2-order of magnitude lower affinity compared 
to NADH, data suggest distinctly different conformations generated upon binding the two 
dinucleotides. 
4.3.1.4 pH Dependence of the Ki for AMP 
The pKi profile for AMP, a competitive inhibitor of NADH, indicates that two 
groups with pKa values of about 7.1 must be unprotonated, and one group about the same 
apparent pKa must be protonated for optimal binding of AMP. Since AMP has only one 
pKa over the pH range 5-10 with a value of 6.2-6.4 for 5’-phosphate, one of the groups 
with a pKa of 7.0 that must be unprotonated and the group with a pKa of 7.2 that must be 
protonated must come from the enzyme. On the basis of the proposed chemical 
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mechanism of SDH, the two groups seen in the pKiAMP profile are most likely Asp 281 
and Lys 77 (138). The former, with a pKa of about 6.2, is important for binding of 
saccharopine and likely serves as a general base in the oxidation step, while the group 
with a pKa of about 7.2, is likely responsible for activating water in hydrolysis of the 
imine formed upon oxidation of saccharopine, and is known to affect the binding of NAD. 
4.3.2 Keto Acid Analogues 
4.3.2.1 Kinetic Mechanism with Pyruvate 
The kinetic mechanism of SDH with pyruvate as the keto acid substrate has been 
fully characterized by initial velocity, dead-end inhibition, and primary deuterium kinetic 
isotope effect studies. The Initial velocity pattern obtained by varying the concentrations 
of pyruvate and lysine at a fixed level of NADH intersects to the left of the ordinate (data 
not shown), suggesting a sequential mechanism. Uncompetitive inhibition by leucine vs 
NADH indicates that NADH is the first substrate bound. Data suggest that the kinetic 
mechanism with pyruvate is the same as that observed with the natural substrate, α-Kg. 
When both NADH and NADD were used for the pyruvate reaction, finite isotope 







(V/KLys) are identical, within error, and initial velocity data suggest ordered addition 
of NADH before lysine and pyruvate, data suggest an equilibrium mechanism. However, 
the isotope effect on V decreases compared to the α-Kg reaction, suggesting that release 
of the product NAD still contributes to rate-limitation. 
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4.3.2.2 Substrate Analogues of Keto Acid 
Several α-keto acids can replace α-Kg, including glyoxylate, α-Kb, α-Kv, α-Km, 
and α-Ka, Table 3.9. The V/KEt values for all of the alternative substrates relative to α-Kg 
are decreased by 300- (α-Ka) to 2700- (pyruvate) fold, suggesting that the γ-carboxylate 
of α-Kg is important for proper binding of the α-keto acid substrate. However, OAA is 
not a substrate, and α-Ka is a substrate, but with a 5-fold lower V/Et value, indicating that 
the position of the side chain carboxylate is important. The V/Et for α-Kb is identical to 
that with α-Kg, while that of α-Kv is decreased by only about 2-fold. Data suggest that 
the optimum length of the side chain is 3 carbons (from the α-keto group up to and 
including the side chain carboxylate). In addition, α-Km can serve as a substrate but not 
OAA, suggesting that the binding pocket of the keto acid can accommodate a negative 
charge at the C3 but not the C4 position. 
4.3.2.3 Inhibitory Keto Acid Analogues 
The specificity of the keto acid substrate-binding pocket was assessed using 
mimics of α-Kg. Two classes of inhibitors, aliphatic and aromatic, were chosen as probes 
of the α-Kg binding site of SDH. With the exception of pyridine 2,5-dicarboxylate and L-
pipecolic acid, which exhibit no inhibition at high concentrations, and OAA and glutarate, 
which exhibit noncompetitive inhibition, all other compounds are competitive inhibitor of 
α-Kg. Glutarate and OAA give noncompetitive inhibition as a result of combination with 
E:NADH and E:NADH:Lys complexes (138). From these data, Table 3.12, the 
topography of the keto acid binding site is assessed with respect to the spatial relationship 
and distance between the C1-C2 unit and the C5 carboxylate. 
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Oxalylglycine, the tightest binding inhibitor discovered to date, is structurally 
most similar to α-Kg, and suggests optimization of the site for a 5-carbon α-oxo 
dicarboxylic acid. Oxalate, α-Km, OAA, α-Kg, OG, α-Ka, and α-Kp constitute a series of 
α-keto dicarboxylic acids and can be compared to α-Kg as such, Fig. 3.16B-C. The log of 
the affinity constant for each of the keto acid analogues can be plotted against the chain 
length corresponding to numbers of C atoms, Fig. 4.1. The binding affinity of OAA and 
α-Ka, which are a methylene group shorter and longer than α-Kg, respectively, have 
decreased about 50-fold in affinity compared to α-Kg. Similarly, the binding affinity of 
α-Km and α-Kp, with two methylene groups shorter and longer than α-Kg, respectively 
have decreased about 200-fold in affinity, while in the case of oxalate, with three fewer 
methylene groups, the binding affinity has been decreased by about 360-fold. Thus, 
binding of a 3 carbon chain is optimal, and the distance between the C1-C2 unit and the 
C5 carboxylate is an important factor for determining the affinity of SDH for the α-keto 
acid substrate. However, of the 5 α-keto acid analogues of α-Kg, only α-Km and α-Ka 
can serve as an alternative substrate. The keto acid substrate binding pocket can thus 
accommodate the geometry of α-Ka, suggesting that the flexibility of the α-Ka side chain 
allows binding of the δ-carboxylate to the group on enzyme that interacts with the γ-
carboxylate of α-Kg, while in the case of α-Km, the α-carboxylate is far enough away to 
eliminate its interaction with the same group. In addition, the α-oxo groups of α-Ka and 






Figure 4.1: Binding affinity of keto acid substrates against chain length from C3 and 
including the side chain carboxylate. From left to right are oxalate, α-Km, OAA, α-Kg, α-
Ka, and α-Kp, respectively. Points are experimental values, and curve is drawn by eye. 
 
Malonate, succinate, glutarate, and adipate, dicarboxylic acids, can also be 
considered as a series, Fig. 3.16C. Glutarate has the lowest Ki value, suggesting that a 
carboxylate at the 1 and 5 positions provides the tightest binding, consistent with the 
above consideration of α-keto acid analogues. Increasing or decreasing the chain length 
by a methylene or more decreases affinity by more than an order of magnitude. In 
addition, the inhibition constants of α-Kg and α-Ka, which have the α-oxo group, are 
decreased compared to those of glutarate and adipate, which have the same chain length, 
but no α-oxo group; the α-oxo contributes a factor of 10 in affinity. With malonate/α-Km 
as the inhibitors, there is no effect of the α-oxo group suggesting that the two 
carboxylates are likely bound to the α-carboxylate and α-oxo binding sites of α-Kg. 
Similarly, with succinate/OAA, an increase by a factor of 3 is observed for the α-oxo acid. 
Since the α-oxo contributes a factor of 10 in binding energy, the β-carboxylate of OAA 
must decrease the affinity by about 3-fold. This is likely a result either of binding the β-
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The importance of the C5 carboxylate group can be further illustrated by a series 
of α-keto analogues with hydrophobic side chains; the Ki or Km values of α-Kiv, α-Kv, 
and α-Kb are 36, 94, and 153 mM, respectively. However, all are alternative substrates, 
likely as a result of a lack of interaction with the group that binds the γ-carboxylate of α-
Kg. 
Finally, pyridine carboxylates provide information on the geometry of the bound 
α-Kg. If one assumes that the nitrogen atom of the pyridine ring mimics the oxygen atom 
of the α-keto group, a carboxylate in the 2-position is required. Addition of a second 
carboxylate, mimicking the γ-carboxylate of α-Kg can best be accommodated at the 4-
position as in pyridine 2,4-dicarboxylate, which has the lowest Ki value (1.1 mM at pH 
7.0). In addition, the Ki values of pyridine 2,4-dicarboxylate and glutarate are identical, 
within error, suggesting that the bulky aromatic ring does not affect binding when 
properly positioned. The distance between the two carboxylates of pyridine 2,4-
dicarboxylate is 3.77 Å, very close to that of glutarate in its extended conformation, 3.83 
Å (Cambridge Structural Database). Pyridine 2,3-dicarboxylate has a Ki value similar to 
those of malonate and succinate, which is not unreasonable, because the aromatic ring of 
the pyridine may orient these two carboxylates such that this part of structure mimics the 
3- and 4-carbon dicarboxylic acids. Data suggest that the keto acid binding pocket is 
relatively large and flexible, and can accommodate the bulky aromatic ring of the 
pyridine. 
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4.3.3 Amino Acid Analogues 
4.3.3.1 Inhibitory Amino Acid Analogues 
SDH exhibits an absolute specificity toward its amino acid substrate L-lysine. D-
Lysine is not a substrate, and binds with 5-fold lower affinity compared with L-lysine, 
consistent with the stereospecificity. To gain insight into the structural requirements for 
amino acid binding, lysine analogues were tested for their effectiveness to inhibit the 
reaction. The frame of reference is the Kd for lysine from the central complex. The 
primary deuterium kinetic isotope effects on V and (V/KLys) at pH 7.0 are identical, within 
error, and thus the Kd value for L-lysine is identical to its Km, i.e., 1.1 ± 0.2 mM (139). 
The inhibition constant of L-ornithine, a competitive inhibitor of L-lysine, with 
one fewer methylene group, is lower at pH 7.0 than that at pH 7.6, consistent with 
optimal binding as a result of interaction with the neutral form of an enzyme carboxylate 
(138). Interestingly, when ornithine was substituted for lysine, the inhibition constant is 
increased by about 5-fold compared to the Kd of lysine, suggesting that the length of 
hydrophobic portion of amino acid carbon side chain is essential for optimal binding. L-
Arginine and L-glutamine are poor inhibitors vs L-lysine, and L-asparagine causes no 
inhibition at 50 mM, indicating that the amino acid substrate binding site is hydrophobic, 
in agreement with previous results (138). 
The inhibition constants for aliphatic amino acids, L-valine, L-isoleucine, L-
methionine, L-norvaline, and L-leucine, as competitive inhibitors against L-lysine at pH 
7.0, are increased by at least 2-fold compared to the value at pH 6.0, consistent with the 
previously reported pH dependence of the pKi for leucine, which binds optimally at pH 
values below 6.0 (138). The pH dependence reflects a close proximity of the leucine 
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hydrophobic side chain to an enzyme carboxylate. Hydrophobic amino acids with a linear 
3 or 4 carbon side chain are good inhibitors. 
L-Leucine binds to the amino acid binding site with a higher affinity than the 
natural substrate L-lysine, suggesting the binding pocket can accommodate a branch at 
the γ-carbon. Consistent with this idea, L-methionine, with a large S atom substituent at 
δ-carbon, has the same binding affinity as L-lysine. However, a branch at the β-carbon, as 
is present in L-valine and L-isoleucine, increases the inhibition constant dramatically, 
indicating a tighter binding site at the C1 and C2 positions. 
4.3.4 Double Inhibition Studies 
In the direction of saccharopine formation, the double-inhibition pattern obtained 
with OG and ornithine is shown in Fig. 3.17. The inhibition by ornithine alone is 
observed as the line at zero OG, reflecting the E:NADH:ornithine complex, while the 
inhibition by OG alone (ordinate) reflects the E:NADH:OG complex. The slope effect 
indicates the enhancement of inhibition as a result of synergism of binding between OG 
and ornithine. A value of 0.7 obtained for α suggests a 1.4-fold increase in the affinity of 
OG in the presence of ornithine, compared to its absence. Since OG and ornithine are 
competitive inhibitors of α-Kg and lysine, respectively, the observed synergism of 
binding between OG and ornithine suggests a slight synergism of binding between α-Kg 
and lysine. However, when concentration was increased, OG began to compete with 
ornithine for the lysine binding site (data not shown), consistent with the proposed kinetic 
mechanism (124). In contrast, results obtained with pyridine 2,4-dicarboxylic acid and 
ornithine double inhibition gives a value of 2.4 for α, suggesting antagonism of binding. 
The difference in the double-inhibition patterns of OG and pyridine 2,4-dicarboxylic acid 
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is due to difference in structure of the bulky pyridine and the optimally bound OG. The 
bulky aromatic ring of pyridine 2,4-dicarboxylic acid likely interferes with the binding of 
ornithine, while in the case of OG, structurally very similar to α-Kg, a better indication of 
the interaction of α-Kg and lysine is obtained. 
 
4.4 Conclusion 
4.4.1 Kinetic Mechanism 
Kinetic data have been measured for SDH from S. cerevisiae, suggesting the 
ordered addition of NAD
 
followed by saccharopine in the physiologic reaction direction. 
In the opposite direction, NADH adds to the enzyme first, while there is no preference for 
the order of binding of α-Kg and lysine. In the direction of saccharopine formation, data 
also suggest that, at high concentrations, lysine inhibits the reaction by binding to free 
enzyme. In addition, uncompetitive substrate inhibition by α-Kg and double inhibition by 
NAD and α-Kg suggest the existence of an abortive E:NAD:α-Kg complex. Product 
inhibition by saccharopine is uncompetitive vs NADH, suggesting a practical 
irreversibility of the reaction at pH 7.0 in agreement with the overall Keq. Saccharopine is 
noncompetitive vs lysine or α-Kg, suggesting the existence of both E:NADH:Sacc and 
E:NAD:Sacc complexes. NAD is competitive vs NADH, and noncompetitive vs lysine 
and α-Kg, indicating the combination of the dinucleotides with free enzyme. Dead-end 
inhibition studies are also consistent with the random addition of α-Kg and lysine. 
Leucine and oxalylglycine serve as lysine and α-Kg dead-end analogues, respectively, 
and are uncompetitive against NADH and noncompetitive against α-Kg and lysine, 
respectively. OAA, pyruvate, and glutarate, behave as dead-end analogue of lysine, 
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which suggests that the lysine-binding site has a higher affinity for keto acid analogues 
than does the α-Kg site or that dicarboxylic acids have more than one binding mode on 
the enzyme. In addition, OAA and glutarate also bind to free enzyme as does lysine at 
high concentration. Glutarate gives S-parabolic noncompetitive inhibition vs NADH, 
indicating the formation of a E:(glutarate)2 complex as a result of occupying both the 
lysine- and α-Kg-binding sites. Pyruvate, a slow alternative keto acid substrate, exhibits 
competitive inhibition vs both lysine and α-Kg, suggesting the combination to the 
E:NADH:α-Kg and E:NADH:lysine enzyme forms. The equilibrium constant for the 
reaction has been measured at pH 7.0 as 3.9 x 10
-7
 M by monitoring the change in NADH 
upon the addition of the enzyme. The Haldane relationship is in very good agreement 
with the directly measured value. 
4.4.2 Chemical Mechanism 
The proton shuttle chemical mechanism is proposed on the basis of the pH 
dependence of kinetic parameters, dissociation constants for competitive inhibitors, and 
isotope effects. In the direction of lysine formation, once NAD and saccharopine bind, a 
group with a pKa of 6.2 accepts a proton from the secondary amine of saccharopine as it 
is oxidized. This protonated general base then does not participate in the reaction again 
until lysine is formed at the completion of the reaction. A general base with a pKa of 7.2 
accepts a proton from H2O as it attacks the Schiff base carbon of saccharopine to form 
the carbinolamine intermediate. The same residue then serves as a general acid and 
donates a proton to the carbinolamine nitrogen to give the protonated carbinolamine. 
Collapse of carbinolamine is then facilitated by the same group accepting a proton from 
the carbinolamine hydroxyl to generate α-Kg and lysine. The amine nitrogen is then 
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protonated by the group that originally accepted a proton from the secondary amine of 
saccharopine, and products are released. In the reverse reaction direction, finite primary 
deuterium kinetic isotope effects were observed for all parameters with the exception of 
V2/KNADH, consistent with a steady-state random mechanism and indicative of a 
contribution from hydride transfer to rate limitation. The pH dependence, as determined 




(V2/KLys), suggests that a step other than 
hydride transfer becomes rate-limiting as the pH is increased. This step is likely 
protonation/deprotonation of the carbinolamine nitrogen formed as an intermediate in 
imine hydrolysis. The observed solvent isotope effect indicates that proton transfer also 
contributes to rate limitation. A concerted proton and hydride transfer is suggested by 
multiple substrate/solvent isotope effect, as well as a proton transfer in another step, 
likely hydrolysis of the carbinolamine. In agreement, dome-shaped proton inventories are 
observed for V2 and V2/KLys, suggesting that proton transfer exists in at least two 
sequential transition states. 
4.4.3 Substrate Specificity and Binding Pockets 
Saccharopine dehydrogenase is the only enzyme in the α-aminoadipate pathway 
for lysine biosynthesis in fungi for which mechanistic data have been obtained and for 
which a structure has recently been determined (Albert M. Berghuis, personal 
communication). This allows an elucidation of the molecular basis for the specificity of 
SDH for all of its substrates.  A survey of NADH, α-Kg, and lysine analogues has been 
undertaken to define the geometry of the active site and to identify functional groups on 
all three substrates important for substrate binding. The following can be concluded. 
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1. The majority of the binding energy of dinucleotides comes from the AMP 
portion of the molecule. 
2. Distinctly different conformations are generated upon binding of the oxidized 
and reduced dinucleotides, and upon binding of NADH or NADPH. 
3. The binding pocket for the nicotinamide ring is largely hydrophilic. 
4. A side chain with 3 carbons (from the α-keto group up to and including the side 
chain carboxylate), with 2 carbons between the C1-C2 unit and the C5 carboxylate is 
optimal for binding of α-keto acids; the α-oxo group contributes a factor of 10 in affinity. 
5. The keto acid binding pocket is relatively large and flexible, and can 
accommodate the bulky aromatic ring of pyridine dicarboxylic acid and a negative charge 
at the C3 but not the C4 position. 
6. The amino acid substrate binding pocket is hydrophobic, and the optimal length 
of the hydrophobic portion of the amino acid side chain is 3 or 4 carbons. 
7. The amino acid binding pocket can accommodate a branch at the γ-carbon, but 












Multiple Sequence Alignments 
 
CLUSTAL W multiple sequence alignment of saccharopine dehydrogenases (SDH) and 




                      10        20        30        40        50        60 









                                  : :  * *  * * .*:*     *   .. : :*   .   
Prim.cons.    MAATAPESATTSA23M22V222LRAETKPLEARSALTPTTVK3LLDAGFEVYVE32ASPQ 
 
 
                      70        80        90       100       110       120 









                *        *  ::   .          :. :**    .   : :  : *:  * .   
Prim.cons.    RIFDD2EYEQ2GA2IVPEGSWV3DAPKDRMIIGLKELPENETFPL8HEHIQFAHCYKDQA 
 
 
                     130       140       150       160       170       180 









              .  .:          :  : :       * :. :   :  **                   
Prim.cons.    GW22VLSRFP3G2GTLYDLEFLED3D2GRRVAAFGFHAGFAGAAIGVL2WAFQQTHPGGE 
 
 
                     190       200       210       220       230       240 










                        :            :                      ::.            
Prim.cons.    GTKGEGEG3LLPGV3PYPNEKEL2K2VK32L2EALKK2GG4GPKVL2IGALGRCGSGAID 
 
 
                     250       260       270       280       290       300 









                           .    :.     :       *::: .: :.   .       :      
Prim.cons.    L2RKVGIP23NIIKWDI3ETKKGGPFQEIVDEADIFINCIYLSKPIPPFINTESLN3PGA 
 
 
                     310       320       330       340       350       360 









               :   .: **: *     . :      * .  **                 .: ::*  : 
Prim.cons.    NR2LSVIVDVSADTTNPHNPIP2Y2IATTFD3PTVEV22V3LAAGPKLSVISIDHLPSLL 
 
 
                     370       380       390       400       410       420 









              *  ::  :    :*    : :     .      *                           
Prim.cons.    PREASEAFSE2LLPSLLQLPNRDTAPVWVRAK2LFD3HVARLG3S5REAV322LGYEYVP 
 
 
                     430 









                             
Prim.cons.    AE2222D22SVAGA 
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Sequence alignment of saccharopine reductase (SR) and saccharopine dehydrogenase 
(SDH) (12 % identity and 20 % similarity) 
 
                       10        20        30        40        50        60 
                        |         |         |         |         |         | 
(SR)Scerevisia MGKNVLLLGSGFVAQPVIDTLAANDDINVTVACRTLANAQALAKPSGSKAISLDVTDDSA 
(SDH)Scerevisi ------MAAVTLHLRAETKPLEARAALTPTTVKKLIAKGFKIYVEDSP-------QSTFN 
                     : .  :  :.  ..* *.  :. *.. : :*:.  :   ...        .    
Prim.cons.     MGKNVL22222222222222L2A222222T222222A22222222222KAISLDV22222 
 
                       70        80        90       100       110       120 
                        |         |         |         |         |         | 
(SR)Scerevisia LDKVLADNDVVISLIPYTFHP-NVVKSAIRTKTDVVTSSYISPALRELEPEIVKAGITVM 
(SDH)Scerevisi INEYRQAGAIIVPAGSWKTAPRDRIIIGLKEMPETDTFPLVHEHIQFAHCYKDQAGWQNV 
               :::    . :::.  .:.  * : :  .::  .:. * . :   ::  .    :**   : 
Prim.cons.     22222222222222222222PR22222222222222T22222222222222222AG2222 
 
                      130       140       150       160       170       180 
                        |         |         |         |         |         | 
(SR)Scerevisia NEIGLDPGIDHLYAVKTIDEVHRAGGKLKSFLSYCGGLPAPEDSDNPLGYKFSWSSRGVL 
(SDH)Scerevisi -LMRFIKGHGTLYDLEFLENDQ--GRRVAAFGFYAG---------------F----AGAA 
                 : :  * . ** :: ::: :  * :: :*  *.*               *     *.  
Prim.cons.     N222222G222LY222222222RAG22222F22Y2GGLPAPEDSDNPLGYKFSWSS2G22 
 
                      190       200       210       220       230       240 
                        |         |         |         |         |         | 
(SR)Scerevisia LALRNSAKYWKDGKIETVSSEDLMATAKPYFIYPGYAFVCYPNRDSTLFKDLYHIPEAET 
(SDH)Scerevisi LGVRDWA--FKQTHS--DD-EDLPAVS-P-----------YPN-EKALVKDVTKD---Y- 
               *.:*: *  :*: :    . *** *.: *           *** :.:*.**: :       
Prim.cons.     L22R22AKY2K2222ET22SEDL2A22KPYFIYPGYAFVCYPNR222L2KD2222PEA2T 
 
                      250       260       270       280       290       300 
                        |         |         |         |         |         | 
(SR)Scerevisia VIRGTLRYQGFPEFVKALVDMGMLKDDANEIFSKPIAWNEALKQYLGAKSTSKEDLIASI 
(SDH)Scerevisi --KEALATGARKPTVLIIGALGRCGSGAIDLLHK-VGIPDANILKWDIKETSRGGPFDEI 
                 : :*   .    *  :  :*   ..* ::: * :.  :*     . *.**: . : .* 
Prim.cons.     VI222L22222222V222222G22222A22222KP22222A2222222K2TS2222222I 
 
                      310       320       330       340       350       360 
                        |         |         |         |         |         | 
(SR)Scerevisia DSKATWKDDEDRERILSGFAWLGLFSDAKITPRGNALDTLCARLEELMQYEDNERDMVVL 
(SDH)Scerevisi PQADIFINCIYLSKPIAPFTNMEKLNNPNRRLR--------TVVDVSADTTNPHNPIPIY 
                .   : :    .: :: *: :  :.:.:   *        : ::   :  : .. : :  
Prim.cons.     222222222222222222F2222222222222RGNALDTLC2222222222222222222 
 
                      370       380       390       400       410       420 
                        |         |         |         |         |         | 
(SR)Scerevisia QHKFGIEWADGTTETRTSTLVDYGKVGGYSSMAATVGYPVAIATKFVLDGTIKGPGLLAP 
(SDH)Scerevisi TVATVFNKPTVLVPTTAGPKLSVISIDHLPSLLP-----R-EASEFFSHDLLPSLELLPQ 
                    :: .   . * :.. :.  .:.  .*: .        *::*. .. : .  **.  
Prim.cons.     22222222222222T222222222222222S222TVGYP2A2A22F2222222222LL22 
 
                      430       440 
                        |         | 
(SR)Scerevisia YSPEINDPIMKELKDKYGIYLKEKTVA 
(SDH)Scerevisi RKTAPVWVRAKKLFDRHCARVKRSSRL 
                ..       *:* *::   :*..:   
Prim.cons.     2222222222K2L2D222222K22222 
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Sequence alignment of α-aminoadipate semialdehyde synthetase (AASS) N-terminus 
from human and SDH from S. cerevisiae (19 % identity and 18 % similarity) 
 
                     10        20        30        40        50        60 
                      |         |         |         |         |         | 
AASSHum      MLQVHRTGLGRLGVSLSKGLHHKAVLAVRREDVNAWERRAPLAPKHIKGITNLGYKVLIQ 
SDHScer      ---------------------MAAVTLHLRAETKPLEARAALTPTTVKKLIAKGFKIYVE 
                                    **    * :.:. * **.*:*. :* :   *:*: :: 
Prim.cons.   MLQVHRTGLGRLGVSLSKGLH22AV2222R222222E2RA2L2P222K22222G2K2222 
 
                     70        80        90       100       110       120 
                      |         |         |         |         |         | 
AASSHum      PSNRRAIHDKDYVKAGGILQED-----ISEACLILGVKRPPE-EKLMSRKTYAFFSHTIK 
SDHScer      DSPQSTFNINEYRQAGAIIVPAGSWKTAPRDRIIIGLKEMPETDTFPLVHEHIQFAHCYK 
              * : ::: ::* :**.*:         ..  :*:*:*. ** :.:   : :  *:*  * 
Prim.cons.   2S222222222Y22AG2I2222GSWKT222222I2G2K22PET22222222222F2H22K 
 
                    130       140       150       160       170       180 
                      |         |         |         |         |         | 
AASSHum      AQEANMGLLDEILKQEIRLIDYEKMVDHRGVRVVAFGQWAGVAGMINILHGMGLRLLALG 
SDHScer      DQAGWQNVLMRFIKGHGTLYDLEFLENDQGRRVAAFGFYAGFAGAA--LG---VRDWAFK 
              * .  .:* .::* .  * * * : :.:* **.*** :**.**    *    :*  *:  
Prim.cons.   2Q222222L2222K2222L2D2E222222G2RV2AFG22AG2AG22NIL2GMG2R22A22 
 
                    190       200       210       220       230       240 
                      |         |         |         |         |         | 
AASSHum      -HHTPFMHIGMAHNYRNSSQAVQAVRDAGYEISLGLMPKSIGPLTFVFTGTGNVSKGAQA 
SDHScer      QTHSDDEDLPAVSPYPNEK---ALVKDVTKDYKEALATGARKPTVLIIGALGRCGSGAID 
               *:   .:  .  * *..     *:*.  : . .* . :  * .::: . *. ..**   
Prim.cons.   Q2H22222222222Y2N22QAV22V2D22222222L222222P22222222G2222GA22 
 
                    250       260       270       280       290       300 
                      |         |         |         |         |         | 
AASSHum      IFN--ELPCEYVEPHELKEVSQTGDLRKVYGTVLSRHHHLVRKTDAVYDPAEYDKHPERY 
SDHScer      LLHKVGIPDANILKWDIKETSRGGPFDEIPQADIFINCIYLSKPIAPFTNMEKLNNPNRR 
             :::   :*   :   ::**.*: * : ::  : :  :   : *. * :   *  ::*:*  
Prim.cons.   222KV22P222222222KE2S22G222222222222222222K22A22222E2222P2R2 
 
                    310       320       330       340       350       360 
                      |         |         |         |         |         | 
AASSHum      ISRFNTDIAPYTTCLINGIYWEQNTPRLLTRQDAQSLLAPGKFSPAGVEGCPALPHKLVA 
SDHScer      LR------------------------------------------------------TVVD 
             :                                                       .:*  
Prim.cons.   22RFNTDIAPYTTCLINGIYWEQNTPRLLTRQDAQSLLAPGKFSPAGVEGCPALPH22V2 
 
                    370       380       390       400       410       420 
                      |         |         |         |         |         | 
AASSHum      ICDISADTGGSIEFMTECTTIEHPFCMYDADQHIIHDSVEGSGILMCSIDNLPAQLPIEA 
SDHScer      VSADTTNPHNPIPIYTVATVFNKP-------TVLVPTTV-GPKLSVISIDHLPSLLPREA 
             :.  :::. ..* : * .*.:::*         ::  :* *. : : ***:**: ** ** 
Prim.cons.   22222222222I222T22T2222PFCMYDAD2222222VEG222222SID2LP22LP2EA 
 
                    430       440       450       460       470 
                      |         |         |         |         | 
AASSHum      TECFGDMLYPYVEEMILSDATQPLESQNFSPVVRDAVITSNGTLPDKYKYIQTLRESRE 
SDHScer      SEFFSHDLLPSLELLPQRKTAP--------VWVR------AKKLFDR-HCARVKRSSRL 
             :* *.. * * :* :   .::           **        .* *: :  :. *.**  
Prim.cons.   2E2F222L2P22E222222222PLESQNFS22VRDAVITS222L2D2Y222222R2SR2 
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Sequence alignment of α-aminoadipate semialdehyde synthetase (AASS) C-terminus 
from human and SR from S. cerevisiae (39 % identity and 26 % similarity) 
 
                     10        20        30        40        50        60 
                      |         |         |         |         |         | 
AASSHum      MGTRRKVLVLGSGYISEPVLEYLSRDGNIEITVGSDMKNQIEQLGKKYNINPVSMDICKQ 
SRScere      MG--KNVLLLGSGFVAQPVIDTLAANDDINVTVACRTLANAQALAKPSGSKAISLDVT-D 
             **  ::**:****::::**:: *: :.:*::**..    : : *.*  . :.:*:*:  : 
Prim.cons.   MGTR22VL2LGSG2222PV222L22222I22TV2222222222L2K2222222S2D22K2 
 
                     70        80        90       100       110       120 
                      |         |         |         |         |         | 
AASSHum      EEKLGFLVAKQDLVISLLPYVLHPLVAKACITNKVNMVTASYITPALKELEKSVEDAGIT 
SRScere      DSALDKVLADNDVVISLIPYTFHPNVVKSAIRTKTDVVTSSYISPALRELEPEIVKAGIT 
             :. *. ::*.:*:****:**.:** *.*:.* .*.::**:***:***:*** .: .**** 
Prim.cons.   222L2222A22D2VISL2PY22HP2V2K22I22K222VT2SYI2PAL2ELE22222AGIT 
 
                    130       140       150       160       170       180 
                      |         |         |         |         |         | 
AASSHum      IIGELGLDPGLDHMLAMETIDKAKEVGATIESYISYCGGLPAPEHSNNPLRYKFSWSPVG 
SRScere      VMNEIGLDPGIDHLYAVKTIDEVHRAGGKLKSFLSYCGGLPAPEDSDNPLGYKFSWSSRG 
             ::.*:*****:**: *::***:.:..*..::*::**********.*:*** ******. * 
Prim.cons.   222E2GLDPG2DH22A22TID22222G2222S22SYCGGLPAPE2S2NPL2YKFSWS22G 
 
                    190       200       210       220       230       240 
                      |         |         |         |         |         | 
AASSHum      VLMNVMQSATYLLDGKVVNVAGGISFLDAVTSMDFFPGLNLEGYPNRDSTKYAEIYGISS 
SRScere      VLLALRNSAKYWKDGKIETVSS-EDLMATAKPYFIYPGYAFVCYPNRDSTLFKDLYHIPE 
             **: : :**.*  ***: .*:.  .:: :...  ::**  :  ******* : ::* *.. 
Prim.cons.   VL22222SA2Y22DGK222V22G2222222222222PG22222YPNRDST22222Y2I22 
 
                    250       260       270       280       290       300 
                      |         |         |         |         |         | 
AASSHum      AHTLLRGTLRYKGYMKALNGFVKLGLINREALPAFRPEANPLTWKQLLCDLVGISPSSEH 
SRScere      AETVIRGTLRYQGFPEFVKALVDMGMLKDDANEIFS---KPIAWNEALKQYLGAKSTSKE 
             *.*::******:*: : ::.:*.:*::: :*   *    :*::*:: * : :* ..:*:. 
Prim.cons.   A2T22RGTLRY2G22222222V22G22222A222F2PEA2P22W222L2222G2222S22 
 
                    310       320       330       340       350       360 
                      |         |         |         |         |         | 
AASSHum      DVLK----EAVLKKLGGDNTQLEAAEWLGLLGDEQVPQAESILDALSKHLVMKLSYGPEE 
SRScere      DLIASIDSKATWKDDEDRERILSGFAWLGLFSDAKITPRGNALDTLCARLEELMQYEDNE 
             *::     :*. *.  . :  *..  ****:.* ::.   . **:*. :*   :.*  :* 
Prim.cons.   D222SIDS2A22K22222222L2222WLGL22D222222222LD2L222L22222Y222E 
 
                    370       380       390       400       410       420 
                      |         |         |         |         |         | 
AASSHum      KDMIVMRDSFGIRHPSGHLEHKTIDLVAYGDINGFSAMAKTVGLPTAMAAKMLLDGEIGA 
SRScere      RDMVVLQHKFGIEWADGTTETRTSTLVDYGKVGGYSSMAATVGYPVAIATKFVLDGTIKG 
             :**:*::..***. ..*  * :*  ** **.:.*:*:** *** *.*:*:*::*** * . 
Prim.cons.   2DM2V2222FGI2222G22E22T22LV2YG222G2S2MA2TVG2P2A2A2K22LDG2I22 
 
                    430       440       450 
                      |         |         | 
AASSHum      KGLMGPFSKEIYGPILERIKAEGIIYTTQSTIKP 
SRScere      PGLLAPYSPEINDPIMKELKDKYGIYLKEKTVA- 
              **:.*:* ** .**::.:* :  ** .:.*:   
Prim.cons.   2GL22P2S2EI22PI2222K2222IY2222T22P 
 
ClustalW at NPS@ (Network Protein Sequence Analysis) from Pole 
Bioinformatique Lyonnais, France was used to perform multiple sequence alignments of 
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SDH and Ala, SDH and SR, respectively. Results suggest that the residues involved in 
the substrate binding site and/or active site of ADH from P. lapideum (Lys10, Lys74, 
Glu13, Arg15, His95, Glu117, and Asp269) are all highly conserved in SDH among 
different organisms. However, SR shares very little sequence similarity with SDH at the 
amino acid level. 
Family and Domain searches were carried out using the InterPro tool from 
EMBL-EBI (European Molecular Biology Laboratories – European Bioinformatic 
Institute) and Superfamily program (version 1.69) from HMM (Hidden Markov Models) 
library and genome assignment server. SDH belongs to the Alanine Dehydrogenase and 
Pyridine Nucleotide Transhydrogenase family (IPR 008141). It contains Alanine 
dehydrogenase/PNT, C-terminal domain (IPR 007698) and Alanine dehydrogenase/PNT, 
N-terminal domain (IPR 007886). It also contain a NAD(P)-binding Rossmann-fold 
domain (SSF 51735), and a Formate/glycerate dehydrogenase catalytic domain-like (SSF 
52283). By comparison, SR belongs to the Saccharopine Dehydrogenase family (IPR 
005097), and this family is comprised of three structural domains that can not be 
separated in the linear sequence. 
In aminals including humans, interestingly, the AASS, a bi-functional enzyme, 
catalyzes both SR and SDH reactions. The sequence alignment of the N-terminus of 
AASS and SDH, and the C-terminus of AASS and SR has been carried out, respectively. 
The residues involved in the substrate binding site and/or active site of SDH (Lys13, 
Glu16, Arg18, Lys77, His96, Glu122, Arg131, Asp319, and His320), and in the substrate 
binding sites of SR (Trp173, Pro126, Arg246, Arg223, and Ser98) are highly conserved 
in AASS N- and C- terminus, respectively. 
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APPENDIX II 
Pre-steady-state Kinetic, Physical, and Spectral Properties of SDH 
 
II.1 INTRODUCTION 
In addition to the studies carried out on SDH and presented in the main body of 
this dissertation, studies included in this Appendix were also carried out. In all cases the 
studies are preliminary. However, each of the studies represents a viable line of research 
that can be followed up in the future. Methods are first presented followed by 
presentation of data and interpretation. It should be noted that none of the following 
individual projects in this Appendix is in the shape for publication. 
II.2 MATERIALS AND METHODS 
II.2.1 Pre-Steady-State Study of SDH by Stopped-Flow Kinetic Experiment 
Pre-steady-state kinetic measurements were carried out using a temperature-
controlled OLIS-RSM 1000 stopped-flow spectrophotometer. Sample solutions were 
prepared in two syringes at the same pH with a final buffer concentration of 100 mM 
Hepes at pH 7.0. The first syringe contained 2 mL of 45 μM SDH, while the second 
syringe contained a 2 mL mixture of NAD and saccharopine at concentrations of 10 mM 
and 100 mM, respectively. Thus, after mixing, final concentrations were half of those 
given above. Data were obtained in the rapid-scanning mode, over the wavelength range 
300-540 nm. A spectrum obtained by mixing ddH2O in the first syringe and the reactant 
mixture in the second syringe was used as a baseline for the plus enzyme experiments. 
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Data Processing. The time course of data at 340 nm from the rapid kinetic 
experiment was fitted using eq II.1 for a sequential process A-B-C, monitoring B and C, 
respectively. 
 














                                                                           (II.1) 
 
In eq II.1, k1 and k2 are fist-order rate constants, t is time, and e is 2.718. Fits to the data 
using an equation that describes two parallel first-order reactions were poor as judged by 
the residuals and a comparison of the theoretical time course derived from the fitted 
estimates and the experimental. 
II.2.2 Determination of the Oligomerization State of SDH by HPLC 
The Beckman analytical HPLC system was used to estimate the native M.W. of 
SDH by size exclusion chromatography. A TSK G3000SW column with a Mr 
fractionation range of 10-50 kDa was used. The running buffer (mobile phase) contained 
100 mM KH2PO4 and 100 mM K2SO4 at pH 7.5. The flow rate was set to 0.75 mL/min. 
A 10 μL (2 mg/mL) sample of His-tagged SDH (44 kDa per monomer) was loaded onto 
the column and collected over a chromatogram time of 1 hr. The standards for molecular 
mass determination were blue dextran (BD, 2000 kDa), alcohol dehydrogenase from 
yeast (AlcDH, 150 kDa), bovine serum albumin (BSA, 66 kDa), and carbonic anhydrase 
from bovine erythrocytes (CA, 29 kDa). Samples of 20 uL of each were loaded at the 
following concentrations: 1, 1, 1, and 2 mg/mL, respectively. The retention time for BD, 
AlcDH, BSA, CA, and SDH is 11. 7, 16.8, 18.4, 22.1, and 20.7 min, respectively. Elution 
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was monitored at 280 nm. And data were analyzed by plotting logM.W. against retention 
time using the Excel program. 
II.2.3 Substrate Binding Study of SDH by Isothermal Titration Calorimetry 
Titrations were carried out with a Micro Calorimetry System from MicroCal, Inc. 
The enzyme prepared for ITC was dialyzed overnight against 100 mM Tris at pH 7.5. In 
order to match the pH and buffer concentration between the solutions in the stirred cell 
and the injection syringe, the dialysis buffer was used to make up the substrate solutions 
for the injection syringe. The stirred cell contained SDH at a typical concentration of 
about 0.12 mM (enzyme monomer). The injection syringe contained substrates at a 
concentration greater than 10 times their respective Km depending on the experiment. If 
necessary, in addition to the enzyme, the stirred cell also contained a substrate at a 
concentration greater than 10 Km. The concentrations of substrates used in each 
experiment are given in the legends. For all experiments, a total 21 injections of a 4 μL 
injection volume were made at 240 s intervals at 15 ºC. Blank titrations were done in the 
absence of the enzyme to correct for heats of dilution and mixing. The control titrations 
were subtracted from the experimental titrations prior to data analysis. The data were 
analyzed by the Origin software provided by MicroCal, Inc, and data were fitted to a 
single-site model. 
II.2.4 Substrate Binding by Fluorescence Titration 
Fluorescence spectra were recorded on a Shimadzu RF-5301 PC 
spectrofluorometer. The reaction temperature was maintained at 25 ºC by a cuvette holder 
using a circular water bath. A quartz cuvette with a 1 mL volume and 1 cm path length 
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was used to record the spectrum for both sample and blank. Excitation and emission slit 
widths were set to 3.0 nm, and emission was scanned from 300-550 nm with the 
excitation monochromator fixed at 298 nm so that only Trps were excited. Blank spectra 
contained all sample components with the exception of enzyme (360 μg/mL), and were 
subtracted from sample spectra. The spectra of free enzyme were measured at pH 7.0 
using a final concentration of 100 mM Tris. The concentrations of each substrate were 
either maintained at their reported Km values or at saturation (10Km). 
II.2.5 Secondary Structure Determination of SDH by Circular Dichroism 
Circular dichroic spectra were measured at room temperature using an upgraded 
AVIV-62DS-CD spectrometer equipped with a circulating bath to maintain temperature 
constant at 25 ºC. Spectra were obtained in a 0.2 cm quartz cuvette with a sample volume 
of 0.5 mL. The SDH concentration was 50 μg/mL in 20 mM KH2PO4 at pH 7.0. The 
blank contained all the components with the exception of enzyme and was subtracted to 
obtain the corrected spectrum. The time constant and the bandwidth were maintained at 
100 ms and 1 nm, respectively. The averaging and dwell time were set at 1 s. The spectra 
were recorded in the far-UV range (250-198 nm), at intervals of 1 nm. The sample was 
scanned three times and the average is shown. 
II.3 RESULTS AND DISCUSSIONS 
II.3.1 Pre-Steady-State Study of SDH 
The rapid-scanning-stopped-flow kinetic experiment was carried out by pushing a 
45 μM SDH against a reaction mixture containing 10 mM NAD and 100 mM 
saccharopine. A prominent burst is the observed at the beginning of the progress curve, 
130 
Fig. II.1. The calculated burst rate is 8.8 ± 1.0 s
-1
, the calculated steady-state rate is 0.8 ± 
0.1 s
-1

































Figure II.1: Spectra from rapid-scanning-stopped-flow kinetic experiments. (A) 
Rapid scanning spectra of SDH.  (B) Time course for the SDH reaction with NAD and 
saccharopine monitored at 340 nm. The final concentrations after dilution are as follows: 
enzyme, 22.5 μM; NAD, 5 mM; saccharopine, 50 mM. Solid curve is drawn through the 
experimental points generated from the fitted kinetic constants. 
 
 
The burst observed in the stopped-flow experiment in the pre-steady-state time 
scale of SDH reaction indicates that a slow step occurs after the formation of NADH, the 
chromophoric substrate monitored. Results from the pH dependence of the primary 




(V2/KLys) suggest that a step other than hydride transfer 
becomes rate-limiting as the pH is increased, and this step is likely 
protonation/deprotonation of the carbinolamine nitrogen formed as an intermediate in 
imine hydrolysis (Discussion 4.2.1.1.2). Therefore, the pre-steady-state data are 
consistent with the isotope effect results. In addition, the calculated steady-state rate k2 
(kss, 0.8 s
-1
) from pre-steady-state study is identical, within error, with the kcat (1.1 s
-1
) 




II.3.2 Size Exclusion Chromatography HPLC 
On the basis of the elution profile of the standards, a standard curve was 
constructed and is shown in Fig. II.2. The equation for the standard curve is y = -5.3348x 
+ 44.929. The retention time of the SDH is 20.7 min, allowing an estimation of a M.W. 
of 34,400 ± 4,800 Da. By comparison, the ProtParam tool from ExPASy (Expert Protein 
Analysis System) proteomics server of the Swiss Institute of Bioinformatics has been 
used to estimate the physical properties of SDH with and without His-tag, as shown in 
























Figure II.2: HPLC elution profile. The position of standards for molecular mass 
determination is shown as ■, and from left to right, are carbonic anhydrase (29 kDa, 22.1 
min), BSA (66 kDa, 18.4 min), alcohol dehydrogenase (150 kDa, 16.8 min), and blue 
dextran (2000 kDa, 11.7), respectively. SDH is shown as ♦. 
 
 
Table II.1: Estimated Physical Properties of SDHs by ProtParam Tool. 
 SDH His-SDH 
No. of amino acids 373 394 
molecular weight 41464.8 43985.4 









II.3.3 Substrate Binding by Isothermal Titration Calorimetry 
The binding of substrates to SDH was examined by ITC, which allows an 
estimation of the equilibrium binding constant, enthalpy, and stoichiometry of binding if 
there is sufficient heat of binding. The ΔG of binding may be calculated using eq II.2, and 
the entropy of binding may be calculated using eq II.3. 
 
KRTG ln                                                                                                           (II.2) 
 STHG                                                                                                       (II.3) 
 
where R is the gas constant, T is the temperature, and K is the association constant. 
Binding of NADH to SDH was detected by ITC, suggesting the existence of 
E:NADH complex. These data consistent with kinetic data, which indicate ordered 
binging of NADH prior to lysine and α-Kg (Discussion 4.1.1).The binding isotherm and 
the fitted data for binding of NADH to SDH is shown in Fig. II.3, A. The NADH titration 
was repeated twice with similar results. The data were fitted best to a model that specifies 
one set of sites, giving a stoichiometry (N) of 0.97, which refers to binding of one mole of 
ligand per mole of enzyme monomer. The obtained dissociation constant of NADH to 
SDH is 50 µM, in a good agreement with the kinetic value of 18 µM, determined from 
systematic initial velocity studies (Discussion 4.1.4). The fit also gave a ΔHº of -11.2 
kcal/mol, and the free energy and entropy associated with the binding of NADH are -23.8 




, respectively. The errors on the fitted parameters mentioned 
above are all less than 10%. 
Attempts to titrate SDH with α-Kg and NAD, respectively, gave no evidence of 
direct binding of these two substrates to SDH. A titration of enzyme with α-Kg in the 
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presence of saturating NADH, i.e. E:NADH gave no evidence of binding of α-Kg. The 
negative results may due to the high dissociation constants of substrate to enzyme. 





Figure II.3: Titrations of SDH with substrates. (A) Titration of SDH with NADH. The 
cell contained 0.12 mM SDH monomer in 100 mM Tris at pH 7.5. The syringe contained 
7 mM NADH in the same buffer. (B) Titration of SDH with α-Kg. The cell contained 
0.12 mM SDH monomer in 100 mM Tris at pH 7.5. The syringe contained 15 mM α-Kg 
in the same buffer. (C) Titration of SDH with NAD. The cell contained 0.12 mM SDH 
monomer in 100 mM Tris at pH 7.5. The syringe contained 7 mM NAD in the same 
buffer.(D) Titration of SDH:NADH complex with α-Kg. The cell contained 0.12 mM 
SDH monomer and 7 mM NADH in 100 mM Tris at pH 7.5. The syringe contained 7 
mM NADH and 15 mM α-Kg in the same buffer. In all experiments, a total of 21 
injections were made at 240 s intervals. Top panels are raw ITC data, while the bottom 
panels are data after the subtraction of the control titration and peak integration. The solid 
line is the fit to a one-site binding model. 
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II.3.4 Substrate Binding by Fluorescence Titration 
The emission spectra of SDH did not change much, if at all, when either NADH, 
α-Kg, or NAD was added into SDH solution with a concentration of their respective 
reported Km values (1), Fig. II.4 A-C. However, when concentration was increased about 
10 times their respective Km, a significant decrease in fluorescence signal at 335 nm was 
observed. In the case of lysine, signal did not change much at both limiting and saturating 
levels, Fig. II.4D. Since α-Kg and lysine do not absorb much at 298 nm, and the 
absorbance of 0.2 mM NADH and 2 mM NAD at 298 nm are 0.57 and 0.76, respectively, 
there is no significant interfilter effect in the fluorescence studies. Therefore, the decrease 
of fluorescence signal at 335 nm when the concentration of NADH, α-Kg, and NAD was 
increased, most likely due to a change on local environment around Trp residues as these 
substrates were added into enzyme solution. There are 5 Trps present in the primary 
amino acid sequence. Based on the apo-structure of SDH (unpublished data), Trp 104 is 
located on the top of the active site (a loop region) and solvent accessible. Trp 226 and 
Trp 353 are located on the surface of SDH and away from the active site, with the former 
in the nucleotide binding domain, and the latter in the catalytic domain. In addition, both 
Trp64 and Trp 151 are buried and away from the active site. Structural data suggest that 
Trp 104 might contribute the majority of the fluorescence signals, and Trp 226 and Trp 
353 may also contribute due to the enzyme conformational change as substrate binds to 
the active site. 
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II.3.5 Secondary Structure Determination of SDH by Circular Dichroism 
A sensitive physical method for estimating the secondary structural element of 
proteins is circular dichroism spectroscopy at wavelengths near the absorption band of 





Figure II.4: Fluorescence emission spectra of SDH. Spectra were recorded with 360 
μg/mL SDH in 100 mM Tris at pH 7.0, and corrected by subtracting blanks. (A) SDH 
only (red), SDH with 10 μM NADH (green), SDH with 0.2 mM NADH (blue) (B) SDH 
only (red), SDH with 50 μM NAD (green), SDH with 2 mM NAD (blue) (C) SDH only 
(red), SDH with 0.2 mM α-Kg (green), SDH with 5 mM α-Kg (blue) (D) SDH only (red), 
SDH with 1 mM lysine (green), SDH with 20 mM lysine (blue). 
 
 
Because of the high dynode voltage at wavelengths below 210 nm, Hepes buffer was not 
used for CD studies. The CD spectrum of the His-tagged SDH was recorded in 20 mM 
KH2PO4 at pH 7.0 (Fig. II.5). As shown, the spectrum shows a strong negative ellipticity 
at 208 and 222 nm, suggesting both α-helical and β-sheet secondary structural 




band is lower than that of 222 nm (127). The mean residue ellipticity [θ] was calculated 







                                                                                                                (II.4) 
 
where [θ] is the molar ellipticity in degrees centimeter squared per decimole,   is the 
measured ellipticity angle recorded by the instrument in milidegrees at wavelength λ, the 
mean residue weight (MRW) is 111 from amino acid analysis, l is the optical path length 
of the cell in cm, c is the concentration of protein in mg/mL. The calculated [θ]208nm and 






Figure II.5: Far-UV circular dichroism spectrum of SDH. Spectrum was recorded with 50 
μg/mL SDH in 20 mM KH2PO4 at pH 7.0, and corrected by subtracting blank. 
 
Based on [θ]222nm, percentage of α-helix of SDH has been estimated to be 19% 
using eq II.5 (128): 
 
   39000/3000222  nmhelixfraction                                                            (II.5) 
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However, results of secondary structure prediction using the PhD program from 
PredictProtein Server of EMBL-Heidelberg, Germany, suggests that SDH contains 36% 
α-helix, 17% β-sheet, and 47% coil structure, while the His-tagged SDH contains 37% α-
helix, 16% β-sheet, and 47% coil structure. The precise information on secondary 
structure awaits the structural analysis of three dimensional structure of SDH. 
138 
APPENDIX III 
Crystallization of SDH 
III.1 INTRODUCTION 
Structure is a powerful tool to study the mechanisms of enzymes. With a detailed 
three-dimensional structure in hand, SDH can be studied at a deeper level. Functions of 
different domains can be defined through the domain or motif search from the Protein 
Data Bank once SDH structure is obtained. It is also possible that a conformational 
change of SDH may occur upon substrate binding. Therefore, by comparing the crystal 
structures of apo and ligand-bound SDH, the substrate binding site(s) and/or enzyme 
active site can be defined. Furthermore, the structure will give a clue to which amino acid 
residues may be selected to perform site-directed mutagenesis to test the proposed 
chemical mechanism. 
The first step and the first bottle-neck to solve SDH structures by X-ray 
crystallography is to obtain SDH crystals. The hanging drop vapor diffusion technique 
and the commercial sparse matrix screen from Hampton Research are commonly used to 
initiate protein crystallization trials. Once conditions are optimized and cryo-conditions 
are worked out, X-ray diffraction data can be collected and processed via either an in-
house source or at the synchrotron. This chapter describes the crystallization of SDH, and 
preliminary X-ray diffraction analysis. 
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III.2 MATERIALS AND METHODS 
III.2.1 Protein Sample Preparation 
The purified SDH in 100 mM Hepes at pH 7.0 and 300 mM imidazole was 
dialyzed against 100 mM Tris at pH 7.0, and then concentrated to about 10 mg/mL using 
an Amicon ultrafiltration device with a YM 10 membrane. Purified SDH was judged to 
be monomeric in solution based on HPLC. The protein concentration was determined by 





sample was filter sterilized before crystallization trials. 
III.2.2 Protein Crystallization 
All crystallization experiments were performed at 4 ºC and 25 ºC using the 
hanging drop vapor diffusion method (129). Equal volumes (2 μL) of the reservoir and 
protein solution were mixed to form drops on the cover slides. The Hampton Research 
Crystal Screens I & II, designed using the sparse-matrix screening technique (130), were 
used to identify initial crystallization conditions. In order to obtain more preliminary 
crystallization conditions of SDH, the purified protein sample was shipped to the 
Hauptman-Woodward Institute (HWI) for screening of their 1536 conditions using the 
microbatch method under paraffin oil. 
III.2.3 Characterization of Crystals 
Crystals were soaked in a cryoprotectant solution containing mother liquor with 
15 % glycerol for 5-10 min prior to mounting in a 100 K (Oxford Series 700 cryosystem) 
nitrogen stream. Diffraction data were collected at the Cu Kα wavelength (1.5418 Å) 
using a Rigaku/MSC RU-H3R rotating-anode X-ray generator operated at 50 kV/100 mA 
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with a R-Axis IV
++
 image-plate detector. The crystal to detector distances were set at 100 
or 120 mm, and data were collected using an oscillation angle of 0.5° or 1°. The exposure 
times were set to 4 min per image. Diffraction data were indexed, integrated and scaled 
using the d*TREK® data processing package (version 9.2D) (131). 
III.2.4 Ellman (DTNB) Assay 
In order to estimate the number of accessible thiols in SDH, the enzyme was 
treated with 5,5’-dithiobis (2-nitrobenzoate) (DTNB). The product of TNB was 
monitored at 412 nm. Purified SDH was dialyzed against a solution containing 100 mM 
K2HPO4 at pH 7.3 and 1 mM EDTA. The DTNB stock solution (3 mM) was made up in 
100 mM K2HPO4 buffer at pH 7.3. Spectra were recorded on a Beckman DU 640 UV/vis 
spectrophotometer, and blanked with the dialysis buffer. Temperature was maintained at 
25 ºC using a Beckman temperature controller. Reactions were carried out in cuvettes 
with a path length of 1 cm in a final volume of 1 mL containing SDH with a 
concentration greater than 2 μM. The increase of the absorbance at 412 nm was 
monitored immediately after 50 μL of 3 mM DTNB was added into the 1 mL protein 
sample, followed by through mixing. From the increase in absorbance, the number of 





III.3 RESULTS AND DISCUSSION 
III.3.1 Ellman (DTNB) Assay 
The concentration of SDH used for DTNB assay was determined to be 13 μM by 
both the Bradford assay and UV absorbance at 280 nm. The absorbance was increased 
about 0.2386 once DTNB was added into the SDH protein sample, resulting in a 
141 
calculation of 16.9 μM thiol accessible. The ratio of the thiol and enzyme concentrations 
gave a value of 1.35, suggesting that one cysteine of SDH out of total four is accessible to 
solvent, which is most likely Cys 364. Based on the apo-structure of SDH (unpublished 
data), Cys 364 is sitting on the surface of SDH, located on an α-helix of the catalytic 
domain, away from the central cavity. In addition, structural data suggest that Cys 205 
forms a disulfide bond with Cys 249 in the nucleotide binding domain, inconsistent with 
previously reported result (93). 
III.3.2 Protein Crystallization 
Several conditions from Hampton Research Crystal Screen I and II resulted in 
crystals of various size, morphology, and quantity (Hampton Screen I Formulations 6, 9, 
15, 17, 28, 31, and 39, and Hampton Screen II Formulations 13, 14, 23, 26, and 42). 
Polyethylene glycol (PEG) or PEG monomethyl ether (PEGMME) in the molecular 
weight range 2000-8000, and ammonium sulfate were used as precipitant for the positive 
conditions. Crystals were observed over a wide pH range (4.6-8.5), at both 4 °C and 
25 °C. In the case of the HWI screening, about 30 promising conditions were found. PEG 
in the M.W. range 4000-20000 was common to all of the positive conditions. Crystals 
were also observed over a wide pH range (4.0-10.0). A number of different salts, e.g., 
KCl, NH4Br, NH4Cl, (NH4)2SO4, KH2PO4, NH4SCN, LiBr, KNO3, and RbCl, can be 
used as a additive at a concentration of 100 mM. 
Optimization studies using PEG of different molecular weights and ammonium 
sulfate at different concentrations, variation of the protein concentration, and inclusion of 
different salt additives at different concentrations in the crystallization setup, resulted in 
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the growth of four crystal forms of SDH, Table III.1. Data collection and processing 
statistics for the different crystal forms are summarized in Table III.2. 
 
Table III.1: Summary of Crystallization Conditions. 












4.5 4.0 3.8 5.0 
Additive 
0.2 M ammonium 
sulfate 
-- 
0.2 M ammonium 
sulfate 
2% (w/v) PEG 400 
pH 
0.1 M Tris 
pH 7.0 
0.1 M Tris 
pH 7.0 
0.1 M Tris 
pH 7.0 
0.1 M Tris 
pH 7.0 
Average Size (0.29*0.35*0.05) mm (0.13*0.13*0.13) mm (0.08*0.08*0.04) mm (0.2*0.1*0.02) mm 
 
 
Table III.2: Data-collection and Processing Statistics for SDH Crystals. 
 Form I Form II Form III Form IV 
Bravais Lattice 











a=112.4, b=55.1, c=74.8 
α=90º, β=116.5º, γ=90º 
a=112.6, b=55.0,c=75.0 
α=90º, β=116.3º, γ=90º 
a=65.0, b=75.0, c=74.5 
α=90º, β=90º, γ=90º 
a=112.6, b=55.0, =74.9 
α=90º, β=116.5º, γ=90º 
Resolution (Å) 1.7 1.8 1.9 2.0 
Mean I/ζ (I) 27.6 (4.0) 11.0 (2.4) 12.7 (2.5) 5.0 (2.1) 
No. of 
observations 
372012 226400 248475 136510 
Unique 
reflections 
53040 41240 60660 27436 
Completeness 
(%) 
98.6 (98.2) 99.1 (100.0) 99.0 (98.0) 99.2 (97.9) 
Rmerge 0.05 (0.36) 0.10 (0.45) 0.07 (0.32) 0.11 (0.27) 
Mosaicity 
(degree) 
0.96 0.825 0.93 1.08 
Molecules in 
asymmetric unit 




2.4 -- 2.1 -- 
Solvent content 
(%) 
48.3 -- 40.4 -- 
Values for the outer resolution shell of data are given in parentheses. 
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Crystal Form I was grown with a 4.5 mg/mL protein stock solution and reservoir 
consisting of 0.2 M ammonium sulfate, 0.1 M Tris pH 7.0, 26% (w/v) PEGMME 2000. 
These crystals displayed a diamond-like morphology, Fig. III.1 (a), and diffracted to 1.7 
Å resolution when data were collected using a Cu rotating anode X-ray diffraction system. 
Autoindexing calculations performed with d*TREK (131) indicated a centered monoclinic 
lattice with unit cell dimensions a =112.4, b =55.1, c =74.8. Analysis of the solvent 
content using the method of Matthews (132) suggested the presence of only one SDH 
molecule per asymmetric unit and a solvent content of 48.3%. Clearly, form I is optimal 
for high-resolution structure determination due to its high diffraction quality. 
Crystal Form II was obtained using a protein stock solution of 4.6 mg/mL. The 
optimal reservoir condition was 26% (w/v) PEG 4000, 0.1 M ammonium sulfate, and 0.1 
M Tris at pH 7.0. These crystals grew within a week after setup and took the cubic form 
with an average size of (0.13*0.13*0.13) mm, Fig. III.1 (b). Diffraction to 1.8 resolution 
was observed, and autoindexing suggested a centered monoclinic lattice with unit cell 
dimensions a =112.6, b =55.0, c =75.0. 
Crystal Form III grew in the presence of 3.8 mg/mL SDH, 22% (w/v) PEG 8000, 
and 0.1 M Tris at pH 7.0. Form III crystals have space group P212121 with unit cell 
dimensions a =112.6, b =55.0, c =75.0. The asymmetric unit contains two SDH 
molecules, with a Matthews coefficient of 2.1 and a solvent content of 40.4%. These 
crystals are relatively small compared to the other form crystals, but, diffracted to 1.9 Å. 
Crystal Form IV was obtained when ammonium sulfate was used as precipitant, 
instead of PEG. The optimal reservoir condition was 2.4 M ammonium sulfate, 2% (w/v) 
PEG 400, and 0.1 M Tris at pH 7.0. Crystals exhibited a triangular plate-like morphology, 
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Fig. III.1 (d), and grew very slow. They originally grew as thin plates with very poor 
diffraction quality, but eventually reached an average size of (0.2*0.1*0.02) mm in about 
1 month. Although they had a thin edge, these crystals still diffracted to 2.0 Å. 
 
 
Figure III.1: Four crystal forms of SDH. Forms I, II, III, and IV are shown in panels (a), 
(b), (c), and (d), respectively. The bar in each figure represents approximately 100 μm. 
 
With these native diffraction datasets, we reached a good starting point to 
elucidate the 3D structure of SDH. However, there is still a second bottle neck, the phase 
problem, which needs to be solved in order to determine the structure of SDH. Molecular 
replacement is often employed to solve the phase problem by borrowing the phase angles 
from a homologous model. However, if a suitable candidate is not available, two 
alternative methods, multiple isomorphous replacement (MIR) and multiple anomalous 
dispersion (MAD), can be considered. Once the intensity, position, and phase information 
of all reflections have been obtained, an initial electron density map can be calculated. A 
model can then be built by fitting the primary amino acid sequence into the electron 
density map. After model refinement and structure validation, the three dimensional 






Cloning and Expression of PIPOX 
IV. 1 INTRODUCTION 
The substrate for SDH in the direction of lysine formation is saccharopine. 
Because the cost of commercial saccharopine is very high, it can be synthesized 
enzymatically from L-pipecolic acid according to Fig. IV.1. The pathway for L-pipecolic 
acid oxidation is found in Rhodotorula glutinis (133), and also as part of the lysine 
degradative pathway in monkeys and humans (134). L-pipecolic acid is first oxidized by 
L-pipecolic acid oxidase (PIPOX), an H2O2-forming peroxisomal oxidase containing 
covalently bound FAD, to ∆
1
–piperidine-6-carboxylic acid, a cyclic imine that 
spontaneously hydrolyzes to form α-aminoadipic acid semialdehyde (AAS) at 
physiologic pH. The semialdehyde can then be converted to saccharopine by 














































Figure IV.1: Enzymatic synthesis of saccharopine 
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IV. 2 MATERIALS AND METHODS 
IV.2.1 Molecular Cloning of PIPOX 
A 1187 bp DNA fragment encoding PIPOX was successfully amplified by PCR 
reaction with a human cDNA ligated into a pOTB7 plasmid as the template using the 
following protocol: one cycle of initial denaturation at 94 °C for 2 min, followed by 35 
cycles of denaturation at 94 °C for 30 s, annealing at 45 °C for 45 s, and extension at 
72 °C for 1.5 min. The enzyme used was Platinum Pfx polymerase, which produces 
blunt-end PCR products. The forward primer was designed as 
AAACATATGGCGGCTCAGAAAGATCTCTGG, while the reverse primer was 
designed as TTTCTCGAGTCAAAGGTGGGCTTTGCCCAGG. The purified PCR 
product (PIPOX DNA) was then ligated into linearized pUC12 vector which was digested 
with SmaI to create blunt-end and was gel-purified. E. coli DH5α cells were transformed 
with the recombinant plasmid, and positive colonies were verified by the X-gal and IPTG 
colony screening protocol. 
For subcloning into an expression vector, a procedure similar to that for the Lys1 
(SDH gene) was used (Materials and Methods 2.2). The PIPOX gene was excised from 
the recombinant plasmid described above with two NdeI/XhoI restriction endonucleases. 
The purified fragment containing the PIPOX gene was subcloned using T4 ligase into the 
pET16b expression vector, which was previously treated by NdeI/XhoI. E. coli 
BL21(DE3) RIL cells were then transformed, single colonies were grown on LB/Amp 
medium. The new plasmid was designated pipoxHX2, and restriction endonuclease 
mapping was performed to confirm the presence of the PIPOX gene. 
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The pipoxHX2 plasmid-containing strain was grown at 37 °C in LB supplemented 
with 100 μg/mL amplicillin and 25 μg/mL chloramphenicol. Induction with 2 mM IPTG 
(final concentration) was accomplished once the OD600 reached 0.8. Cell growth was then 
continued at 30 ºC overnight. After centrifugation, the harvested cells were suspended in 
100 mM KCl and 50 mM Hepes at pH 8.0, containing the following protease inhibitors: 
1mM EDTA, 0.1 mM benzamidine, 0.4 μg/mL leupeptin, and 0.7 μg/mL pepstain. Cells 
were sonicated on ice for 1.5 minutes with a 15 s pulse followed by a 30 s rest, using a 
MISONIX Sonicator XL. After the cell debris was removed by centrifugation at 12000g 
for 15 min, the collected supernatant was mixed with the Ni-NTA resin at 4 ºC, washed 
with 5 mM imidazole at pH 7.5, and then eluted with buffer containing 30 mM imidazole 
at pH 7.5. The PIPOX-containing sample, identified by SDS-PAGE, was concentrated 
and dialyzed against 100 mM K2HPO4 in D2O using an Amicon ultrafiltration device 
with a YM 10 membrane. 
IV.2.2 PIPOX Reaction Monitored by NMR 
Since L-pipecolic acid, ∆
1
–piperidein-6-carboxylic acid (the cyclic form), and 
AAS (the linear form) have different structures, 
1
H NMR spectra were used to follow the 
PIPOX reaction. The chemical shifts for protons were predicted using the ChemDraw 
program, Fig. IV.2 A. 
Solution in D2O of 30 mM L-pipecolic acid and 100 mM K2HPO4 buffer was 
prepared, and adjusted to pD 8.4 using either DCl or NaOD. Experiments were performed 
on a Varian Mercury VX-300 MHz spectrometer with a Varian four-nucleus 
autoswitchable PFG probe, and spectra were collected using the PRESAT pulse sequence 
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supplied by Varian, Inc. The spectra were collected with a sweep width of 4803.1 Hz, 
152 repetitions, and an acquisition time of 1.998 s. 
IV. 3 RESULTS AND DISCUSSION 
A chemical shift at 9.95 ppm was observed after PIPOX was added into L-
pipecolic acid solution, Fig. IV.2 B. This peak corresponded to the C(6)-H of the 
semialdehyde, indicating the production of aldehyde. However, the same peak 
disappeared after the reaction mixture was allowed to sit overnight, suggesting the 
production of 2-amino-6,6-dihydroxy-hexanoic acid and the unstability of AAS. The 
production of AAS was recorded according to the chemical shift of aldehyde at 9.95 ppm 
over a time period of 20 min in the presence of PIPOX, Fig. IV.2 C. The area of the peak 
reached a maximum in 5 min after PIPOX was added. In order to examine whether the 
AAS produced can serve as a substrate for SR, 100 μL of freshly made L-pipecolic acid 
and PIPOX mixture was added into a reaction mixture containing 100 mM Hepes at pH 
6.8, 0.2 mM NADPH, 10 mM L-glutamate, and 0.27 μM SR. The observed 
disappearance of absorbance at 340 nm (NADPH) suggested that AAS produced by 












H NMR spectra of PIPOX reaction. (A) Predicted NMR chemical shifts for 
L-pipecolic acid (a), ∆
1
–piperidein-6-carboxylic acid (b), α-aminoadipic acid 
semialdehyde (c), and 2-amino-6,6-dihydroxy-hexanoic acid (d), respectively. Estimation 
quality: blue = good, magenta = medium, and red = rough. (B) Appearance of the 
chemical shift at 9.95 ppm after PIPOX was added into L-pipecolic acid solution. (a) is 
the spectrum one hour after PIPOX was added., while (b) is the spectrum obtained after 
adding PIPOX at time zero. (C) the time course of PIPOX reaction by monitoring the 
area of the chemical shift of aldehyde at 9.95 ppm. Numbers at the right side are time in 
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